Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
122227 1346 27 None -97 3 Rat 7.1 pEC50 = 7.1 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL None None None None 10.1016/S0960-894X(97)10042-7
3825 1346 27 None -97 3 Rat 7.1 pEC50 = 7.1 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL None None None None 10.1016/S0960-894X(97)10042-7
644 1346 27 None -97 3 Rat 7.1 pEC50 = 7.1 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL None None None None 10.1016/S0960-894X(97)10042-7
CHEMBL264100 1346 27 None -97 3 Rat 7.1 pEC50 = 7.1 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL None None None None 10.1016/S0960-894X(97)10042-7
44323260 106519 0 None - 1 Rat 6.0 pEC50 = 6.0 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL 845 32 10 10 0.7 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O 10.1016/S0960-894X(97)10042-7
CHEMBL315388 106519 0 None - 1 Rat 6.0 pEC50 = 6.0 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL 845 32 10 10 0.7 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O 10.1016/S0960-894X(97)10042-7
11757682 121513 0 None - 1 Human 10.4 pIC50 = 10.4 Functional
Antagonist activity against human Bradykinin receptor B1 was determined in a fluorescence imaging plate reader assayAntagonist activity against human Bradykinin receptor B1 was determined in a fluorescence imaging plate reader assay
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 121513 0 None - 1 Human 10.4 pIC50 = 10.4 Functional
Antagonist activity against human Bradykinin receptor B1 was determined in a fluorescence imaging plate reader assayAntagonist activity against human Bradykinin receptor B1 was determined in a fluorescence imaging plate reader assay
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11214480 148635 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 514 7 4 5 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccc(CCC3=NCCN3)cc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL394370 148635 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 514 7 4 5 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccc(CCC3=NCCN3)cc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
57397292 69701 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 522 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939758 69701 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 522 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
54772237 65437 0 None 6 2 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
CHEMBL1834752 65437 0 None 6 2 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
60142570 125381 0 None - 1 Human 10.0 pIC50 = 10 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)CC2)no1 nan
CHEMBL3648475 125381 0 None - 1 Human 10.0 pIC50 = 10 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)CC2)no1 nan
60142706 125386 0 None - 1 Human 10.0 pIC50 = 10 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 551 7 2 8 4.6 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
CHEMBL3648480 125386 0 None - 1 Human 10.0 pIC50 = 10 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 551 7 2 8 4.6 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
11570120 69698 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 536 7 2 5 3.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939755 69698 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 536 7 2 5 3.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
24970287 187829 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 574 7 2 6 4.2 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL502140 187829 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 574 7 2 6 4.2 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
46230121 200449 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 9 3.3 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL609157 200449 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 9 3.3 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
46230161 199725 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 561 7 2 10 3.3 CCN(NC(=O)c1cc(OC)no1)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL604735 199725 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 561 7 2 10 3.3 CCN(NC(=O)c1cc(OC)no1)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
54582655 61852 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 552 7 2 5 3.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCC(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777969 61852 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 552 7 2 5 3.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCC(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44587189 171865 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.055
CHEMBL447870 171865 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.055
56594769 65380 0 None 6 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834619 65380 0 None 6 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
665 957 2 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
9916412 957 2 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
CHEMBL189123 957 2 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
665 957 2 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
9916412 957 2 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
CHEMBL189123 957 2 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
46216675 198915 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 513 5 2 7 4.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCC(F)(F)CC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL599285 198915 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 513 5 2 7 4.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCC(F)(F)CC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
46230160 198887 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 547 7 2 10 2.7 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL599153 198887 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 547 7 2 10 2.7 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
11387387 61850 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777967 61850 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
57523216 125382 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 562 7 2 8 4.4 COc1ncc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
CHEMBL3648476 125382 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 562 7 2 8 4.4 COc1ncc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
60142962 125394 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)on1 nan
CHEMBL3648488 125394 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)on1 nan
60142963 125395 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125395 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
60143095 125396 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)cn1 nan
CHEMBL3648490 125396 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)cn1 nan
60141038 125400 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 564 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
CHEMBL3648494 125400 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 564 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
60141185 125408 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 10 2.6 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)cn1 nan
CHEMBL3648502 125408 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 10 2.6 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)cn1 nan
60141464 125414 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 9 3.4 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3cncnc3)CC2)n1 nan
CHEMBL3648508 125414 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 9 3.4 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3cncnc3)CC2)n1 nan
60141466 125416 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 10 3.6 COc1cc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)on1 nan
CHEMBL3648510 125416 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 10 3.6 COc1cc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)on1 nan
57398978 69700 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 496 7 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939757 69700 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 496 7 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
53248885 61841 0 None 18 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777958 61841 0 None 18 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
53248885 61841 0 None 18 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1777958 61841 0 None 18 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
57396447 69746 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 488 5 2 5 2.2 CN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
CHEMBL1939944 69746 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 488 5 2 5 2.2 CN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
57400696 69702 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 508 8 3 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939759 69702 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 508 8 3 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
57392941 69741 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 488 6 2 5 2.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CCCC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939939 69741 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 488 6 2 5 2.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CCCC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
11442712 84788 0 None 9 2 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225607 84788 0 None 9 2 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
46230120 197520 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 547 7 2 9 3.9 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL589820 197520 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 547 7 2 9 3.9 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
46230203 198955 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 532 5 2 7 3.6 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL599574 198955 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 532 5 2 7 3.6 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
57395448 69699 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 6 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939756 69699 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 6 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
57398238 69743 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 5 3 5 1.8 CC1(C)CNCC[C@@H]1NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939941 69743 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 5 3 5 1.8 CC1(C)CNCC[C@@H]1NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2011.11.112
57391173 69745 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 2 5 2.2 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C)CC2(C)C)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939943 69745 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 2 5 2.2 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C)CC2(C)C)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
46230404 198665 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 492 6 2 7 5.2 CC(=O)Nn1c(Cl)cnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
CHEMBL597747 198665 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 492 6 2 7 5.2 CC(=O)Nn1c(Cl)cnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
56589598 65436 0 None 7 2 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
CHEMBL1834751 65436 0 None 7 2 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
11214819 61833 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777885 61833 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
60142704 125384 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 521 6 2 7 4.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
CHEMBL3648478 125384 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 521 6 2 7 4.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
60143096 125397 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 8 4.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
CHEMBL3648491 125397 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 8 4.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
60141324 125411 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 10 2.8 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
CHEMBL3648505 125411 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 10 2.8 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
57401664 69744 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 5 3 5 1.8 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCNCC2(C)C)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939942 69744 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 5 3 5 1.8 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCNCC2(C)C)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
11342704 61839 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 642 7 2 6 4.2 O=C(CC1C(=O)NCCN1S(=O)(=O)c1sc(Cl)cc1Br)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777956 61839 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 642 7 2 6 4.2 O=C(CC1C(=O)NCCN1S(=O)(=O)c1sc(Cl)cc1Br)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54586519 61860 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 9 3 5 2.6 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777977 61860 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 9 3 5 2.6 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44587188 192758 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 562 7 3 6 4.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.055
CHEMBL525092 192758 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 562 7 3 6 4.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.055
54583617 61851 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 7 2 6 2.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777968 61851 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 7 2 6 2.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
57390218 69703 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 538 8 3 5 3.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939760 69703 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 538 8 3 5 3.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
16108961 908 0 None 2 3 Human 9.4 pIC50 = 9.4 Functional
Antagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 908 0 None 2 3 Human 9.4 pIC50 = 9.4 Functional
Antagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 908 0 None 2 3 Human 9.4 pIC50 = 9.4 Functional
Antagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
60142703 125383 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648477 125383 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
60141041 125402 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 548 6 2 8 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)COC2)no1 nan
CHEMBL3648496 125402 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 548 6 2 8 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)COC2)no1 nan
60141182 125405 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 567 7 2 9 3.8 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
CHEMBL3648499 125405 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 567 7 2 9 3.8 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
71229238 125409 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 9 2.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
CHEMBL3648503 125409 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 9 2.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
60141323 125410 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
CHEMBL3648504 125410 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
57392940 69733 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 434 5 2 5 1.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939931 69733 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 434 5 2 5 1.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
46230119 197519 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 8 4.5 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL589819 197519 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 8 4.5 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
54581635 61834 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 554 8 2 6 2.8 COc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777886 61834 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 554 8 2 6 2.8 COc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
53360054 69731 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 420 5 3 5 0.9 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCNCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939929 69731 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 420 5 3 5 0.9 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCNCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
16747694 87511 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity in human bradykinin B1 receptor by FLIPR methodAntagonist activity in human bradykinin B1 receptor by FLIPR method
ChEMBL 469 6 2 6 5.4 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)c2ccno2)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234097 87511 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity in human bradykinin B1 receptor by FLIPR methodAntagonist activity in human bradykinin B1 receptor by FLIPR method
ChEMBL 469 6 2 6 5.4 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)c2ccno2)CC1 10.1016/j.bmcl.2007.03.059
46230163 198716 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 532 5 2 6 4.7 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL598124 198716 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 532 5 2 6 4.7 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
11364466 61829 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 7 2 5 2.7 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777881 61829 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 7 2 5 2.7 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11341479 61861 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 526 9 3 5 2.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777978 61861 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 526 9 3 5 2.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44587186 172139 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 642 7 2 6 5.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL450541 172139 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 642 7 2 6 5.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
54587514 61831 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777883 61831 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
46230990 198946 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 473 7 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C(CF)CF)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL599490 198946 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 473 7 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C(CF)CF)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
60142303 125368 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 6 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648462 125368 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 6 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60142304 125369 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 7 3.0 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648463 125369 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 7 3.0 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142437 125372 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648466 125372 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60142440 125374 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 6 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648468 125374 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 6 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142834 125389 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 580 7 2 8 4.5 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)cn1 nan
CHEMBL3648483 125389 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 580 7 2 8 4.5 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)cn1 nan
60142836 125391 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 8 4.7 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)on1 nan
CHEMBL3648485 125391 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 8 4.7 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)on1 nan
60141465 125415 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 539 6 2 9 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
CHEMBL3648509 125415 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 539 6 2 9 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
57398235 69735 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 462 7 2 5 2.0 CCCN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
CHEMBL1939933 69735 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 462 7 2 5 2.0 CCCN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
11168954 61830 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777882 61830 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
44587187 188115 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL504531 188115 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
44587187 188115 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL504531 188115 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
46216847 198746 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 559 8 2 11 5.4 COc1cc(C(=O)Nc2nsnc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
CHEMBL598349 198746 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 559 8 2 11 5.4 COc1cc(C(=O)Nc2nsnc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
54581667 61858 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 8 3 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777975 61858 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 8 3 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
60142028 125360 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648455 125360 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60142438 125373 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648467 125373 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60142835 125390 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 7 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648484 125390 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 7 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
60142963 125395 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125395 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
54772237 65437 0 None -6 2 Rabbit 9.2 pIC50 = 9.2 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
CHEMBL1834752 65437 0 None -6 2 Rabbit 9.2 pIC50 = 9.2 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
57396446 69734 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 448 6 2 5 1.6 CCN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
CHEMBL1939932 69734 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 448 6 2 5 1.6 CCN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
46230202 198568 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 548 5 2 7 4.1 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL597115 198568 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 548 5 2 7 4.1 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
54581634 61832 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777884 61832 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
10239095 83487 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
CHEMBL220657 83487 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
57398237 69742 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 5 3 5 1.8 CC1(C)CNCC[C@@H]1NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2011.11.112
CHEMBL1939940 69742 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 5 3 5 1.8 CC1(C)CNCC[C@@H]1NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2011.11.112
46230309 197786 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 591 8 2 10 6.0 COc1cc(C(=O)Nn2c(NCc3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)nc3ccccc32)on1 10.1016/j.bmcl.2009.11.120
CHEMBL591676 197786 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 591 8 2 10 6.0 COc1cc(C(=O)Nn2c(NCc3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)nc3ccccc32)on1 10.1016/j.bmcl.2009.11.120
57398236 69740 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 6 2 5 2.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CCC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939938 69740 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 6 2 5 2.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CCC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
11477390 84723 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1nc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)no1 10.1021/jm049394l
CHEMBL225218 84723 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1nc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)no1 10.1021/jm049394l
46230941 199567 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 463 5 2 7 3.7 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCCC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL603907 199567 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 463 5 2 7 3.7 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCCC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
54587552 61849 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 7 2 5 2.7 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777966 61849 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 7 2 5 2.7 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
16221282 85098 0 None 13 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL227713 85098 0 None 13 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
44587181 188082 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 588 7 3 6 4.3 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL503847 188082 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 588 7 3 6 4.3 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
16221282 85098 0 None 13 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL227713 85098 0 None 13 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
25105469 186468 6 None 2 2 Rat 9.1 pIC50 = 9.1 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 467 8 3 7 2.6 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc(C2=NCCN2)nc1 10.1016/j.bmcl.2008.08.014
CHEMBL491198 186468 6 None 2 2 Rat 9.1 pIC50 = 9.1 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 467 8 3 7 2.6 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc(C2=NCCN2)nc1 10.1016/j.bmcl.2008.08.014
60142567 125378 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 7 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648472 125378 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 7 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
11386138 84006 0 None 8 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL221998 84006 0 None 8 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
44587183 172645 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 616 8 3 6 5.0 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL452331 172645 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 616 8 3 6 5.0 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
57403391 69736 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 476 7 2 5 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(CC(C)C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939934 69736 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 476 7 2 5 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(CC(C)C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
10217706 82798 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 494 6 2 5 4.4 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1021/jm061094b
CHEMBL218605 82798 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 494 6 2 5 4.4 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1021/jm061094b
11363856 84100 0 None 13 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
CHEMBL222038 84100 0 None 13 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
11215488 61837 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777954 61837 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
46230067 197797 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 541 5 2 4 4.8 CCN(NC(=O)c1cc(F)cc(C(F)(F)F)c1)C(=O)N[C@H](C)c1ncc(C(=O)N2[C@@H](C)CC[C@H]2C)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL591742 197797 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 541 5 2 4 4.8 CCN(NC(=O)c1cc(F)cc(C(F)(F)F)c1)C(=O)N[C@H](C)c1ncc(C(=O)N2[C@@H](C)CC[C@H]2C)cc1F 10.1016/j.bmcl.2009.11.119
46230939 198588 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 437 5 2 7 3.2 CC(C)N(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
CHEMBL597235 198588 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 437 5 2 7 3.2 CC(C)N(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
46216846 199534 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 543 8 2 11 4.9 COc1cc(C(=O)Nc2nonc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
CHEMBL603668 199534 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 543 8 2 11 4.9 COc1cc(C(=O)Nc2nonc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
56594642 65377 0 None 21 2 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834616 65377 0 None 21 2 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
44587182 188095 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 602 7 2 6 4.6 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL504119 188095 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 602 7 2 6 4.6 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
57394684 69738 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 510 7 2 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(Cc3ccccc3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939936 69738 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 510 7 2 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(Cc3ccccc3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
56594772 65435 0 None 15 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834750 65435 0 None 15 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
56594769 65380 0 None -6 2 Rabbit 9.0 pIC50 = 9.0 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834619 65380 0 None -6 2 Rabbit 9.0 pIC50 = 9.0 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
57394685 69739 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 6 2 5 1.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939937 69739 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 6 2 5 1.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
44430696 87510 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity in human bradykinin B1 receptor by FLIPR methodAntagonist activity in human bradykinin B1 receptor by FLIPR method
ChEMBL 484 6 2 4 6.1 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234096 87510 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity in human bradykinin B1 receptor by FLIPR methodAntagonist activity in human bradykinin B1 receptor by FLIPR method
ChEMBL 484 6 2 4 6.1 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
11225601 141483 0 None 3 2 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
CHEMBL387638 141483 0 None 3 2 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
46230833 197573 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 423 4 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL590150 197573 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 423 4 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
54580628 61827 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777879 61827 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11272685 61854 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 7 2 6 1.9 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCOCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777971 61854 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 7 2 6 1.9 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCOCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44587041 187284 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 574 6 3 6 4.0 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL496459 187284 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 574 6 3 6 4.0 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
54585540 61859 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 526 7 3 5 3.0 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777976 61859 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 526 7 3 5 3.0 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
46229967 197849 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 537 6 2 3 5.1 C[C@H]1CC[C@@H](C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)c(F)c1 10.1016/j.bmcl.2009.11.119
CHEMBL592239 197849 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 537 6 2 3 5.1 C[C@H]1CC[C@@H](C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)c(F)c1 10.1016/j.bmcl.2009.11.119
46230162 199622 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 548 5 2 6 5.2 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL604177 199622 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 548 5 2 6 5.2 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
46911683 15050 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 629 10 2 4 6.6 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210756 15050 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 629 10 2 4 6.6 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1016/j.bmcl.2010.06.010
57403390 69723 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 489 5 2 6 1.4 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCS(=O)(=O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939921 69723 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 489 5 2 6 1.4 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCS(=O)(=O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
57394683 69737 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 490 6 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(CC(C)(C)C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939935 69737 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 490 6 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(CC(C)(C)C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
44421279 84718 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 442 7 2 6 5.2 COC(=O)c1ccc(C)cc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225133 84718 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 442 7 2 6 5.2 COC(=O)c1ccc(C)cc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1021/jm049394l
46230940 198589 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 451 4 2 7 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C(C)(C)C)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL597236 198589 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 451 4 2 7 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C(C)(C)C)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
44587184 169576 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 630 9 3 6 5.3 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL444431 169576 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 630 9 3 6 5.3 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
11284304 61855 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 553 7 2 6 1.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCN(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777972 61855 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 553 7 2 6 1.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCN(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
57401663 69722 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 455 5 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC(O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939920 69722 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 455 5 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC(O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
11167607 136808 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL375288 136808 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
46216844 198977 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 4 5.5 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL599779 198977 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 4 5.5 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2009.11.119
16102897 86797 13 None - 1 Human 8.8 pIC50 = 8.8 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL232943 86797 13 None - 1 Human 8.8 pIC50 = 8.8 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
17751347 69755 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 480 4 1 5 1.9 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC3(CCN(C)C3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939953 69755 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 480 4 1 5 1.9 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC3(CCN(C)C3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
46230403 198642 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 458 6 2 7 4.5 CC(=O)Nn1ccnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
CHEMBL597546 198642 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 458 6 2 7 4.5 CC(=O)Nn1ccnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
46230459 197531 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 476 6 2 8 5.1 CC(=O)Nc1nsnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
CHEMBL589900 197531 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 476 6 2 8 5.1 CC(=O)Nc1nsnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
46230352 198720 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 541 8 2 10 4.8 COc1cc(C(=O)Nn2ccnc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
CHEMBL598147 198720 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 541 8 2 10 4.8 COc1cc(C(=O)Nn2ccnc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
44587185 188341 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 630 7 3 6 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL508043 188341 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 630 7 3 6 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
11342350 61835 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777887 61835 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
46216845 198979 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 530 7 2 4 5.0 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2OCC(F)F)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL599780 198979 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 530 7 2 4 5.0 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2OCC(F)F)cc1F 10.1016/j.bmcl.2009.11.119
23630715 152109 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 550 7 3 5 4.0 CN1CCC(N2CCC(CCNC(=O)c3n[nH]c(NC(=O)c4ccccc4Cl)c3Br)CC2)CC1 10.1021/jm051292n
CHEMBL397248 152109 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 550 7 3 5 4.0 CN1CCC(N2CCC(CCNC(=O)c3n[nH]c(NC(=O)c4ccccc4Cl)c3Br)CC2)CC1 10.1021/jm051292n
10151875 136442 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 470 6 2 4 3.8 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL374580 136442 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 470 6 2 4 3.8 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
10031511 16750 0 None 1 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
CHEMBL1253497 16750 0 None 1 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
23630813 151266 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 560 5 4 5 4.1 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1F 10.1021/jm051292n
CHEMBL396524 151266 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 560 5 4 5 4.1 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1F 10.1021/jm051292n
16221282 85098 0 None -13 2 Rabbit 8.0 pIC50 = 8.0 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL227713 85098 0 None -13 2 Rabbit 8.0 pIC50 = 8.0 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
16221111 85100 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 571 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227721 85100 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 571 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
11215913 136003 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
CHEMBL373654 136003 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
16220918 160911 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 585 9 2 6 4.7 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCOCC3)ccc21 10.1021/jm070055c
CHEMBL412762 160911 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 585 9 2 6 4.7 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCOCC3)ccc21 10.1021/jm070055c
44579766 192634 0 None - 1 Crab-eating macaque 6.0 pIC50 = 6.0 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 423 6 1 5 3.7 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL523773 192634 0 None - 1 Crab-eating macaque 6.0 pIC50 = 6.0 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 423 6 1 5 3.7 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
49863234 15045 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 12 3 4 6.3 C=C(CNCC1CC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210751 15045 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 12 3 4 6.3 C=C(CNCC1CC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
44561641 186132 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(C[C@@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL488677 186132 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(C[C@@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
11635365 173979 0 None -2 2 Rabbit 8.0 pIC50 = 8.0 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
CHEMBL455642 173979 0 None -2 2 Rabbit 8.0 pIC50 = 8.0 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
11635365 173979 0 None -2 2 Rabbit 8.0 pIC50 = 8.0 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1021/jm200808v
CHEMBL455642 173979 0 None -2 2 Rabbit 8.0 pIC50 = 8.0 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1021/jm200808v
11214998 76187 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 551 8 2 4 5.3 CC(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206247 76187 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 551 8 2 4 5.3 CC(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44428100 152998 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 396 3 2 4 4.5 Cc1nc(-c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)cs1 10.1021/jm051292n
CHEMBL398008 152998 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 396 3 2 4 4.5 Cc1nc(-c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)cs1 10.1021/jm051292n
56594241 65531 0 None 4 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1835756 65531 0 None 4 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
16220987 78687 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL2113274 78687 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/jm070055c
54587551 61844 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777961 61844 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44580012 186453 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 495 8 1 6 4.6 CN(Cc1ccc(-c2nccs2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491041 186453 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 495 8 1 6 4.6 CN(Cc1ccc(-c2nccs2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
24946441 186541 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 468 6 0 6 2.9 CN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491829 186541 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 468 6 0 6 2.9 CN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
60142169 125366 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 494 5 2 4 4.5 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648460 125366 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 494 5 2 4 4.5 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
56835163 69210 0 None 1 2 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934264 69210 0 None 1 2 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
23630613 91637 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 607 8 2 7 5.4 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1-c1ccccn1)c1ccccc1Cl 10.1021/jm051292n
CHEMBL241937 91637 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 607 8 2 7 5.4 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1-c1ccccn1)c1ccccc1Cl 10.1021/jm051292n
11363856 84100 0 None -13 2 Rabbit 7.9 pIC50 = 7.9 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
CHEMBL222038 84100 0 None -13 2 Rabbit 7.9 pIC50 = 7.9 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
23630920 92503 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 636 9 2 7 6.0 COc1ccc(-n2nc(C(=O)NCCC3CCN(c4ccncc4)CC3)c(Br)c2NC(=O)c2ccccc2Cl)cc1 10.1021/jm051292n
CHEMBL244093 92503 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 636 9 2 7 6.0 COc1ccc(-n2nc(C(=O)NCCC3CCN(c4ccncc4)CC3)c(Br)c2NC(=O)c2ccccc2Cl)cc1 10.1021/jm051292n
17751599 69732 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 420 5 3 5 0.9 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCNCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939930 69732 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 420 5 3 5 0.9 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCNCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
57401425 69205 0 None -1 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934259 69205 0 None -1 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
25207727 197747 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 435 6 2 5 2.6 CC1CCC(C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1016/j.bmcl.2009.11.119
CHEMBL591354 197747 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 435 6 2 5 2.6 CC1CCC(C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1016/j.bmcl.2009.11.119
16221054 141528 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 591 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cc(Cl)c(F)cc1F)c1ccccc1 10.1021/jm070055c
CHEMBL387982 141528 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 591 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cc(Cl)c(F)cc1F)c1ccccc1 10.1021/jm070055c
11284458 140045 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2011.03.115
CHEMBL381366 140045 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2011.03.115
11284458 140045 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.055
CHEMBL381366 140045 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.055
23631903 92343 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 531 6 4 6 3.7 Nc1cccc(N2CCC(CNC(=O)c3n[nH]c(NC(=O)c4ccccc4Cl)c3Br)CC2)n1 10.1021/jm051292n
CHEMBL243680 92343 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 531 6 4 6 3.7 Nc1cccc(N2CCC(CNC(=O)c3n[nH]c(NC(=O)c4ccccc4Cl)c3Br)CC2)n1 10.1021/jm051292n
11284458 140045 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381366 140045 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44561786 172084 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 580 9 1 4 7.0 O=C(CC(CS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL449789 172084 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 580 9 1 4 7.0 O=C(CC(CS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
17751422 69748 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 5 1 5 1.5 CN(C)[C@@H]1CCN(C(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C1 10.1016/j.bmcl.2011.11.112
CHEMBL1939946 69748 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 5 1 5 1.5 CN(C)[C@@H]1CCN(C(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C1 10.1016/j.bmcl.2011.11.112
11420875 76969 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 511 7 2 4 5.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL208387 76969 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 511 7 2 4 5.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
44579811 186274 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 502 7 1 6 2.8 CCC(NC(=O)c1nc2ccccc2n1Cc1ccccc1)C(=O)N1CCN(C2CCN(C)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL489588 186274 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 502 7 1 6 2.8 CCC(NC(=O)c1nc2ccccc2n1Cc1ccccc1)C(=O)N1CCN(C2CCN(C)CC2)CC1 10.1016/j.bmcl.2008.08.014
60142707 125387 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 544 5 2 6 5.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648481 125387 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 544 5 2 6 5.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
54580655 61845 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 566 7 2 5 3.8 Cc1ccc(S(=O)(=O)N2CC(C)(C)NC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777962 61845 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 566 7 2 5 3.8 Cc1ccc(S(=O)(=O)N2CC(C)(C)NC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
57399887 69754 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 466 4 1 5 1.3 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2C[C@@H]3CN(C)C[C@@H]3C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939952 69754 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 466 4 1 5 1.3 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2C[C@@H]3CN(C)C[C@@H]3C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
56672397 65527 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human B1 receptor by cell-based assayAntagonist activity at human B1 receptor by cell-based assay
ChEMBL 432 9 1 3 5.6 O=C(CCCCC(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm200808v
CHEMBL1835752 65527 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human B1 receptor by cell-based assayAntagonist activity at human B1 receptor by cell-based assay
ChEMBL 432 9 1 3 5.6 O=C(CCCCC(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm200808v
57399671 69211 0 None -2 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
CHEMBL1934265 69211 0 None -2 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
44579943 186204 0 None - 1 Crab-eating macaque 7.9 pIC50 = 7.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 8 1 6 3.2 CN(Cc1ccc(C2=NCCN2C)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL489191 186204 0 None - 1 Crab-eating macaque 7.9 pIC50 = 7.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 8 1 6 3.2 CN(Cc1ccc(C2=NCCN2C)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
16108965 160771 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
CHEMBL412552 160771 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
16221057 142476 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL389478 142476 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
16221161 143777 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 569 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL390539 143777 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 569 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
44410313 75434 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 527 8 2 5 4.7 COc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL204847 75434 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 527 8 2 5 4.7 COc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
11685446 186112 0 None -14 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
CHEMBL488501 186112 0 None -14 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
56594771 65434 0 None 2 2 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
CHEMBL1834749 65434 0 None 2 2 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
46230069 199330 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 555 5 2 4 5.2 CC(C)N(NC(=O)c1cc(F)cc(C(F)(F)F)c1)C(=O)N[C@H](C)c1ncc(C(=O)N2[C@@H](C)CC[C@H]2C)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL602320 199330 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 555 5 2 4 5.2 CC(C)N(NC(=O)c1cc(F)cc(C(F)(F)F)c1)C(=O)N[C@H](C)c1ncc(C(=O)N2[C@@H](C)CC[C@H]2C)cc1F 10.1016/j.bmcl.2009.11.119
49863229 15040 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210746 15040 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
44579828 192693 0 None 1 2 Rat 7.8 pIC50 = 7.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 502 7 0 6 2.8 CCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL524126 192693 0 None 1 2 Rat 7.8 pIC50 = 7.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 502 7 0 6 2.8 CCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
57399886 69750 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 5 1 5 1.9 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939948 69750 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 5 1 5 1.9 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
49863231 15042 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 585 10 2 4 5.9 C=C(CN(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210748 15042 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 585 10 2 4 5.9 C=C(CN(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
44579795 186352 0 None -30 2 Rat 6.8 pIC50 = 6.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 480 8 2 6 2.8 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490201 186352 0 None -30 2 Rat 6.8 pIC50 = 6.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 480 8 2 6 2.8 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
44579828 192693 0 None -1 2 Crab-eating macaque 7.8 pIC50 = 7.8 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 502 7 0 6 2.8 CCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL524126 192693 0 None -1 2 Crab-eating macaque 7.8 pIC50 = 7.8 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 502 7 0 6 2.8 CCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
11317669 148795 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 481 5 3 4 3.2 C[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)C(=O)N1CCCCC1 10.1021/jm051292n
CHEMBL394514 148795 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 481 5 3 4 3.2 C[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)C(=O)N1CCCCC1 10.1021/jm051292n
11204003 76853 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 579 7 2 4 6.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2006.01.069
CHEMBL207947 76853 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 579 7 2 4 6.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2006.01.069
665 957 2 None -89 4 Dog 7.8 pIC50 = 7.8 Functional
Antagonist activity at dog bradykinin B1 receptorAntagonist activity at dog bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
9916412 957 2 None -89 4 Dog 7.8 pIC50 = 7.8 Functional
Antagonist activity at dog bradykinin B1 receptorAntagonist activity at dog bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
CHEMBL189123 957 2 None -89 4 Dog 7.8 pIC50 = 7.8 Functional
Antagonist activity at dog bradykinin B1 receptorAntagonist activity at dog bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
44410328 75637 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 537 7 1 4 4.9 CN(C)Cc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL205501 75637 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 537 7 1 4 4.9 CN(C)Cc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
23630615 92664 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 601 10 2 7 4.5 CN(C)CCn1nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c(Br)c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
CHEMBL244284 92664 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 601 10 2 7 4.5 CN(C)CCn1nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c(Br)c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
CHEMBL3038104 209182 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
In vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aortaIn vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aorta
ChEMBL None None None NC(N)=NCCC[C@@H](N)C(=O)N[C@@H](CCCNC(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N(CC(=O)O)C1CCCCC1 10.1021/jm950716i
16220917 165771 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 543 9 2 5 5.0 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL427279 165771 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 543 9 2 5 5.0 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
16221056 85120 0 None -97 2 Rabbit 5.8 pIC50 = 5.8 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227870 85120 0 None -97 2 Rabbit 5.8 pIC50 = 5.8 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
46230834 197574 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 4 2 6 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL590151 197574 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 4 2 6 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
46230893 198678 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 4 2 7 2.4 CN(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
CHEMBL597840 198678 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 4 2 7 2.4 CN(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
57390932 69200 0 None 14 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934254 69200 0 None 14 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
16220916 85121 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 571 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227879 85121 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 571 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
16108961 908 0 None -10 3 Rabbit 7.8 pIC50 = 7.8 Functional
Antagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 908 0 None -10 3 Rabbit 7.8 pIC50 = 7.8 Functional
Antagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 908 0 None -10 3 Rabbit 7.8 pIC50 = 7.8 Functional
Antagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
11526891 188281 0 None 1 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL507168 188281 0 None 1 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
16221056 85120 0 None 97 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227870 85120 0 None 97 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
60141326 125412 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(N)CC2)n1 nan
CHEMBL3648506 125412 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(N)CC2)n1 nan
56594772 65435 0 None -15 2 Rabbit 7.8 pIC50 = 7.8 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834750 65435 0 None -15 2 Rabbit 7.8 pIC50 = 7.8 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
57396445 69727 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 419 5 2 4 2.4 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939925 69727 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 419 5 2 4 2.4 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
11213709 91877 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 475 6 4 4 3.0 NC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
CHEMBL242994 91877 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 475 6 4 4 3.0 NC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
16108964 141177 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL385741 141177 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
57398979 69707 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1ccc2c(c1)C(NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1)CCC2 10.1016/j.bmcl.2011.11.112
CHEMBL1939764 69707 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1ccc2c(c1)C(NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1)CCC2 10.1016/j.bmcl.2011.11.112
44579830 186400 0 None 1 2 Crab-eating macaque 7.8 pIC50 = 7.8 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 516 8 0 6 3.2 CCCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490619 186400 0 None 1 2 Crab-eating macaque 7.8 pIC50 = 7.8 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 516 8 0 6 3.2 CCCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
57390219 69710 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 441 5 2 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939767 69710 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 441 5 2 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
46230258 198745 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 486 6 2 7 5.2 CC(=O)Nn1c(NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)nc(C)c1C 10.1016/j.bmcl.2009.11.120
CHEMBL598348 198745 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 486 6 2 7 5.2 CC(=O)Nn1c(NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)nc(C)c1C 10.1016/j.bmcl.2009.11.120
11512379 165441 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 555 7 2 7 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2nsnc12 10.1016/j.bmcl.2006.01.069
CHEMBL425416 165441 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 555 7 2 7 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2nsnc12 10.1016/j.bmcl.2006.01.069
11342079 161225 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL414091 161225 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
57392728 69209 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3c(Cl)cccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934263 69209 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3c(Cl)cccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
44579890 186024 0 None - 1 Crab-eating macaque 6.7 pIC50 = 6.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 534 7 1 6 3.9 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)C1CCN(C(=O)c2nc3ccccc3n2Cc2ccccc2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL487909 186024 0 None - 1 Crab-eating macaque 6.7 pIC50 = 6.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 534 7 1 6 3.9 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)C1CCN(C(=O)c2nc3ccccc3n2Cc2ccccc2)CC1 10.1016/j.bmcl.2008.08.014
57403175 69204 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3c(Cl)cccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934258 69204 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3c(Cl)cccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
57394686 69749 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 480 5 1 5 2.0 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939947 69749 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 480 5 1 5 2.0 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
16221108 85092 0 None 22 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL227600 85092 0 None 22 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
44579969 186308 0 None - 1 Crab-eating macaque 6.7 pIC50 = 6.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 509 9 1 5 4.5 CN(Cc1ccc(CN2CCCCC2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL489810 186308 0 None - 1 Crab-eating macaque 6.7 pIC50 = 6.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 509 9 1 5 4.5 CN(Cc1ccc(CN2CCCCC2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
44580043 184149 0 None - 1 Crab-eating macaque 5.7 pIC50 = 5.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 460 6 1 5 3.6 O=C(NCCC(=O)N1CCC2(CCOCC2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL485079 184149 0 None - 1 Crab-eating macaque 5.7 pIC50 = 5.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 460 6 1 5 3.6 O=C(NCCC(=O)N1CCC2(CCOCC2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
25105469 186468 6 None -2 2 Crab-eating macaque 8.7 pIC50 = 8.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 467 8 3 7 2.6 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc(C2=NCCN2)nc1 10.1016/j.bmcl.2008.08.014
CHEMBL491198 186468 6 None -2 2 Crab-eating macaque 8.7 pIC50 = 8.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 467 8 3 7 2.6 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc(C2=NCCN2)nc1 10.1016/j.bmcl.2008.08.014
60142027 125359 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648454 125359 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
54584600 61848 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CC(=O)NCC2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777965 61848 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CC(=O)NCC2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56589598 65436 0 None -7 2 Rabbit 8.7 pIC50 = 8.7 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
CHEMBL1834751 65436 0 None -7 2 Rabbit 8.7 pIC50 = 8.7 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
46230835 199306 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 439 4 2 6 4.6 Cc1nc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL602115 199306 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 439 4 2 6 4.6 Cc1nc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
25195622 61838 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 606 7 2 5 4.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2011.03.115
CHEMBL1777955 61838 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 606 7 2 5 4.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2011.03.115
54587553 61862 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 8 3 5 3.2 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777979 61862 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 8 3 5 3.2 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
60142441 125377 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 6 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648471 125377 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 6 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
11442712 84788 0 None -9 2 Rabbit 8.6 pIC50 = 8.6 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225607 84788 0 None -9 2 Rabbit 8.6 pIC50 = 8.6 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
54581666 61853 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 566 7 2 5 3.7 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC(C)(C)C4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777970 61853 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 566 7 2 5 3.7 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC(C)(C)C4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
57399382 69496 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 1 5 2.3 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1938412 69496 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 1 5 2.3 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
60141042 125403 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 537 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)COC2)no1 nan
CHEMBL3648497 125403 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 537 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)COC2)no1 nan
11663809 173019 0 None -5 2 Rabbit 7.7 pIC50 = 7.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL453339 173019 0 None -5 2 Rabbit 7.7 pIC50 = 7.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
16221228 165453 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 593 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL425490 165453 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 593 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
57398239 69747 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 5 1 5 1.5 CN(C)[C@H]1CCN(C(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C1 10.1016/j.bmcl.2011.11.112
CHEMBL1939945 69747 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 5 1 5 1.5 CN(C)[C@H]1CCN(C(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C1 10.1016/j.bmcl.2011.11.112
11526891 188281 0 None -1 2 Rabbit 7.7 pIC50 = 7.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL507168 188281 0 None -1 2 Rabbit 7.7 pIC50 = 7.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
23630810 143957 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 452 7 3 5 3.7 O=C(NCCC1CCN(c2ccncc2)CC1)c1cc(NC(=O)c2ccccc2Cl)[nH]n1 10.1021/jm051292n
CHEMBL390692 143957 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 452 7 3 5 3.7 O=C(NCCC1CCN(c2ccncc2)CC1)c1cc(NC(=O)c2ccccc2Cl)[nH]n1 10.1021/jm051292n
137657568 158989 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL 1920 23 21 26 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N2 10.1021/acs.jmedchem.6b01011
CHEMBL4102547 158989 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL 1920 23 21 26 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N2 10.1021/acs.jmedchem.6b01011
16220988 85096 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1C(F)(F)F)c1ccccc1 10.1021/jm070055c
CHEMBL227697 85096 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1C(F)(F)F)c1ccccc1 10.1021/jm070055c
11405561 91761 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 354 4 3 3 3.9 Cc1c(C(=O)Nc2ccccc2)n[nH]c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
CHEMBL242565 91761 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 354 4 3 3 3.9 Cc1c(C(=O)Nc2ccccc2)n[nH]c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
16221053 141805 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 573 9 3 5 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(F)c(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL388720 141805 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 573 9 3 5 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(F)c(Cl)c1)c1ccccc1 10.1021/jm070055c
16220986 137079 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1Cl)c1ccccc1 10.1021/jm070055c
CHEMBL375709 137079 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1Cl)c1ccccc1 10.1021/jm070055c
17751868 69728 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 393 5 2 5 0.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCOCC2)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939926 69728 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 393 5 2 5 0.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCOCC2)cc1 10.1016/j.bmcl.2011.11.112
49863230 15041 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 597 10 2 4 6.0 C=C(CN1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210747 15041 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 597 10 2 4 6.0 C=C(CN1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
16221226 143853 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 569 9 3 5 5.6 Cc1c(Cl)cccc1S(=O)(=O)N[C@H](CC(=O)N[C@@H]1CCOc2cc(CNC(C)(C)C)ccc21)c1ccccc1 10.1021/jm070055c
CHEMBL390603 143853 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 569 9 3 5 5.6 Cc1c(Cl)cccc1S(=O)(=O)N[C@H](CC(=O)N[C@@H]1CCOc2cc(CNC(C)(C)C)ccc21)c1ccccc1 10.1021/jm070055c
70691814 73490 0 None - 1 Rat 7.7 pIC50 = 7.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 592 8 2 5 5.6 Cc1cc(C)c(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1C 10.1016/j.bmcl.2012.03.065
CHEMBL2018868 73490 0 None - 1 Rat 7.7 pIC50 = 7.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 592 8 2 5 5.6 Cc1cc(C)c(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1C 10.1016/j.bmcl.2012.03.065
23627521 73495 0 None - 1 Rat 7.7 pIC50 = 7.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 648 9 2 6 6.0 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018873 73495 0 None - 1 Rat 7.7 pIC50 = 7.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 648 9 2 6 6.0 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
56594642 65377 0 None -21 2 Rabbit 7.7 pIC50 = 7.7 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834616 65377 0 None -21 2 Rabbit 7.7 pIC50 = 7.7 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
57398980 69711 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 440 5 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCNc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939768 69711 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 440 5 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCNc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
23630510 92852 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 446 5 3 3 4.6 C[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
CHEMBL245129 92852 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 446 5 3 3 4.6 C[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
11635364 173980 0 None -4 2 Rabbit 6.7 pIC50 = 6.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL455643 173980 0 None -4 2 Rabbit 6.7 pIC50 = 6.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
44410186 76849 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 615 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(C(F)(F)C(F)(F)F)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL207945 76849 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 615 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(C(F)(F)C(F)(F)F)cc1 10.1016/j.bmcl.2006.01.069
16220914 85129 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 529 9 3 5 4.6 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL228014 85129 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 529 9 3 5 4.6 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44580013 186454 0 None - 1 Crab-eating macaque 5.7 pIC50 = 5.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 478 8 2 5 3.9 CN(Cc1ccc(-c2ccn[nH]2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491042 186454 0 None - 1 Crab-eating macaque 5.7 pIC50 = 5.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 478 8 2 5 3.9 CN(Cc1ccc(-c2ccn[nH]2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
11444165 140335 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 545 7 2 4 5.7 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1Cl 10.1016/j.bmcl.2006.01.069
CHEMBL381979 140335 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 545 7 2 4 5.7 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1Cl 10.1016/j.bmcl.2006.01.069
60142024 125356 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 446 5 2 4 3.5 COC(=O)c1ccccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648451 125356 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 446 5 2 4 3.5 COC(=O)c1ccccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
49863233 15044 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 615 13 3 5 5.6 C=C(CNCCOC)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210750 15044 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 615 13 3 5 5.6 C=C(CNCCOC)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
44587207 187555 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 573 6 2 6 4.4 O=Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL498489 187555 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 573 6 2 6 4.4 O=Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
23630811 91878 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 470 7 3 5 3.9 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1F)c1ccccc1Cl 10.1021/jm051292n
CHEMBL242995 91878 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 470 7 3 5 3.9 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1F)c1ccccc1Cl 10.1021/jm051292n
44579830 186400 0 None -1 2 Rat 7.6 pIC50 = 7.6 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 516 8 0 6 3.2 CCCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490619 186400 0 None -1 2 Rat 7.6 pIC50 = 7.6 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 516 8 0 6 3.2 CCCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
57394688 69752 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 508 5 1 5 2.8 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939950 69752 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 508 5 1 5 2.8 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
11307733 74532 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 579 8 2 4 6.0 CC(C)(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL203174 74532 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 579 8 2 4 6.0 CC(C)(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44579866 192573 0 None - 1 Crab-eating macaque 5.6 pIC50 = 5.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 508 5 0 6 3.7 O=C(c1nc2ccccc2n1Cc1ccccc1)N1CCC(C(=O)N2CCN(c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL523266 192573 0 None - 1 Crab-eating macaque 5.6 pIC50 = 5.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 508 5 0 6 3.7 O=C(c1nc2ccccc2n1Cc1ccccc1)N1CCC(C(=O)N2CCN(c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
54585539 61856 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777973 61856 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.03.115
54585539 61856 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1777973 61856 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
56835163 69210 0 None -1 2 Rabbit 7.6 pIC50 = 7.6 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934264 69210 0 None -1 2 Rabbit 7.6 pIC50 = 7.6 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
16220990 85107 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL227786 85107 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/jm070055c
60142167 125363 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 2.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)n1 nan
CHEMBL3648458 125363 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 2.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)n1 nan
88925471 125371 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 3.5 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648465 125371 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 3.5 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142305 125370 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648464 125370 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
44410143 76968 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 497 7 2 4 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2006.01.069
CHEMBL208386 76968 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 497 7 2 4 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2006.01.069
54587550 61842 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777959 61842 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
57390932 69200 0 None -14 2 Rabbit 6.6 pIC50 = 6.6 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934254 69200 0 None -14 2 Rabbit 6.6 pIC50 = 6.6 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
17751827 69730 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 421 5 2 5 1.3 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCOCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939928 69730 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 421 5 2 5 1.3 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCOCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
44561643 185056 0 None -5 2 Rabbit 7.6 pIC50 = 7.6 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL486456 185056 0 None -5 2 Rabbit 7.6 pIC50 = 7.6 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
57391172 69726 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 405 5 2 4 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939924 69726 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 405 5 2 4 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2C)cc1 10.1016/j.bmcl.2011.11.112
71449505 80497 0 None -3 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human CHO cells assessed as inhibition of calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human CHO cells assessed as inhibition of calcium flux by FLIPR assay
ChEMBL 475 8 1 5 5.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)CCCc2ccc3cccnc3n2)c(F)c1 10.1016/j.bmcl.2011.04.091
CHEMBL2153436 80497 0 None -3 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human CHO cells assessed as inhibition of calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human CHO cells assessed as inhibition of calcium flux by FLIPR assay
ChEMBL 475 8 1 5 5.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)CCCc2ccc3cccnc3n2)c(F)c1 10.1016/j.bmcl.2011.04.091
16221225 168791 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1Cl)c1ccccc1 10.1021/jm070055c
CHEMBL442056 168791 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1Cl)c1ccccc1 10.1021/jm070055c
57401426 69208 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cc(Cl)ccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934262 69208 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cc(Cl)ccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
24946440 192440 0 None - 1 Crab-eating macaque 6.6 pIC50 = 6.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 488 6 0 6 2.4 CN1CCC(N2CCN(C(=O)CN(C)C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL522308 192440 0 None - 1 Crab-eating macaque 6.6 pIC50 = 6.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 488 6 0 6 2.4 CN1CCC(N2CCN(C(=O)CN(C)C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
44579812 186542 0 None - 1 Crab-eating macaque 6.6 pIC50 = 6.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 482 7 0 6 3.3 CCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491830 186542 0 None - 1 Crab-eating macaque 6.6 pIC50 = 6.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 482 7 0 6 3.3 CCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
57390933 69201 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(Cl)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934255 69201 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(Cl)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
46229968 199690 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 538 6 2 4 4.5 C[C@H]1CC[C@@H](C)N1C(=O)c1cnc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)c(F)c1 10.1016/j.bmcl.2009.11.119
CHEMBL604575 199690 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 538 6 2 4 4.5 C[C@H]1CC[C@@H](C)N1C(=O)c1cnc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)c(F)c1 10.1016/j.bmcl.2009.11.119
23627396 73489 0 None - 1 Rat 7.6 pIC50 = 7.6 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 618 8 2 5 6.0 O=C(CC1c2ccccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018867 73489 0 None - 1 Rat 7.6 pIC50 = 7.6 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 618 8 2 5 6.0 O=C(CC1c2ccccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
60142166 125362 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)no1 nan
CHEMBL3648457 125362 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)no1 nan
11375297 92126 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 490 6 3 5 3.7 COC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
CHEMBL243467 92126 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 490 6 3 5 3.7 COC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
23630509 92825 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 453 4 4 4 2.5 O=C(Nc1[nH]nc(C(=O)N[C@@H]2CCCCNC2=O)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL244955 92825 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 453 4 4 4 2.5 O=C(Nc1[nH]nc(C(=O)N[C@@H]2CCCCNC2=O)c1Br)c1ccccc1Cl 10.1021/jm051292n
44580044 184150 0 None - 1 Crab-eating macaque 5.5 pIC50 = 5.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 459 6 1 5 3.1 CN1CCC2(CCN(C(=O)CCNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)C1 10.1016/j.bmcl.2008.08.014
CHEMBL485080 184150 0 None - 1 Crab-eating macaque 5.5 pIC50 = 5.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 459 6 1 5 3.1 CN1CCC2(CCN(C(=O)CCNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)C1 10.1016/j.bmcl.2008.08.014
11620980 173130 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1C(F)(F)F 10.1016/j.bmcl.2008.07.108
CHEMBL453596 173130 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1C(F)(F)F 10.1016/j.bmcl.2008.07.108
23631902 161303 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 530 7 3 5 4.5 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL414892 161303 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 530 7 3 5 4.5 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Br)c1ccccc1Cl 10.1021/jm051292n
11215677 61840 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 614 7 2 6 4.6 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cc2cc(Cl)ccc2s1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777957 61840 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 614 7 2 6 4.6 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cc2cc(Cl)ccc2s1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11561240 69704 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 439 5 2 4 2.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939761 69704 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 439 5 2 4 2.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
16108961 908 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
664 908 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
CHEMBL415848 908 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
16108961 908 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 908 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 908 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
60142705 125385 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 8 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3nnc(C)o3)CC2)no1 nan
CHEMBL3648479 125385 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 8 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3nnc(C)o3)CC2)no1 nan
46230354 199768 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 541 8 3 9 5.2 COc1cc(C(=O)Nc2c[nH]nc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
CHEMBL604999 199768 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 541 8 3 9 5.2 COc1cc(C(=O)Nc2c[nH]nc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
23630919 142014 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 606 8 2 6 6.0 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1-c1ccccc1)c1ccccc1Cl 10.1021/jm051292n
CHEMBL389097 142014 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 606 8 2 6 6.0 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1-c1ccccc1)c1ccccc1Cl 10.1021/jm051292n
23631902 161303 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 530 7 3 5 4.5 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Br)c1ccccc1Cl 10.1021/jm1000776
CHEMBL414892 161303 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 530 7 3 5 4.5 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Br)c1ccccc1Cl 10.1021/jm1000776
46230889 198800 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 419 4 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(C)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL598665 198800 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 419 4 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(C)c2)no1 10.1016/j.bmcl.2009.11.121
54581664 61843 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777960 61843 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
60142439 125376 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648470 125376 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142837 125392 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 7 5.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648486 125392 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 7 5.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
11225601 141483 0 None -3 2 Rabbit 8.4 pIC50 = 8.4 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
CHEMBL387638 141483 0 None -3 2 Rabbit 8.4 pIC50 = 8.4 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
46230989 198495 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 477 5 2 7 4.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCCCC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL596623 198495 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 477 5 2 7 4.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCCCC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
11433587 15039 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210745 15039 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
23630511 144230 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 486 7 3 5 4.4 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Cl)c1ccccc1Cl 10.1021/jm051292n
CHEMBL390916 144230 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 486 7 3 5 4.4 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Cl)c1ccccc1Cl 10.1021/jm051292n
56835162 69206 0 None -7 2 Rabbit 7.5 pIC50 = 7.5 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934260 69206 0 None -7 2 Rabbit 7.5 pIC50 = 7.5 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
11519239 185168 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL486640 185168 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
60142961 125393 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648487 125393 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3038096 209175 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aortaIn vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aorta
ChEMBL None None None NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C1CCCCC1 10.1021/jm950716i
16108966 83945 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 555 10 2 4 6.1 C[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)c1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL221925 83945 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 555 10 2 4 6.1 C[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)c1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
46230836 197575 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 389 4 2 6 3.5 Cc1nc(-c2c(F)cccc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL590153 197575 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 389 4 2 6 3.5 Cc1nc(-c2c(F)cccc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
11203826 139579 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 563 9 2 4 5.3 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL380117 139579 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 563 9 2 4 5.3 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
56594770 65382 0 None -7 2 Rabbit 7.5 pIC50 = 7.5 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834620 65382 0 None -7 2 Rabbit 7.5 pIC50 = 7.5 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
24946265 186471 0 None 1 2 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 454 6 1 6 2.6 O=C(NCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491219 186471 0 None 1 2 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 454 6 1 6 2.6 O=C(NCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
42605727 197717 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 8 2 5 2.1 CCN(CC)C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1016/j.bmcl.2009.11.119
CHEMBL591111 197717 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 8 2 5 2.1 CCN(CC)C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1016/j.bmcl.2009.11.119
57399885 69725 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 405 5 2 4 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCC(C)CC2)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939923 69725 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 405 5 2 4 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCC(C)CC2)cc1 10.1016/j.bmcl.2011.11.112
49863227 15035 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 2 4 6.9 CC(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210741 15035 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 2 4 6.9 CC(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
46230890 199565 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 408 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc(CNC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL603894 199565 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 408 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc(CNC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
49863232 15043 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 601 12 4 5 4.9 C=C(CNCCO)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210749 15043 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 601 12 4 5 4.9 C=C(CNCCO)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
23631015 92511 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 626 8 2 6 5.5 CN1CCC(N2CCC(CCNC(=O)c3nn(-c4ccccc4)c(NC(=O)c4ccccc4Cl)c3Br)CC2)CC1 10.1021/jm051292n
CHEMBL244124 92511 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 626 8 2 6 5.5 CN1CCC(N2CCC(CCNC(=O)c3nn(-c4ccccc4)c(NC(=O)c4ccccc4Cl)c3Br)CC2)CC1 10.1021/jm051292n
2818985 92751 5 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 431 3 2 2 6.0 CC(C)(C)c1ccc(-c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)cc1 10.1021/jm051292n
CHEMBL244522 92751 5 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 431 3 2 2 6.0 CC(C)(C)c1ccc(-c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)cc1 10.1021/jm051292n
44579913 183579 0 None - 1 Crab-eating macaque 5.5 pIC50 = 5.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 514 5 0 6 2.9 CN1CCC(N2CCN(C(=O)[C@H]3CCCN3C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL483036 183579 0 None - 1 Crab-eating macaque 5.5 pIC50 = 5.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 514 5 0 6 2.9 CN1CCC(N2CCN(C(=O)[C@H]3CCCN3C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
44419046 97809 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 595 10 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NC1CCc2cc(CCN3CCCCC3)ccc2C1 10.1021/jm061224g
CHEMBL274624 97809 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 595 10 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NC1CCc2cc(CCN3CCCCC3)ccc2C1 10.1021/jm061224g
659 2842 13 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
9831083 2842 13 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
CHEMBL273869 2842 13 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
44579968 192512 0 None - 1 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 490 8 1 6 3.9 CN(Cc1ccc(-c2ncccn2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL522789 192512 0 None - 1 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 490 8 1 6 3.9 CN(Cc1ccc(-c2ncccn2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
16220989 141955 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL389054 141955 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1 10.1021/jm070055c
60142568 125379 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 526 5 2 6 5.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648473 125379 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 526 5 2 6 5.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
56594373 65537 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
CHEMBL1835762 65537 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
56594771 65434 0 None -2 2 Rabbit 6.5 pIC50 = 6.5 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
CHEMBL1834749 65434 0 None -2 2 Rabbit 6.5 pIC50 = 6.5 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
44579652 186584 0 None -57 2 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 508 9 1 6 3.6 CCN(CC(=O)N(C)Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL492211 186584 0 None -57 2 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 508 9 1 6 3.6 CCN(CC(=O)N(C)Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
60142963 125395 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125395 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
46230308 199891 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 393 5 2 4 4.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2nc3ccccc3[nH]2)c(F)c1 10.1016/j.bmcl.2009.11.120
CHEMBL605634 199891 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 393 5 2 4 4.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2nc3ccccc3[nH]2)c(F)c1 10.1016/j.bmcl.2009.11.120
46230259 198781 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 319 4 1 3 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNC(C)=O)c(F)c1 10.1016/j.bmcl.2009.11.120
CHEMBL598552 198781 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 319 4 1 3 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNC(C)=O)c(F)c1 10.1016/j.bmcl.2009.11.120
16220913 85112 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 515 8 3 5 4.3 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227828 85112 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 515 8 3 5 4.3 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44579829 186399 0 None 1 2 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 496 8 0 6 3.7 CCCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490618 186399 0 None 1 2 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 496 8 0 6 3.7 CCCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
16108967 83912 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 541 10 2 4 5.6 O=C(CC(NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL221691 83912 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 541 10 2 4 5.6 O=C(CC(NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
57395451 69709 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1cccc2c1CCCC2NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939766 69709 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1cccc2c1CCCC2NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1 10.1016/j.bmcl.2011.11.112
57394687 69751 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 494 5 1 5 2.4 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939949 69751 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 494 5 1 5 2.4 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL3038105 209183 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
In vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aortaIn vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aorta
ChEMBL None None None NC(N)=NCCC[C@@H](N)C(=O)N[C@@H](CCCNC(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N(CC(=O)N1C2CCCCC2C[C@H]1C(=O)O)Cc1ccccc1 10.1021/jm950716i
11555433 188392 0 None 2 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL508632 188392 0 None 2 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
57403174 69202 0 None -5 2 Rabbit 6.4 pIC50 = 6.4 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934256 69202 0 None -5 2 Rabbit 6.4 pIC50 = 6.4 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
44579829 186399 0 None -1 2 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 496 8 0 6 3.7 CCCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490618 186399 0 None -1 2 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 496 8 0 6 3.7 CCCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
56835162 69206 0 None 7 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934260 69206 0 None 7 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
56594770 65382 0 None 7 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834620 65382 0 None 7 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
11663809 173019 0 None 5 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL453339 173019 0 None 5 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
16108961 908 0 None -2 3 Rat 8.4 pIC50 = 8.4 Functional
Antagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 908 0 None -2 3 Rat 8.4 pIC50 = 8.4 Functional
Antagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 908 0 None -2 3 Rat 8.4 pIC50 = 8.4 Functional
Antagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
60142302 125367 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648461 125367 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60141039 125401 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 553 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
CHEMBL3648495 125401 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 553 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
53248885 61841 0 None -18 2 Rabbit 8.4 pIC50 = 8.4 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1021/jm200808v
CHEMBL1777958 61841 0 None -18 2 Rabbit 8.4 pIC50 = 8.4 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1021/jm200808v
54582656 61857 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 510 8 3 5 2.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777974 61857 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 510 8 3 5 2.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
11635365 173979 0 None 2 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
CHEMBL455642 173979 0 None 2 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
60141181 125404 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 551 6 2 8 4.1 Cc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
CHEMBL3648498 125404 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 551 6 2 8 4.1 Cc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
46230068 199353 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 527 4 2 4 4.4 C[C@H]1CC[C@@H](C)N1C(=O)c1cnc([C@@H](C)NC(=O)N(C)NC(=O)c2cc(F)cc(C(F)(F)F)c2)c(F)c1 10.1016/j.bmcl.2009.11.119
CHEMBL602555 199353 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 527 4 2 4 4.4 C[C@H]1CC[C@@H](C)N1C(=O)c1cnc([C@@H](C)NC(=O)N(C)NC(=O)c2cc(F)cc(C(F)(F)F)c2)c(F)c1 10.1016/j.bmcl.2009.11.119
44561643 185056 0 None 5 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL486456 185056 0 None 5 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
60142566 125375 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648469 125375 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
46230938 199576 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 423 5 2 7 2.8 CCN(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
CHEMBL603962 199576 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 423 5 2 7 2.8 CCN(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
46216744 199886 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 508 6 2 7 5.7 CC(=O)Nn1c(NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)nc2ccccc21 10.1016/j.bmcl.2009.11.120
CHEMBL605570 199886 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 508 6 2 7 5.7 CC(=O)Nn1c(NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)nc2ccccc21 10.1016/j.bmcl.2009.11.120
60143099 125399 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 534 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648493 125399 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 534 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
57394689 69753 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 496 5 1 5 2.6 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939951 69753 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 496 5 1 5 2.6 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
60141327 125413 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 554 6 2 10 3.3 Cc1nnc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)o1 nan
CHEMBL3648507 125413 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 554 6 2 10 3.3 Cc1nnc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)o1 nan
57395702 69715 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 453 5 2 5 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC(=O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939771 69715 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 453 5 2 5 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC(=O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
44579889 186023 0 None - 1 Crab-eating macaque 5.4 pIC50 = 5.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 528 5 0 6 3.2 CN1CCC(N2CCN(C(=O)C3CCN(C(=O)c4nc5ccccc5n4Cc4ccccc4)CC3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL487908 186023 0 None - 1 Crab-eating macaque 5.4 pIC50 = 5.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 528 5 0 6 3.2 CN1CCC(N2CCN(C(=O)C3CCN(C(=O)c4nc5ccccc5n4Cc4ccccc4)CC3)CC2)CC1 10.1016/j.bmcl.2008.08.014
137640759 156528 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL 1756 21 21 23 -5.9 CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N2 10.1021/acs.jmedchem.6b01011
CHEMBL4074308 156528 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL 1756 21 21 23 -5.9 CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N2 10.1021/acs.jmedchem.6b01011
44579967 186430 0 None - 1 Crab-eating macaque 6.4 pIC50 = 6.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 489 8 1 5 4.5 CN(Cc1ccc(-c2ccccn2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490827 186430 0 None - 1 Crab-eating macaque 6.4 pIC50 = 6.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 489 8 1 5 4.5 CN(Cc1ccc(-c2ccccn2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
44579891 191487 0 None - 1 Crab-eating macaque 5.4 pIC50 = 5.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 5 0 6 3.4 O=C([C@H]1CCCN1C(=O)c1nc2ccccc2n1Cc1ccccc1)N1CCN(c2ccncc2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL520304 191487 0 None - 1 Crab-eating macaque 5.4 pIC50 = 5.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 5 0 6 3.4 O=C([C@H]1CCCN1C(=O)c1nc2ccccc2n1Cc1ccccc1)N1CCN(c2ccncc2)CC1 10.1016/j.bmcl.2008.08.014
11331054 15037 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 625 10 2 4 6.8 C=C(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210743 15037 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 625 10 2 4 6.8 C=C(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
24946265 186471 0 None -1 2 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 454 6 1 6 2.6 O=C(NCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491219 186471 0 None -1 2 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 454 6 1 6 2.6 O=C(NCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
16108962 141176 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL385740 141176 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
46911684 15047 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 599 11 3 4 6.3 C=C(CNC(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210753 15047 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 599 11 3 4 6.3 C=C(CNC(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
23627523 73494 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 654 8 2 5 6.3 O=C(CC1c2cc(F)cc(F)c2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018872 73494 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 654 8 2 5 6.3 O=C(CC1c2cc(F)cc(F)c2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
11215189 168217 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 565 9 2 4 5.6 CC(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL437509 168217 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 565 9 2 4 5.6 CC(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
46230306 198512 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 345 4 0 3 3.5 COC(=O)c1c(F)cccc1-c1ccc(CN2CCCC2=O)c(F)c1 10.1016/j.bmcl.2009.11.120
CHEMBL596718 198512 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 345 4 0 3 3.5 COC(=O)c1c(F)cccc1-c1ccc(CN2CCCC2=O)c(F)c1 10.1016/j.bmcl.2009.11.120
23627583 73496 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 655 9 1 5 7.5 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)N[C@H]1CC[C@H](CCN2CCCC2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018874 73496 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 655 9 1 5 7.5 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)N[C@H]1CC[C@H](CCN2CCCC2)CC1 10.1016/j.bmcl.2012.03.065
44410254 75590 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cnccc12 10.1016/j.bmcl.2006.01.069
CHEMBL205242 75590 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cnccc12 10.1016/j.bmcl.2006.01.069
44410020 137679 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 549 7 1 4 5.0 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL377011 137679 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 549 7 1 4 5.0 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
49863236 15048 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 11 3 4 6.5 C=C(CNC1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210754 15048 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 11 3 4 6.5 C=C(CNC1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
23630918 92300 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 544 7 2 6 4.5 Cn1nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c(Br)c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
CHEMBL243650 92300 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 544 7 2 6 4.5 Cn1nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c(Br)c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
11635364 173980 0 None 4 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL455643 173980 0 None 4 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
44410250 75587 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cccnc12 10.1016/j.bmcl.2006.01.069
CHEMBL205227 75587 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cccnc12 10.1016/j.bmcl.2006.01.069
16108968 165574 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 541 10 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL426165 165574 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 541 10 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
16202227 73493 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 636 8 2 5 6.1 O=C(CC1c2cc(F)ccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018871 73493 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 636 8 2 5 6.1 O=C(CC1c2cc(F)ccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
16220915 85095 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 557 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227690 85095 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 557 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
16221108 85092 0 None -22 2 Rabbit 6.4 pIC50 = 6.4 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL227600 85092 0 None -22 2 Rabbit 6.4 pIC50 = 6.4 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
60142165 125361 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 496 5 2 5 3.3 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CC[C@@H]2NC(=O)C1(NC(=O)C(F)(F)F)COC1 nan
CHEMBL3648456 125361 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 496 5 2 5 3.3 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CC[C@@H]2NC(=O)C1(NC(=O)C(F)(F)F)COC1 nan
CHEMBL3038103 209181 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aortaIn vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aorta
ChEMBL None None None NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C1CCCCC1)C1CCCC1 10.1021/jm950716i
11478613 140048 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 567 10 2 5 4.6 COCCNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381372 140048 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 567 10 2 5 4.6 COCCNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
16221229 85128 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 605 10 3 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CNC3CCC3)ccc21 10.1021/jm070055c
CHEMBL227977 85128 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 605 10 3 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CNC3CCC3)ccc21 10.1021/jm070055c
44579850 186573 0 None - 1 Crab-eating macaque 6.3 pIC50 = 6.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 516 7 0 6 3.2 CC(C)N(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL492048 186573 0 None - 1 Crab-eating macaque 6.3 pIC50 = 6.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 516 7 0 6 3.2 CC(C)N(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
49863237 15049 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 625 11 3 4 6.9 C=C(CNC1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210755 15049 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 625 11 3 4 6.9 C=C(CNC1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
11330286 76102 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 549 8 2 4 5.1 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL205981 76102 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 549 8 2 4 5.1 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
60142026 125358 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 480 5 2 4 4.1 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648453 125358 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 480 5 2 4 4.1 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
54583583 61828 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 462 6 2 5 1.3 CS(=O)(=O)N1CCNC(=O)C1CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777880 61828 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 462 6 2 5 1.3 CS(=O)(=O)N1CCNC(=O)C1CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
56594241 65531 0 None -4 2 Rabbit 6.3 pIC50 = 6.3 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1835756 65531 0 None -4 2 Rabbit 6.3 pIC50 = 6.3 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
11663606 192972 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(C[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL530554 192972 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(C[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
23630513 143434 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 542 5 4 5 4.0 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1 10.1021/jm051292n
CHEMBL390272 143434 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 542 5 4 5 4.0 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1 10.1021/jm051292n
11224694 92320 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 447 6 3 4 3.4 O=C(Nc1[nH]nc(C(=O)NCCc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL243667 92320 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 447 6 3 4 3.4 O=C(Nc1[nH]nc(C(=O)NCCc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
44579795 186352 0 None 30 2 Crab-eating macaque 8.3 pIC50 = 8.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 480 8 2 6 2.8 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490201 186352 0 None 30 2 Crab-eating macaque 8.3 pIC50 = 8.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 480 8 2 6 2.8 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
42606292 197848 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 519 6 2 3 5.0 CC1CCC(C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)cc1 10.1016/j.bmcl.2009.11.119
CHEMBL592238 197848 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 519 6 2 3 5.0 CC1CCC(C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)cc1 10.1016/j.bmcl.2009.11.119
60142569 125380 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 426 4 2 5 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648474 125380 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 426 4 2 5 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(N)CC2)no1 nan
11478717 92342 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 576 5 4 5 4.6 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL243679 92342 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 576 5 4 5 4.6 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1Cl 10.1021/jm051292n
16108969 82604 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL218152 82604 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
16108969 82604 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL218152 82604 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
16108960 168682 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL441188 168682 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
60141183 125406 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 8 3.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)n1 nan
CHEMBL3648500 125406 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 8 3.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)n1 nan
11670860 185170 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL486641 185170 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
42606173 197718 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 437 8 2 5 2.9 CC(C)N(C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1)C(C)C 10.1016/j.bmcl.2009.11.119
CHEMBL591112 197718 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 437 8 2 5 2.9 CC(C)N(C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1)C(C)C 10.1016/j.bmcl.2009.11.119
16108963 161406 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL415849 161406 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
23627458 73491 0 None - 1 Rat 7.3 pIC50 = 7.3 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 564 8 2 5 5.0 Cc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018869 73491 0 None - 1 Rat 7.3 pIC50 = 7.3 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 564 8 2 5 5.0 Cc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
44579849 186307 0 None - 1 Crab-eating macaque 6.3 pIC50 = 6.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 438 7 3 5 3.7 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc2cn[nH]c2c1 10.1016/j.bmcl.2008.08.014
CHEMBL489808 186307 0 None - 1 Crab-eating macaque 6.3 pIC50 = 6.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 438 7 3 5 3.7 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc2cn[nH]c2c1 10.1016/j.bmcl.2008.08.014
11452874 151845 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 418 4 3 3 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL397037 151845 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 418 4 3 3 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
44579865 186210 0 None - 1 Crab-eating macaque 7.3 pIC50 = 7.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 9 2 6 3.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CCNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL489203 186210 0 None - 1 Crab-eating macaque 7.3 pIC50 = 7.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 9 2 6 3.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CCNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
11238372 168463 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 563 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL439505 168463 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 563 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
44419100 82737 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 555 11 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL218314 82737 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 555 11 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
44410179 165752 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 573 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL427208 165752 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 573 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.01.069
11373520 151517 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 419 4 3 4 3.7 O=C(Nc1[nH]nc(C(=O)Nc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL396735 151517 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 419 4 3 4 3.7 O=C(Nc1[nH]nc(C(=O)Nc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
16221227 142474 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 614 9 3 6 5.5 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(C#N)cc1 10.1021/jm070055c
CHEMBL389477 142474 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 614 9 3 6 5.5 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(C#N)cc1 10.1021/jm070055c
16221163 85131 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL228030 85131 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/jm070055c
46230892 198837 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 395 4 3 7 2.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)NO)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL598868 198837 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 395 4 3 7 2.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)NO)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
44410269 165570 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 569 11 2 5 5.9 CCCCOc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL426130 165570 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 569 11 2 5 5.9 CCCCOc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
44579652 186584 0 None 57 2 Crab-eating macaque 8.2 pIC50 = 8.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 508 9 1 6 3.6 CCN(CC(=O)N(C)Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL492211 186584 0 None 57 2 Crab-eating macaque 8.2 pIC50 = 8.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 508 9 1 6 3.6 CCN(CC(=O)N(C)Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
44419045 136751 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NC1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL375229 136751 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NC1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
23630809 166795 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 451 4 3 4 2.9 O=C(Nc1[nH]nc(C(=O)N[C@@H]2CN3CCC2CC3)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL429463 166795 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 451 4 3 4 2.9 O=C(Nc1[nH]nc(C(=O)N[C@@H]2CN3CCC2CC3)c1Br)c1ccccc1Cl 10.1021/jm051292n
16221110 84597 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 543 10 3 5 5.0 CCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL224071 84597 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 543 10 3 5 5.0 CCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
16221164 161185 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 577 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(C)(C)C)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL413786 161185 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 577 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(C)(C)C)cc1)c1ccccc1 10.1021/jm070055c
24946267 186401 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 488 7 1 6 2.4 CN1CCC(N2CCN(C(=O)CCNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL490626 186401 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 488 7 1 6 2.4 CN1CCC(N2CCN(C(=O)CCNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
60141184 125407 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 7 2.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)n1 nan
CHEMBL3648501 125407 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 7 2.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)n1 nan
46230307 199530 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 393 4 0 3 4.6 COC(=O)c1c(F)cccc1-c1ccc(CN2Cc3ccccc3C2=O)c(F)c1 10.1016/j.bmcl.2009.11.120
CHEMBL603657 199530 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 393 4 0 3 4.6 COC(=O)c1c(F)cccc1-c1ccc(CN2Cc3ccccc3C2=O)c(F)c1 10.1016/j.bmcl.2009.11.120
44587206 187554 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 575 6 3 6 4.0 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CO)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL498488 187554 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 575 6 3 6 4.0 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CO)ccc21 10.1016/j.bmcl.2008.07.055
44579945 186237 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 478 8 1 6 3.7 CN(Cc1ccc(-n2ccnc2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL489389 186237 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 478 8 1 6 3.7 CN(Cc1ccc(-n2ccnc2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
23630612 91636 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 544 7 2 6 4.5 Cn1nc(NC(=O)c2ccccc2Cl)c(Br)c1C(=O)NCCC1CCN(c2ccncc2)CC1 10.1021/jm051292n
CHEMBL241935 91636 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 544 7 2 6 4.5 Cn1nc(NC(=O)c2ccccc2Cl)c(Br)c1C(=O)NCCC1CCN(c2ccncc2)CC1 10.1021/jm051292n
23630814 151559 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 508 5 4 5 3.3 CC(C)C(=O)Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br 10.1021/jm051292n
CHEMBL396771 151559 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 508 5 4 5 3.3 CC(C)C(=O)Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br 10.1021/jm051292n
57399671 69211 0 None 2 2 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
CHEMBL1934265 69211 0 None 2 2 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
11444270 76351 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 553 7 2 5 5.9 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1csc2ccccc12 10.1016/j.bmcl.2006.01.069
CHEMBL206554 76351 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 553 7 2 5 5.9 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1csc2ccccc12 10.1016/j.bmcl.2006.01.069
24755613 192514 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 474 6 1 6 2.1 CN1CCC(N2CCN(C(=O)CNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL522798 192514 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 474 6 1 6 2.1 CN1CCC(N2CCN(C(=O)CNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
16221160 96808 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 597 10 3 5 6.3 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CNC3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL268911 96808 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 597 10 3 5 6.3 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CNC3CCCCC3)ccc21 10.1021/jm070055c
57399670 69199 0 None 13 2 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
CHEMBL1934253 69199 0 None 13 2 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
11386138 84006 0 None -8 2 Rabbit 8.1 pIC50 = 8.1 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL221998 84006 0 None -8 2 Rabbit 8.1 pIC50 = 8.1 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
16102899 83914 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 480 5 2 2 5.0 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1F 10.1021/jm061094b
CHEMBL221695 83914 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 480 5 2 2 5.0 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1F 10.1021/jm061094b
57390411 69716 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 497 5 2 6 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC3(OCCO3)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939772 69716 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 497 5 2 6 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC3(OCCO3)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
46230458 197530 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 460 6 2 8 4.6 CC(=O)Nc1nonc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
CHEMBL589899 197530 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 460 6 2 8 4.6 CC(=O)Nc1nonc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
11326315 149497 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 374 4 3 3 4.2 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Cl)c1ccccc1Cl 10.1021/jm051292n
CHEMBL395055 149497 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 374 4 3 3 4.2 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Cl)c1ccccc1Cl 10.1021/jm051292n
44410084 76562 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 591 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC(F)(F)F)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL207033 76562 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 591 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC(F)(F)F)ccc21 10.1016/j.bmcl.2006.01.069
60143098 125398 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 428 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648492 125398 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 428 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(N)CC2)no1 nan
23630614 141566 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 620 9 2 6 6.0 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1Cc1ccccc1)c1ccccc1Cl 10.1021/jm051292n
CHEMBL388270 141566 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 620 9 2 6 6.0 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1Cc1ccccc1)c1ccccc1Cl 10.1021/jm051292n
44579944 186205 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 8 1 7 3.8 Cc1nc(-c2ccc(CN(C)C(=O)CNC(=O)c3nc4ccccc4n3Cc3ccccc3)cc2)no1 10.1016/j.bmcl.2008.08.014
CHEMBL489192 186205 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 8 1 7 3.8 Cc1nc(-c2ccc(CN(C)C(=O)CNC(=O)c3nc4ccccc4n3Cc3ccccc3)cc2)no1 10.1016/j.bmcl.2008.08.014
57400697 69712 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 2 5 2.0 CC(=O)N1CCC(NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)c2ccccc21 10.1016/j.bmcl.2011.11.112
CHEMBL1939769 69712 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 2 5 2.0 CC(=O)N1CCC(NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)c2ccccc21 10.1016/j.bmcl.2011.11.112
44410316 140319 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381964 140319 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2006.01.069
11691896 186113 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 504 8 1 4 5.6 O=C(CCCS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL488512 186113 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 504 8 1 4 5.6 O=C(CCCS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
44580046 183656 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 438 7 3 5 3.7 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc2nc[nH]c2c1 10.1016/j.bmcl.2008.08.014
CHEMBL483653 183656 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 438 7 3 5 3.7 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc2nc[nH]c2c1 10.1016/j.bmcl.2008.08.014
60142025 125357 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 7 2 3 5.6 O=C(NC1(C(=O)NC2CCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
CHEMBL3648452 125357 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 7 2 3 5.6 O=C(NC1(C(=O)NC2CCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
57403174 69202 0 None 5 2 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934256 69202 0 None 5 2 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
49863235 15046 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 613 10 3 4 6.7 C=C(CNC(C)(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210752 15046 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 613 10 3 4 6.7 C=C(CNC(C)(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
11421944 85106 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/jm070055c
CHEMBL227778 85106 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/jm070055c
11555599 173018 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 534 9 1 5 5.2 CO[C@H](CCS(=O)(=O)c1ccc2ccccc2c1)C(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL453338 173018 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 534 9 1 5 5.2 CO[C@H](CCS(=O)(=O)c1ccc2ccccc2c1)C(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
11526655 185975 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 534 9 1 5 5.2 CO[C@@H](CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL487823 185975 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 534 9 1 5 5.2 CO[C@@H](CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
57398013 69203 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cc(Cl)ccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934257 69203 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cc(Cl)ccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
57402467 69708 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1ccc2c(c1)CCCC2NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939765 69708 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1ccc2c(c1)CCCC2NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1 10.1016/j.bmcl.2011.11.112
23627520 73492 0 None - 1 Rat 7.1 pIC50 = 7.1 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 580 9 2 6 4.7 COc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018870 73492 0 None - 1 Rat 7.1 pIC50 = 7.1 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 580 9 2 6 4.7 COc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
44410273 76347 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(Cl)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL206541 76347 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(Cl)cc1 10.1016/j.bmcl.2006.01.069
11259614 92820 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 455 6 3 4 2.7 CC[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)C(=O)N(C)C 10.1021/jm051292n
CHEMBL244935 92820 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 455 6 3 4 2.7 CC[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)C(=O)N(C)C 10.1021/jm051292n
60142168 125364 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 7 2 3 6.0 O=C(NC1(C(=O)NC2CCCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
CHEMBL3648459 125364 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 7 2 3 6.0 O=C(NC1(C(=O)NC2CCCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
56951319 69729 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 392 5 3 5 0.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCNCC2)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939927 69729 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 392 5 3 5 0.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCNCC2)cc1 10.1016/j.bmcl.2011.11.112
57395449 69705 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 413 6 2 4 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H](C)c2ccccc2)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939762 69705 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 413 6 2 4 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H](C)c2ccccc2)cc1 10.1016/j.bmcl.2011.11.112
11584184 172533 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 500 8 3 6 2.7 Cc1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL452057 172533 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 500 8 3 6 2.7 Cc1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
46230310 198511 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 569 8 2 10 5.5 COc1cc(C(=O)Nn2c(NCc3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)nc(C)c2C)on1 10.1016/j.bmcl.2009.11.120
CHEMBL596717 198511 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 569 8 2 10 5.5 COc1cc(C(=O)Nn2c(NCc3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)nc(C)c2C)on1 10.1016/j.bmcl.2009.11.120
11555433 188392 0 None -2 2 Rabbit 7.1 pIC50 = 7.1 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL508632 188392 0 None -2 2 Rabbit 7.1 pIC50 = 7.1 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
9804704 92819 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 467 6 3 4 3.5 CN1CCC(CCNC(=O)c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)CC1 10.1021/jm051292n
CHEMBL244934 92819 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 467 6 3 4 3.5 CN1CCC(CCNC(=O)c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)CC1 10.1021/jm051292n
11467345 161390 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL415629 161390 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
49863228 15036 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 639 10 2 4 6.8 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1)N[C@@H]1CCCc2cc(C3(CN4CCCCC4)CC3)ccc21 10.1016/j.bmcl.2010.06.010
CHEMBL1210742 15036 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 639 10 2 4 6.8 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1)N[C@@H]1CCCc2cc(C3(CN4CCCCC4)CC3)ccc21 10.1016/j.bmcl.2010.06.010
44579915 183607 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 514 5 0 6 2.9 CN1CCC(N2CCN(C(=O)[C@@H]3CCCN3C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL483241 183607 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 514 5 0 6 2.9 CN1CCC(N2CCN(C(=O)[C@@H]3CCCN3C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
16102920 82783 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 500 7 2 4 4.7 CCOC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL218553 82783 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 500 7 2 4 4.7 CCOC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
23630512 92109 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 466 7 3 5 4.1 Cc1c(C(=O)NCCC2CCN(c3ccncc3)CC2)n[nH]c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
CHEMBL243208 92109 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 466 7 3 5 4.1 Cc1c(C(=O)NCCC2CCN(c3ccncc3)CC2)n[nH]c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
16221283 85093 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 609 12 3 6 4.9 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227655 85093 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 609 12 3 6 4.9 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
16221109 143503 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 9 3 5 6.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL390311 143503 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 9 3 5 6.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
11387915 15038 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 10 2 4 6.4 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210744 15038 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 10 2 4 6.4 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
16221055 142204 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL389249 142204 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
11685446 186112 0 None 14 2 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
CHEMBL488501 186112 0 None 14 2 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
57395450 69706 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 425 5 2 4 2.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939763 69706 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 425 5 2 4 2.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
44410026 76428 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 567 7 2 5 5.2 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206901 76428 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 567 7 2 5 5.2 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
60142833 125388 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648482 125388 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
57400937 69714 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 454 5 3 5 1.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CC(=O)Nc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939770 69714 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 454 5 3 5 1.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CC(=O)Nc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
16221162 143779 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 611 9 2 5 6.7 CC1CCCC(C)N1Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL390540 143779 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 611 9 2 5 6.7 CC1CCCC(C)N1Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44410368 76393 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 553 7 2 5 4.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206801 76393 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 553 7 2 5 4.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
24946437 186182 0 None - 1 Crab-eating macaque 6.0 pIC50 = 6.0 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 468 7 1 6 2.9 O=C(NCCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL488983 186182 0 None - 1 Crab-eating macaque 6.0 pIC50 = 6.0 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 468 7 1 6 2.9 O=C(NCCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
11605512 173021 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 486 8 3 6 2.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.108
CHEMBL453340 173021 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 486 8 3 6 2.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.108
57401425 69205 0 None 1 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934259 69205 0 None 1 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
57399670 69199 0 None -13 2 Rabbit 7.0 pIC50 = 7.0 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
CHEMBL1934253 69199 0 None -13 2 Rabbit 7.0 pIC50 = 7.0 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
54586518 61846 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 552 7 1 5 3.4 Cc1ccc(S(=O)(=O)N2CCN(C)C(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777963 61846 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 552 7 1 5 3.4 Cc1ccc(S(=O)(=O)N2CCN(C)C(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
642 2266 17 None 2 2 Human 6.0 pIC50 = 6 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL None None None None 10.1021/acs.jmedchem.6b01011
CHEMBL384721 2266 17 None 2 2 Human 6.0 pIC50 = 6 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL None None None None 10.1021/acs.jmedchem.6b01011
57394682 69724 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 391 5 2 4 1.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939922 69724 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 391 5 2 4 1.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2)cc1 10.1016/j.bmcl.2011.11.112
44354176 96294 0 None - 0 Rat 7.0 pKd = 7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 28 10 10 0.6 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL264517 96294 0 None - 0 Rat 7.0 pKd = 7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 28 10 10 0.6 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354059 116545 0 None - 0 Rat 7.0 pKd = 7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 34 11 10 1.8 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](CO)NC(=O)CCCCCCCCCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)O 10.1021/jm980495r
CHEMBL339159 116545 0 None - 0 Rat 7.0 pKd = 7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 34 11 10 1.8 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](CO)NC(=O)CCCCCCCCCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)O 10.1021/jm980495r
44354039 114704 0 None - 0 Rat 6.0 pKd = 6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 883 27 9 10 1.3 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL334538 114704 0 None - 0 Rat 6.0 pKd = 6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 883 27 9 10 1.3 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354174 141015 0 None - 0 Rat 5.0 pKd = 5 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1081 35 14 12 -1.3 NC(N)=NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H](NC(=O)[C@H](CO)NC(=O)CCCCCCCCCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](N)CCCN=C(N)N)C1Cc2ccccc2C1)C(=O)O 10.1021/jm980495r
CHEMBL384846 141015 0 None - 0 Rat 5.0 pKd = 5 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1081 35 14 12 -1.3 NC(N)=NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H](NC(=O)[C@H](CO)NC(=O)CCCCCCCCCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](N)CCCN=C(N)N)C1Cc2ccccc2C1)C(=O)O 10.1021/jm980495r
CHEMBL133560 206968 0 None - 0 Rat 5.0 pKd = 5 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NC1(C(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCC1 10.1021/jm980495r
CHEMBL339389 209865 0 None - 0 Rat 5.9 pKd = 5.9 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NC1(C(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
56668285 62973 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1145 26 13 15 -1.1 C=C([C@H]1Cc2ccccc2CN1C(=O)[C@H](CO)CC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL1793829 62973 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1145 26 13 15 -1.1 C=C([C@H]1Cc2ccccc2CN1C(=O)[C@H](CO)CC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL2370699 208160 4 None - 0 Rat 7.7 pKd = 7.7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](N)CCCN=C(N)N)C1Cc2ccccc2C1)C1Cc2ccccc2C1)C(=O)O 10.1021/jm980495r
44354162 24184 0 None - 0 Rat 5.7 pKd = 5.7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 840 22 10 10 -1.7 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL134135 24184 0 None - 0 Rat 5.7 pKd = 5.7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 840 22 10 10 -1.7 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354032 155194 0 None - 0 Rat 5.7 pKd = 5.7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1037 26 12 12 -1.4 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCC(=O)NC1(C(=O)NCCCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
CHEMBL405644 155194 0 None - 0 Rat 5.7 pKd = 5.7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1037 26 12 12 -1.4 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCC(=O)NC1(C(=O)NCCCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
44354038 19640 0 None - 0 Rat 6.6 pKd = 6.6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 28 9 10 1.5 CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL130222 19640 0 None - 0 Rat 6.6 pKd = 6.6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 28 9 10 1.5 CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354033 96583 0 None - 0 Rat 5.6 pKd = 5.6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1009 24 12 12 -2.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCC(=O)NC1(C(=O)NCCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
CHEMBL266975 96583 0 None - 0 Rat 5.6 pKd = 5.6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1009 24 12 12 -2.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCC(=O)NC1(C(=O)NCCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
CHEMBL131647 206940 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NC1(C(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCCC1 10.1021/jm980495r
16108961 908 0 None 2 3 Human 7.4 pKd = 7.4 Functional
Antagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical veinAntagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical vein
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 908 0 None 2 3 Human 7.4 pKd = 7.4 Functional
Antagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical veinAntagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical vein
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 908 0 None 2 3 Human 7.4 pKd = 7.4 Functional
Antagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical veinAntagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical vein
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
44354214 114996 0 None - 0 Rat 5.4 pKd = 5.4 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 869 24 10 10 -1.0 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL335247 114996 0 None - 0 Rat 5.4 pKd = 5.4 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 869 24 10 10 -1.0 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354175 96447 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1025 35 12 12 0.8 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@@H]1C(=O)O)C1Cc2ccccc2C1 10.1021/jm980495r
CHEMBL265814 96447 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1025 35 12 12 0.8 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@@H]1C(=O)O)C1Cc2ccccc2C1 10.1021/jm980495r
44354187 116287 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 29 11 10 0.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)O)C[C@H]2CCCC[C@H]21)C1Cc2ccccc2C1 10.1021/jm980495r
CHEMBL337833 116287 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 29 11 10 0.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)O)C[C@H]2CCCC[C@H]21)C1Cc2ccccc2C1 10.1021/jm980495r
CHEMBL410363 211059 17 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)O 10.1021/jm980495r
CHEMBL133164 206961 0 None - 0 Rat 5.2 pKd = 5.2 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NC1(C(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCCCC1 10.1021/jm980495r
CHEMBL218454 207642 0 None - 0 Rat 5.2 pKd = 5.2 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCC(=O)NC1(C(=O)NCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
CHEMBL2370700 208161 0 None - 0 Rat 8.1 pKd = 8.1 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C1Cc2ccccc2C1)C1Cc2ccccc2C1 10.1021/jm980495r
44354179 165031 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 911 27 10 10 0.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL424272 165031 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 911 27 10 10 0.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354239 141057 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1011 33 11 12 0.9 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL385081 141057 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1011 33 11 12 0.9 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
11620871 165471 0 None - 0 Human 10.4 pKi = 10.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assay
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1021/jm200371q
CHEMBL425588 165471 0 None - 0 Human 10.4 pKi = 10.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assay
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1021/jm200371q
53248885 61841 0 None 18 2 Human 10.0 pKi = 10 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1021/jm200808v
CHEMBL1777958 61841 0 None 18 2 Human 10.0 pKi = 10 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1021/jm200808v
11342704 61839 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 642 7 2 6 4.2 O=C(CC1C(=O)NCCN1S(=O)(=O)c1sc(Cl)cc1Br)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777956 61839 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 642 7 2 6 4.2 O=C(CC1C(=O)NCCN1S(=O)(=O)c1sc(Cl)cc1Br)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11215677 61840 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 614 7 2 6 4.6 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cc2cc(Cl)ccc2s1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777957 61840 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 614 7 2 6 4.6 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cc2cc(Cl)ccc2s1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
44587187 188115 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL504531 188115 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54582655 61852 0 None - 1 Human 10.0 pKi = 10.0 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 2 5 3.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCC(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777969 61852 0 None - 1 Human 10.0 pKi = 10.0 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 2 5 3.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCC(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
25195622 61838 0 None - 1 Human 9.9 pKi = 9.9 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 606 7 2 5 4.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2011.03.115
CHEMBL1777955 61838 0 None - 1 Human 9.9 pKi = 9.9 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 606 7 2 5 4.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2011.03.115
11215488 61837 0 None - 1 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777954 61837 0 None - 1 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
53248885 61841 0 None 18 2 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777958 61841 0 None 18 2 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
54580628 61827 0 None - 1 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777879 61827 0 None - 1 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54583617 61851 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 7 2 6 2.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777968 61851 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 7 2 6 2.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
54581634 61832 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777884 61832 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54586519 61860 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 9 3 5 2.6 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777977 61860 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 9 3 5 2.6 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
11341479 61861 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 526 9 3 5 2.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777978 61861 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 526 9 3 5 2.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594769 65380 0 None 6 2 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834619 65380 0 None 6 2 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
11214819 61833 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777885 61833 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
11387387 61850 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777967 61850 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
16221282 85098 0 None 13 2 Human 9.4 pKi = 9.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL227713 85098 0 None 13 2 Human 9.4 pKi = 9.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11168954 61830 0 None - 1 Human 9.4 pKi = 9.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777882 61830 0 None - 1 Human 9.4 pKi = 9.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11342350 61835 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777887 61835 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54587552 61849 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 7 2 5 2.7 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777966 61849 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 7 2 5 2.7 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54581667 61858 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 8 3 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777975 61858 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 8 3 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
54581635 61834 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 554 8 2 6 2.8 COc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777886 61834 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 554 8 2 6 2.8 COc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56589598 65436 0 None 7 2 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
CHEMBL1834751 65436 0 None 7 2 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
54772237 65437 0 None 6 2 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
CHEMBL1834752 65437 0 None 6 2 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
54587514 61831 0 None - 1 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777883 61831 0 None - 1 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
56594642 65377 0 None 21 2 Human 9.1 pKi = 9.1 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834616 65377 0 None 21 2 Human 9.1 pKi = 9.1 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
9894973 101275 0 None - 0 Rat 9.0 pKi = 9.0 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1016/j.bmcl.2008.08.014
CHEMBL299832 101275 0 None - 0 Rat 9.0 pKi = 9.0 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1016/j.bmcl.2008.08.014
54582656 61857 0 None - 1 Human 9.0 pKi = 9.0 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 510 8 3 5 2.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777974 61857 0 None - 1 Human 9.0 pKi = 9.0 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 510 8 3 5 2.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
11364466 61829 0 None - 1 Human 8.9 pKi = 8.9 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 7 2 5 2.7 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777881 61829 0 None - 1 Human 8.9 pKi = 8.9 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 7 2 5 2.7 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54587553 61862 0 None - 1 Human 8.8 pKi = 8.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 8 3 5 3.2 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777979 61862 0 None - 1 Human 8.8 pKi = 8.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 8 3 5 3.2 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594640 65375 0 None - 0 Human 8.7 pKi = 8.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 524 5 1 5 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(F)cccc12 10.1021/jm200808v
CHEMBL1834614 65375 0 None - 0 Human 8.7 pKi = 8.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 524 5 1 5 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(F)cccc12 10.1021/jm200808v
54581666 61853 0 None - 1 Human 8.7 pKi = 8.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 566 7 2 5 3.7 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC(C)(C)C4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777970 61853 0 None - 1 Human 8.7 pKi = 8.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 566 7 2 5 3.7 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC(C)(C)C4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
10388673 71044 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1021/jm1013693
CHEMBL195883 71044 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1021/jm1013693
16221282 85098 0 None - 2 Rat 6.9 pKi = 6.9 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL227713 85098 0 None - 2 Rat 6.9 pKi = 6.9 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
16221108 85092 0 None - 2 Rat 6.8 pKi = 6.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL227600 85092 0 None - 2 Rat 6.8 pKi = 6.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
56594371 65535 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 508 5 1 4 6.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2csc3ccccc3c2=O)c1 10.1021/jm200808v
CHEMBL1835760 65535 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 508 5 1 4 6.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2csc3ccccc3c2=O)c1 10.1021/jm200808v
16102897 86797 13 None - 1 Rat 5.8 pKi = 5.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2008.08.014
CHEMBL232943 86797 13 None - 1 Rat 5.8 pKi = 5.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2008.08.014
56672397 65527 0 None - 1 Human 5.8 pKi = 5.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 432 9 1 3 5.6 O=C(CCCCC(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm200808v
CHEMBL1835752 65527 0 None - 1 Human 5.8 pKi = 5.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 432 9 1 3 5.6 O=C(CCCCC(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm200808v
54580655 61845 0 None - 1 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 566 7 2 5 3.8 Cc1ccc(S(=O)(=O)N2CC(C)(C)NC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777962 61845 0 None - 1 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 566 7 2 5 3.8 Cc1ccc(S(=O)(=O)N2CC(C)(C)NC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594372 65536 0 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 508 5 1 4 6.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2csc3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1835761 65536 0 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 508 5 1 4 6.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2csc3ccccc3c2=O)cc1 10.1021/jm200808v
56594242 65532 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1835757 65532 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1021/jm200808v
44569935 168914 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 646 13 1 6 5.3 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL443207 168914 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 646 13 1 6 5.3 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Cl 10.1016/j.bmcl.2008.11.005
56594643 65378 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cc(Cl)ccc12 10.1021/jm200808v
CHEMBL1834617 65378 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cc(Cl)ccc12 10.1021/jm200808v
11284304 61855 0 None - 1 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 553 7 2 6 1.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCN(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777972 61855 0 None - 1 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 553 7 2 6 1.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCN(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594772 65435 0 None 15 2 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834750 65435 0 None 15 2 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
16221056 85120 0 None - 2 Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227870 85120 0 None - 2 Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
56594507 65542 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 534 6 1 5 6.3 CC(C)c1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
CHEMBL1835768 65542 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 534 6 1 5 6.3 CC(C)c1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
11284458 140045 2 None - 1 Human 7.6 pKi = 7.6 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2011.03.115
CHEMBL381366 140045 2 None - 1 Human 7.6 pKi = 7.6 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2011.03.115
44569936 172604 0 None - 0 Human 6.6 pKi = 6.6 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 627 14 1 6 5.9 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCCCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL452238 172604 0 None - 0 Human 6.6 pKi = 6.6 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 627 14 1 6 5.9 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCCCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
56594506 65541 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 520 6 1 5 5.7 CCc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
CHEMBL1835767 65541 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 520 6 1 5 5.7 CCc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
56658544 65528 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1ccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1)c1ccccc1 10.1021/jm200808v
CHEMBL1835753 65528 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1ccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1)c1ccccc1 10.1021/jm200808v
11272685 61854 0 None - 1 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 7 2 6 1.9 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCOCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777971 61854 0 None - 1 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 7 2 6 1.9 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCOCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594770 65382 0 None 7 2 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834620 65382 0 None 7 2 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
56594641 65376 0 None - 0 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 542 5 1 5 5.8 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
CHEMBL1834615 65376 0 None - 0 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 542 5 1 5 5.8 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
54587550 61842 0 None - 1 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777959 61842 0 None - 1 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56679097 65530 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1cccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)c1)c1ccccc1 10.1021/jm200808v
CHEMBL1835755 65530 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1cccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)c1)c1ccccc1 10.1021/jm200808v
56594243 65533 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 505 5 1 4 6.0 Cn1cc(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc21 10.1021/jm200808v
CHEMBL1835758 65533 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 505 5 1 4 6.0 Cn1cc(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc21 10.1021/jm200808v
56594374 65538 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
CHEMBL1835763 65538 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
11495796 73173 0 None - 0 Human 5.5 pKi = 5.5 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 436 7 2 4 3.6 COC(=O)c1ccccc1-c1ccc(CNC(=O)C(C)(C)NC(=O)CC(F)(F)F)cc1 10.1021/jm1013693
CHEMBL201717 73173 0 None - 0 Human 5.5 pKi = 5.5 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 436 7 2 4 3.6 COC(=O)c1ccccc1-c1ccc(CNC(=O)C(C)(C)NC(=O)CC(F)(F)F)cc1 10.1021/jm1013693
25181410 171638 1 None - 0 Human 7.4 pKi = 7.4 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL447392 171638 1 None - 0 Human 7.4 pKi = 7.4 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
11635365 173979 0 None 2 2 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1021/jm200808v
CHEMBL455642 173979 0 None 2 2 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1021/jm200808v
54585540 61859 0 None - 1 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 526 7 3 5 3.0 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777976 61859 0 None - 1 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 526 7 3 5 3.0 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594768 65379 0 None - 0 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccc(Cl)cc12 10.1021/jm200808v
CHEMBL1834618 65379 0 None - 0 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccc(Cl)cc12 10.1021/jm200808v
56594639 65374 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 568 6 1 5 6.8 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2nc(-c3ccccc3)c3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1834613 65374 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 568 6 1 5 6.8 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2nc(-c3ccccc3)c3ccccc3c2=O)cc1 10.1021/jm200808v
54586518 61846 0 None - 1 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 1 5 3.4 Cc1ccc(S(=O)(=O)N2CCN(C)C(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777963 61846 0 None - 1 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 1 5 3.4 Cc1ccc(S(=O)(=O)N2CCN(C)C(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44569938 188302 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 629 14 1 7 4.7 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCOCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL507546 188302 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 629 14 1 7 4.7 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCOCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
25181411 188694 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 587 14 1 6 5.0 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN(C)C)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL512111 188694 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 587 14 1 6 5.0 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN(C)C)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
54584600 61848 0 None - 1 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CC(=O)NCC2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777965 61848 0 None - 1 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CC(=O)NCC2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
54581664 61843 0 None - 1 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777960 61843 0 None - 1 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594505 65540 0 None - 0 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 5 5.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2ncc3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1835766 65540 0 None - 0 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 5 5.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2ncc3ccccc3c2=O)cc1 10.1021/jm200808v
54583583 61828 0 None - 1 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 462 6 2 5 1.3 CS(=O)(=O)N1CCNC(=O)C1CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777880 61828 0 None - 1 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 462 6 2 5 1.3 CS(=O)(=O)N1CCNC(=O)C1CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54587551 61844 0 None - 1 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777961 61844 0 None - 1 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56668920 65529 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1ccccc1)c1cccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)c1 10.1021/jm200808v
CHEMBL1835754 65529 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1ccccc1)c1cccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)c1 10.1021/jm200808v
54585539 61856 0 None - 1 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777973 61856 0 None - 1 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594504 65539 0 None - 0 Human 6.2 pKi = 6.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 5 5.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2cnc3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1835765 65539 0 None - 0 Human 6.2 pKi = 6.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 5 5.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2cnc3ccccc3c2=O)cc1 10.1021/jm200808v
11546560 73573 0 None - 0 Human 7.2 pKi = 7.2 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 434 7 2 4 3.4 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)cc1 10.1021/jm1013693
CHEMBL202089 73573 0 None - 0 Human 7.2 pKi = 7.2 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 434 7 2 4 3.4 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)cc1 10.1021/jm1013693
56594373 65537 0 None - 1 Human 5.2 pKi = 5.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1021/jm200808v
CHEMBL1835762 65537 0 None - 1 Human 5.2 pKi = 5.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1021/jm200808v
56594241 65531 0 None 4 2 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1021/jm200808v
CHEMBL1835756 65531 0 None 4 2 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1021/jm200808v
56594771 65434 0 None 2 2 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
CHEMBL1834749 65434 0 None 2 2 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
54581665 61847 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 2 5 3.4 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2(C)CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777964 61847 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 2 5 3.4 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2(C)CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44411297 76993 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assay
ChEMBL 354 5 1 4 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccccn2)c(F)c1 10.1021/jm200371q
CHEMBL208538 76993 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assay
ChEMBL 354 5 1 4 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccccn2)c(F)c1 10.1021/jm200371q
56594508 65543 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 560 5 1 5 6.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2nc(C(F)(F)F)c3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1835769 65543 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 560 5 1 5 6.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2nc(C(F)(F)F)c3ccccc3c2=O)cc1 10.1021/jm200808v
653 559 0 None -199 3 Mouse 6.1 pA2 = 6.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9650825
123884 2264 13 None - 1 Mouse 6.9 pA2 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
641 2264 13 None - 1 Mouse 6.9 pA2 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
CHEMBL80472 2264 13 None - 1 Mouse 6.9 pA2 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
642 2266 17 None -2 2 Mouse 7.0 pA2 = 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
CHEMBL384721 2266 17 None -2 2 Mouse 7.0 pA2 = 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
661 3215 0 None -31 2 Mouse 7.0 pA2 = 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
663 1345 0 None - 1 Mouse 7.2 pA2 = 7.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9650825
653 559 0 None -5 3 Human 7.7 pA2 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9650825
661 3215 0 None 31 2 Human 8.5 pA2 = 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8901831
101865250 3216 0 None - 1 Human 8.6 pA2 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None NCCC[C@@H](C(=O)N[C@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)O)Cc1ccc2c(c1)cccc2)CO)(Cc1ccccc1)C)CCCN=C(N)N)NC(=O)C 24361511
3906 3216 0 None - 1 Human 8.6 pA2 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None NCCC[C@@H](C(=O)N[C@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)O)Cc1ccc2c(c1)cccc2)CO)(Cc1ccccc1)C)CCCN=C(N)N)NC(=O)C 24361511
654 560 0 None - 1 Human 9.2 pA2 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9650825
123884 2264 13 None - 1 Mouse 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
641 2264 13 None - 1 Mouse 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
CHEMBL80472 2264 13 None - 1 Mouse 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
642 2266 17 None 2 2 Human 8.9 pIC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
CHEMBL384721 2266 17 None 2 2 Human 8.9 pIC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
10254 2765 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 26565554
3035449 2470 0 None -39 3 Human 7.1 pIC50 None 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
638 2470 0 None -39 3 Human 7.1 pIC50 None 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
16108961 908 0 None -2 3 Rat 8.4 pIC50 None 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660
664 908 0 None -2 3 Rat 8.4 pIC50 None 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660
CHEMBL415848 908 0 None -2 3 Rat 8.4 pIC50 None 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660
16108961 908 0 None 2 3 Human 8.5 pIC50 None 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660
664 908 0 None 2 3 Human 8.5 pIC50 None 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660
CHEMBL415848 908 0 None 2 3 Human 8.5 pIC50 None 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
665 957 2 None - 2 Rabbit 9.6 pIC50 = 9.6 Binding
Inhibition of rabbit bradykinin B1 receptorInhibition of rabbit bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
9916412 957 2 None - 2 Rabbit 9.6 pIC50 = 9.6 Binding
Inhibition of rabbit bradykinin B1 receptorInhibition of rabbit bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
CHEMBL189123 957 2 None - 2 Rabbit 9.6 pIC50 = 9.6 Binding
Inhibition of rabbit bradykinin B1 receptorInhibition of rabbit bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
122227 1346 27 None 6 3 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
3825 1346 27 None 6 3 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
644 1346 27 None 6 3 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
CHEMBL264100 1346 27 None 6 3 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
44579694 192531 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 486 7 3 5 3.6 Cc1c(C(=O)NCCC2CCN(C3CCN(C)CC3)CC2)n[nH]c1NC(=O)c1ccccc1Cl 10.1016/j.bmcl.2008.08.014
CHEMBL522947 192531 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 486 7 3 5 3.6 Cc1c(C(=O)NCCC2CCN(C3CCN(C)CC3)CC2)n[nH]c1NC(=O)c1ccccc1Cl 10.1016/j.bmcl.2008.08.014
10031511 16750 0 None 1 2 Human 8.7 pIC50 = 8.7 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1253497 16750 0 None 1 2 Human 8.7 pIC50 = 8.7 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
11204003 76853 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 579 7 2 4 6.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2006.01.069
CHEMBL207947 76853 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 579 7 2 4 6.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2006.01.069
44410020 137679 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 549 7 1 4 5.0 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL377011 137679 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 549 7 1 4 5.0 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
44410316 140319 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381964 140319 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2006.01.069
44410269 165570 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 569 11 2 5 5.9 CCCCOc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL426130 165570 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 569 11 2 5 5.9 CCCCOc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
11215189 168217 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 565 9 2 4 5.6 CC(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL437509 168217 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 565 9 2 4 5.6 CC(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
11444270 76351 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 553 7 2 5 5.9 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1csc2ccccc12 10.1016/j.bmcl.2006.01.069
CHEMBL206554 76351 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 553 7 2 5 5.9 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1csc2ccccc12 10.1016/j.bmcl.2006.01.069
11444165 140335 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 545 7 2 4 5.7 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1Cl 10.1016/j.bmcl.2006.01.069
CHEMBL381979 140335 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 545 7 2 4 5.7 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1Cl 10.1016/j.bmcl.2006.01.069
11512379 165441 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 555 7 2 7 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2nsnc12 10.1016/j.bmcl.2006.01.069
CHEMBL425416 165441 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 555 7 2 7 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2nsnc12 10.1016/j.bmcl.2006.01.069
44410368 76393 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 553 7 2 5 4.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206801 76393 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 553 7 2 5 4.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
11203826 139579 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 563 9 2 4 5.3 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL380117 139579 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 563 9 2 4 5.3 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
44410026 76428 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 567 7 2 5 5.2 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206901 76428 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 567 7 2 5 5.2 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
665 957 2 None -1023 2 Rat 6.8 pIC50 = 6.8 Binding
Inhibition of rat bradykinin B1 receptorInhibition of rat bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
9916412 957 2 None -1023 2 Rat 6.8 pIC50 = 6.8 Binding
Inhibition of rat bradykinin B1 receptorInhibition of rat bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
CHEMBL189123 957 2 None -1023 2 Rat 6.8 pIC50 = 6.8 Binding
Inhibition of rat bradykinin B1 receptorInhibition of rat bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
10187347 192747 0 None - 1 Human 6.8 pIC50 = 6.8 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 544 7 2 5 5.5 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(N(C)C)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL52498 192747 0 None - 1 Human 6.8 pIC50 = 6.8 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 544 7 2 5 5.5 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(N(C)C)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
44410143 76968 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 497 7 2 4 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2006.01.069
CHEMBL208386 76968 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 497 7 2 4 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2006.01.069
44410084 76562 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 591 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC(F)(F)F)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL207033 76562 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 591 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC(F)(F)F)ccc21 10.1016/j.bmcl.2006.01.069
10031511 16750 0 None -1 2 Rat 8.6 pIC50 = 8.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1253497 16750 0 None -1 2 Rat 8.6 pIC50 = 8.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
10031511 16750 0 None -1 2 Rat 8.6 pIC50 = 8.6 Binding
Inhibition of rat bradykinin B1 receptorInhibition of rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
CHEMBL1253497 16750 0 None -1 2 Rat 8.6 pIC50 = 8.6 Binding
Inhibition of rat bradykinin B1 receptorInhibition of rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
11478613 140048 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 567 10 2 5 4.6 COCCNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381372 140048 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 567 10 2 5 4.6 COCCNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44410250 75587 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cccnc12 10.1016/j.bmcl.2006.01.069
CHEMBL205227 75587 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cccnc12 10.1016/j.bmcl.2006.01.069
10875606 62729 0 None - 1 Human 5.7 pIC50 = 5.7 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1788318 62729 0 None - 1 Human 5.7 pIC50 = 5.7 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
11284458 140045 2 None - 1 Human 7.6 pIC50 = 7.6 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381366 140045 2 None - 1 Human 7.6 pIC50 = 7.6 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
11017305 59993 0 None - 1 Rat 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744084 59993 0 None - 1 Rat 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
11071992 59991 0 None 3 2 Human 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744082 59991 0 None 3 2 Human 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
11039234 59994 0 None -1 2 Rat 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744085 59994 0 None -1 2 Rat 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
44455075 94895 0 None - 1 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 482 5 2 5 4.5 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL256671 94895 0 None - 1 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 482 5 2 5 4.5 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
44410186 76849 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 615 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(C(F)(F)C(F)(F)F)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL207945 76849 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 615 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(C(F)(F)C(F)(F)F)cc1 10.1016/j.bmcl.2006.01.069
16726096 154717 7 None 2 4 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 154717 7 None 2 4 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
11050306 59992 0 None 1 2 Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744083 59992 0 None 1 2 Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
44455035 95267 0 None - 1 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 7 3.4 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.11.050
CHEMBL258324 95267 0 None - 1 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 7 3.4 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.11.050
44455108 154593 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL402114 154593 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
11330286 76102 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 549 8 2 4 5.1 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL205981 76102 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 549 8 2 4 5.1 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
44410273 76347 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(Cl)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL206541 76347 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(Cl)cc1 10.1016/j.bmcl.2006.01.069
11238372 168463 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 563 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL439505 168463 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 563 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
11071992 59991 0 None -3 2 Rat 7.2 pIC50 = 7.2 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744082 59991 0 None -3 2 Rat 7.2 pIC50 = 7.2 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
11307733 74532 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 579 8 2 4 6.0 CC(C)(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL203174 74532 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 579 8 2 4 6.0 CC(C)(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44455073 95129 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 506 5 2 6 5.0 Cc1noc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
CHEMBL257729 95129 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 506 5 2 6 5.0 Cc1noc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
44455038 95268 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 6 4.5 Cc1noc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
CHEMBL258326 95268 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 6 4.5 Cc1noc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
44410254 75590 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cnccc12 10.1016/j.bmcl.2006.01.069
CHEMBL205242 75590 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cnccc12 10.1016/j.bmcl.2006.01.069
44410328 75637 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 537 7 1 4 4.9 CN(C)Cc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL205501 75637 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 537 7 1 4 4.9 CN(C)Cc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
11284303 65995 0 None -2 2 Human 5.2 pIC50 = 5.2 Binding
Inhibition of Bradykinin receptor B1 expressed in HEK293 cellsInhibition of Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 553 15 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
CHEMBL185068 65995 0 None -2 2 Human 5.2 pIC50 = 5.2 Binding
Inhibition of Bradykinin receptor B1 expressed in HEK293 cellsInhibition of Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 553 15 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
11039234 59994 0 None 1 2 Human 7.2 pIC50 = 7.2 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744085 59994 0 None 1 2 Human 7.2 pIC50 = 7.2 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
44410179 165752 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 573 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL427208 165752 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 573 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.01.069
11050306 59992 0 None -1 2 Rat 8.1 pIC50 = 8.1 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744083 59992 0 None -1 2 Rat 8.1 pIC50 = 8.1 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
11214998 76187 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 551 8 2 4 5.3 CC(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206247 76187 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 551 8 2 4 5.3 CC(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44410313 75434 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 527 8 2 5 4.7 COc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL204847 75434 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 527 8 2 5 4.7 COc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
11017305 59993 0 None - 1 Human 8.1 pIC50 = 8.1 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744084 59993 0 None - 1 Human 8.1 pIC50 = 8.1 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
11420875 76969 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 511 7 2 4 5.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL208387 76969 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 511 7 2 4 5.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
11757682 121513 0 None 2 4 Human 10.8 pKd = 10.8 Binding
Equilibrium dissociation constant of the [35S]- radiolabeled compound against human Bradykinin receptor B1 expressed in CHO membranes was determinedEquilibrium dissociation constant of the [35S]- radiolabeled compound against human Bradykinin receptor B1 expressed in CHO membranes was determined
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 121513 0 None 2 4 Human 10.8 pKd = 10.8 Binding
Equilibrium dissociation constant of the [35S]- radiolabeled compound against human Bradykinin receptor B1 expressed in CHO membranes was determinedEquilibrium dissociation constant of the [35S]- radiolabeled compound against human Bradykinin receptor B1 expressed in CHO membranes was determined
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11444808 53656 0 None - 1 Human 11.0 pKi = 11 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 601 8 3 6 4.1 O=C(C[C@@H]1C(=O)Nc2ccc(Cl)cc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL160547 53656 0 None - 1 Human 11.0 pKi = 11 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 601 8 3 6 4.1 O=C(C[C@@H]1C(=O)Nc2ccc(Cl)cc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11757682 121513 0 None 2 4 Human 10.7 pKi = 10.7 Binding
Binding affinity of the [35S]- radiolabeled compound to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity of the [35S]- radiolabeled compound to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 121513 0 None 2 4 Human 10.7 pKi = 10.7 Binding
Binding affinity of the [35S]- radiolabeled compound to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity of the [35S]- radiolabeled compound to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11757682 121513 0 None 2 4 Human 10.7 pKi = 10.7 Binding
Binding affinity of the [35S]- radiolabeled compound to rhesus monkey Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rhesus monkey Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 121513 0 None 2 4 Human 10.7 pKi = 10.7 Binding
Binding affinity of the [35S]- radiolabeled compound to rhesus monkey Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rhesus monkey Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11319515 66381 0 None - 1 Human 10.7 pKi = 10.7 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 615 8 2 6 4.5 CN1CCN=C1c1ccc(CCNC(=O)C[C@@H]2C(=O)Nc3ccc(Cl)cc3N2S(=O)(=O)c2ccc3ccccc3c2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL185693 66381 0 None - 1 Human 10.7 pKi = 10.7 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 615 8 2 6 4.5 CN1CCN=C1c1ccc(CCNC(=O)C[C@@H]2C(=O)Nc3ccc(Cl)cc3N2S(=O)(=O)c2ccc3ccccc3c2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL3085458 209232 3 None 398 2 Human 10.6 pKi = 10.6 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990961s
CHEMBL3085458 209232 3 None 398 2 Human 10.6 pKi = 10.6 Binding
Binding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligandBinding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligand
ChEMBL None None None NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990962k
665 957 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2004.09.074
9916412 957 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2004.09.074
CHEMBL189123 957 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2004.09.074
665 957 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
9916412 957 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
CHEMBL189123 957 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
665 957 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2012.03.065
9916412 957 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2012.03.065
CHEMBL189123 957 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2012.03.065
665 957 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
9916412 957 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
CHEMBL189123 957 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
665 957 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
9916412 957 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
CHEMBL189123 957 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
90662943 106089 0 None 1778 2 Human 10.5 pKi = 10.5 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1192 30 14 17 -4.3 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990961s
CHEMBL3142391 106089 0 None 1778 2 Human 10.5 pKi = 10.5 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1192 30 14 17 -4.3 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990961s
665 957 2 None 1023 2 Human 10.4 pKi = 10.4 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
9916412 957 2 None 1023 2 Human 10.4 pKi = 10.4 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
CHEMBL189123 957 2 None 1023 2 Human 10.4 pKi = 10.4 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
11620871 165471 0 None - 1 Human 10.4 pKi = 10.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL425588 165471 0 None - 1 Human 10.4 pKi = 10.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11570120 69698 0 None - 1 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 536 7 2 5 3.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939755 69698 0 None - 1 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 536 7 2 5 3.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
665 957 2 None 1023 2 Human 10.3 pKi = 10.3 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
9916412 957 2 None 1023 2 Human 10.3 pKi = 10.3 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
CHEMBL189123 957 2 None 1023 2 Human 10.3 pKi = 10.3 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
11757682 121513 0 None -2 4 Rabbit 10.3 pKi = 10.3 Binding
Binding affinity of the [35S]- radiolabeled compound to rabbit Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rabbit Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 121513 0 None -2 4 Rabbit 10.3 pKi = 10.3 Binding
Binding affinity of the [35S]- radiolabeled compound to rabbit Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rabbit Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11620871 165471 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to human BK1 receptor E273 mutantBinding affinity to human BK1 receptor E273 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL425588 165471 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to human BK1 receptor E273 mutantBinding affinity to human BK1 receptor E273 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11365433 66386 0 None - 1 Human 10.2 pKi = 10.2 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 599 8 3 5 5.1 O=C(C[C@@H]1C(=O)Nc2ccc(Cl)cc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(-c2ncc[nH]2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL185727 66386 0 None - 1 Human 10.2 pKi = 10.2 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 599 8 3 5 5.1 O=C(C[C@@H]1C(=O)Nc2ccc(Cl)cc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(-c2ncc[nH]2)cc1 10.1016/j.bmcl.2004.09.074
11180561 66403 0 None - 1 Human 10.2 pKi = 10.2 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 565 8 3 5 4.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(-c2ncc[nH]2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL185811 66403 0 None - 1 Human 10.2 pKi = 10.2 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 565 8 3 5 4.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(-c2ncc[nH]2)cc1 10.1016/j.bmcl.2004.09.074
11620871 165471 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL425588 165471 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44587187 188115 0 None - 1 Human 10.0 pKi = 10 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL504531 188115 0 None - 1 Human 10.0 pKi = 10 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
10288906 135862 0 None - 1 Human 9.9 pKi = 9.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 4.2 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL373530 135862 0 None - 1 Human 9.9 pKi = 9.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 4.2 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
44587186 172139 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 642 7 2 6 5.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL450541 172139 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 642 7 2 6 5.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
53248885 61841 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1777958 61841 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
24970287 187829 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 574 7 2 6 4.2 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL502140 187829 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 574 7 2 6 4.2 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
57397292 69701 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 522 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939758 69701 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 522 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
16041612 172389 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL451761 172389 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
44455519 97406 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 8 2 3 5.8 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL272278 97406 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 8 2 3 5.8 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
11387624 159017 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 576 9 2 6 5.6 C[C@@H](NC(=O)C1(NC(=O)c2cc(Cl)no2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL410281 159017 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 576 9 2 6 5.6 C[C@@H](NC(=O)C1(NC(=O)c2cc(Cl)no2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
11352746 77158 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.6 CCN1CCC(N2CCN(C(=O)COCCN(C)S(=O)(=O)c3c(C)cc(OC)cc3C)CC2)CC1 10.1021/jm2016057
CHEMBL2087422 77158 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.6 CCN1CCC(N2CCN(C(=O)COCCN(C)S(=O)(=O)c3c(C)cc(OC)cc3C)CC2)CC1 10.1021/jm2016057
44316161 160957 0 None 1 2 Human 9.7 pKi = 9.7 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1043 25 12 16 -4.0 NCCCCC(N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)NC(Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O 10.1021/jm990961s
CHEMBL412824 160957 0 None 1 2 Human 9.7 pKi = 9.7 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1043 25 12 16 -4.0 NCCCCC(N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)NC(Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O 10.1021/jm990961s
122227 1346 27 None 6 3 Human 9.7 pKi = 9.7 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
3825 1346 27 None 6 3 Human 9.7 pKi = 9.7 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
644 1346 27 None 6 3 Human 9.7 pKi = 9.7 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
CHEMBL264100 1346 27 None 6 3 Human 9.7 pKi = 9.7 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
44587189 171865 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL447870 171865 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
16108969 82604 0 None 239883 2 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL218152 82604 0 None 239883 2 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
44587189 171865 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.055
CHEMBL447870 171865 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.055
16108969 82604 0 None 239883 2 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL218152 82604 0 None 239883 2 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
24895452 185707 0 None - 1 Human 9.6 pKi = 9.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 520 10 3 5 4.7 O=C(NCCCN1CCCCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487445 185707 0 None - 1 Human 9.6 pKi = 9.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 520 10 3 5 4.7 O=C(NCCCN1CCCCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
24895452 185707 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 520 10 3 5 4.7 O=C(NCCCN1CCCCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm1000776
CHEMBL487445 185707 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 520 10 3 5 4.7 O=C(NCCCN1CCCCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm1000776
11848206 16901 45 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 500 3 0 4 5.4 O=C(c1cccc(N2Cc3cccc(Cl)c3C2=O)c1)N1CCC2(CC1)CCN(c1ccncc1)CC2 10.1021/jm1000776
CHEMBL1254945 16901 45 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 500 3 0 4 5.4 O=C(c1cccc(N2Cc3cccc(Cl)c3C2=O)c1)N1CCC2(CC1)CCN(c1ccncc1)CC2 10.1021/jm1000776
11953367 16875 12 None 19 2 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm2016057
CHEMBL1254771 16875 12 None 19 2 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm2016057
44455075 94895 0 None - 1 Human 9.5 pKi = 9.5 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 5 2 5 4.5 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL256671 94895 0 None - 1 Human 9.5 pKi = 9.5 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 5 2 5 4.5 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
11953367 16875 12 None 19 2 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm1000776
CHEMBL1254771 16875 12 None 19 2 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm1000776
44580744 187296 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 480 5 2 8 2.9 C[C@@H](NC(=O)C1(O)CCSC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL496530 187296 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 480 5 2 8 2.9 C[C@@H](NC(=O)C1(O)CCSC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
44430696 87510 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.1 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234096 87510 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.1 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
23628223 87493 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 520 6 2 4 5.0 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL233968 87493 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 520 6 2 4 5.0 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
44455268 94752 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 9 2 6 5.0 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL255997 94752 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 9 2 6 5.0 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
44455087 155014 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 549 8 2 7 4.7 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(OC)no3)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL404370 155014 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 549 8 2 7 4.7 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(OC)no3)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
16221282 85098 0 None 316 2 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL227713 85098 0 None 316 2 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
10173772 161310 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 452 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL414962 161310 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 452 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)F)CC2)c(F)c1 10.1021/jm061094b
11283865 77170 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 523 10 0 6 3.3 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C3CCN(C(C)C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087434 77170 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 523 10 0 6 3.3 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C3CCN(C(C)C)CC3)CC2)c(C)c1 10.1021/jm2016057
11442712 84788 0 None 1 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225607 84788 0 None 1 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
24884552 183703 1 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 512 5 2 7 4.0 C[C@@H](NC(=O)C1(O)CCC(F)(F)CC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL484055 183703 1 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 512 5 2 7 4.0 C[C@@H](NC(=O)C1(O)CCC(F)(F)CC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
44455004 97224 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 5 2 7 3.9 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1Cl 10.1016/j.bmcl.2007.11.050
CHEMBL271283 97224 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 5 2 7 3.9 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1Cl 10.1016/j.bmcl.2007.11.050
16102897 86797 13 None 7 3 Human 9.4 pKi = 9.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL232943 86797 13 None 7 3 Human 9.4 pKi = 9.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
44587184 169576 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 630 9 3 6 5.3 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL444431 169576 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 630 9 3 6 5.3 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
16102897 86797 13 None 7 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL232943 86797 13 None 7 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
16102897 86797 13 None 7 3 Human 9.4 pKi = 9.4 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2008.08.014
CHEMBL232943 86797 13 None 7 3 Human 9.4 pKi = 9.4 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2008.08.014
23628223 87493 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 6 2 4 5.0 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL233968 87493 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 6 2 4 5.0 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
57390218 69703 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 538 8 3 5 3.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939760 69703 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 538 8 3 5 3.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
44580743 192034 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 462 5 2 7 3.4 C[C@@H](NC(=O)C1(O)CCCC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL521735 192034 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 462 5 2 7 3.4 C[C@@H](NC(=O)C1(O)CCCC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
11757682 121513 0 None -28 4 Dog 9.3 pKi = 9.3 Binding
Binding affinity of the [35S]- radiolabeled compound to dog Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to dog Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 121513 0 None -28 4 Dog 9.3 pKi = 9.3 Binding
Binding affinity of the [35S]- radiolabeled compound to dog Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to dog Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11284564 155038 1 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 572 10 2 7 5.0 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)on1 10.1016/j.bmcl.2007.11.057
CHEMBL404484 155038 1 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 572 10 2 7 5.0 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)on1 10.1016/j.bmcl.2007.11.057
11363856 84100 0 None 5 3 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
CHEMBL222038 84100 0 None 5 3 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
11225601 141483 0 None 6 3 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
CHEMBL387638 141483 0 None 6 3 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
16726096 154717 7 None 2 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2008.07.126
CHEMBL402831 154717 7 None 2 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2008.07.126
10217706 82798 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 5 4.4 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1021/jm061094b
CHEMBL218605 82798 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 5 4.4 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1021/jm061094b
16102883 165302 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(Cl)Cl)CC2)c(F)c1 10.1021/jm061094b
CHEMBL424919 165302 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(Cl)Cl)CC2)c(F)c1 10.1021/jm061094b
57400696 69702 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 508 8 3 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939759 69702 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 508 8 3 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
10151875 136442 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 6 2 4 3.8 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL374580 136442 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 6 2 4 3.8 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
44455035 95267 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 7 3.4 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.11.050
CHEMBL258324 95267 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 7 3.4 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.11.050
10031511 16750 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
CHEMBL1253497 16750 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
10031511 16750 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1253497 16750 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
9894973 101275 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1016/j.bmcl.2008.08.014
CHEMBL299832 101275 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1016/j.bmcl.2008.08.014
57383007 126675 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 584 8 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)cn1 nan
CHEMBL3657638 126675 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 584 8 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)cn1 nan
16747694 87511 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 469 6 2 6 5.4 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)c2ccno2)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234097 87511 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 469 6 2 6 5.4 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)c2ccno2)CC1 10.1016/j.bmcl.2007.03.059
24895550 173343 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL454086 173343 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
44455090 97003 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 506 8 2 6 4.7 CCOc1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)c3ccno3)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL270173 97003 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 506 8 2 6 4.7 CCOc1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)c3ccno3)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
10239095 83487 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
CHEMBL220657 83487 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
44455038 95268 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1noc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
CHEMBL258326 95268 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1noc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
16726096 154717 7 None 2 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 154717 7 None 2 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
16102898 165639 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 510 6 2 6 3.7 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(Cl)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
CHEMBL426561 165639 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 510 6 2 6 3.7 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(Cl)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
44580049 183995 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 476 5 2 8 2.5 C[C@@H](NC(=O)C1(O)CCC(=O)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL484881 183995 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 476 5 2 8 2.5 C[C@@H](NC(=O)C1(O)CCC(=O)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
44593650 183998 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 498 5 2 7 3.6 CC(NC(=O)C1(O)CCC(F)(F)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL484882 183998 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 498 5 2 7 3.6 CC(NC(=O)C1(O)CCC(F)(F)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
44432186 86257 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 504 6 2 4 4.5 COC(=O)c1c(F)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL231734 86257 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 504 6 2 4 4.5 COC(=O)c1c(F)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
10196170 136019 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 520 7 2 4 4.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL373803 136019 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 520 7 2 4 4.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
11442712 84788 0 None -1 3 Rabbit 9.2 pKi = 9.2 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225607 84788 0 None -1 3 Rabbit 9.2 pKi = 9.2 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
44580048 183551 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 512 5 2 9 1.6 C[C@@H](NC(=O)C1(O)CCS(=O)(=O)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL482829 183551 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 512 5 2 9 1.6 C[C@@H](NC(=O)C1(O)CCS(=O)(=O)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
16041612 172389 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL451761 172389 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
24893993 173342 5 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 480 8 2 6 4.4 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL454085 173342 5 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 480 8 2 6 4.4 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1)OCC1CCCO1 10.1021/jm800199h
44587183 172645 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 616 8 3 6 5.0 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL452331 172645 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 616 8 3 6 5.0 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
16108961 908 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
664 908 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
CHEMBL415848 908 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
11387915 15038 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 10 2 4 6.4 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210744 15038 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 10 2 4 6.4 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
24893993 173342 5 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 480 8 2 6 4.4 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1)OCC1CCCO1 10.1021/jm1000776
CHEMBL454085 173342 5 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 480 8 2 6 4.4 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1)OCC1CCCO1 10.1021/jm1000776
11488817 77169 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 495 9 0 6 2.5 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087433 77169 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 495 9 0 6 2.5 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
11386138 84006 0 None 1 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL221998 84006 0 None 1 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
11477390 84723 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1nc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)no1 10.1021/jm049394l
CHEMBL225218 84723 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1nc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)no1 10.1021/jm049394l
44411294 76965 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 450 7 2 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208371 76965 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 450 7 2 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)c(F)c1 10.1016/j.bmcl.2006.01.112
16726109 146349 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 487 6 2 5 3.7 COC(=O)c1c(Cl)cccc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL392551 146349 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 487 6 2 5 3.7 COC(=O)c1c(Cl)cccc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
16108961 908 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 908 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 908 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
44455073 95129 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 5 2 6 5.0 Cc1noc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
CHEMBL257729 95129 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 5 2 6 5.0 Cc1noc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
57382836 126657 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 501 7 2 7 3.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3ccno3)COC2)c(F)c1 nan
CHEMBL3657620 126657 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 501 7 2 7 3.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3ccno3)COC2)c(F)c1 nan
68869647 77159 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 522 10 0 7 1.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CCN(C4CC4)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087423 77159 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 522 10 0 7 1.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CCN(C4CC4)CC3)CC2)c(C)c1 10.1021/jm2016057
11167607 136808 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL375288 136808 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
44580742 187295 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 506 6 3 7 3.7 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2noc(CO)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL496529 187295 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 506 6 3 7 3.7 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2noc(CO)n2)cc1F 10.1016/j.bmcl.2008.07.126
44418930 82889 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 7 2 4 3.6 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL219083 82889 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 7 2 4 3.6 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
16102896 83111 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 486 7 2 4 4.1 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)Cl)CC2)c(F)c1 10.1021/jm061094b
CHEMBL220371 83111 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 486 7 2 4 4.1 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)Cl)CC2)c(F)c1 10.1021/jm061094b
11281533 64731 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL182378 64731 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
11620871 165471 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL425588 165471 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411452 76550 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 8 1 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207022 76550 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 8 1 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
665 957 2 None 1023 2 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
9916412 957 2 None 1023 2 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
CHEMBL189123 957 2 None 1023 2 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
CHEMBL2369827 207939 0 None - 1 Human 9.1 pKi = 9.1 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCCN)C(=O)O 10.1021/jm990961s
44455574 155081 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 472 7 2 3 4.9 CCOc1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL404683 155081 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 472 7 2 3 4.9 CCOc1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
44455875 155085 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 556 9 2 3 5.9 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OC(CF)CF)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL404705 155085 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 556 9 2 3 5.9 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OC(CF)CF)cc1F 10.1016/j.bmcl.2007.11.057
10031511 16750 0 None -1 2 Rat 9.0 pKi = 9.0 Binding
Binding affinity to rat bradykinin B1 receptorBinding affinity to rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
CHEMBL1253497 16750 0 None -1 2 Rat 9.0 pKi = 9.0 Binding
Binding affinity to rat bradykinin B1 receptorBinding affinity to rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
10031511 16750 0 None -1 2 Rat 9.0 pKi = 9.0 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1253497 16750 0 None -1 2 Rat 9.0 pKi = 9.0 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
16102918 83843 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 416 6 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(C)=O)CC2)c(F)c1 10.1021/jm061094b
CHEMBL221288 83843 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 416 6 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(C)=O)CC2)c(F)c1 10.1021/jm061094b
44580209 183678 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 478 5 2 8 2.6 C[C@@H](NC(=O)C1(O)CCOCC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL483858 183678 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 478 5 2 8 2.6 C[C@@H](NC(=O)C1(O)CCOCC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
57382837 126658 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 515 7 2 7 3.6 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(C)no3)COC2)c(F)c1 nan
CHEMBL3657621 126658 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 515 7 2 7 3.6 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(C)no3)COC2)c(F)c1 nan
57382923 126667 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
CHEMBL3657630 126667 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
57382925 126669 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4ccnnc4)COC3)c(F)c2)no1 nan
CHEMBL3657632 126669 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4ccnnc4)COC3)c(F)c2)no1 nan
11281533 64731 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL182378 64731 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
11320189 65139 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 746 17 1 8 4.5 CN(C)CCCN(CCCN(C)C)C(=O)C1CCN(S(=O)(=O)c2ccc(NCC(c3ccccc3)c3ccccc3)c(C(=O)N3CCOCC3)c2)CC1 10.1021/jm049747g
CHEMBL183048 65139 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 746 17 1 8 4.5 CN(C)CCCN(CCCN(C)C)C(=O)C1CCN(S(=O)(=O)c2ccc(NCC(c3ccccc3)c3ccccc3)c(C(=O)N3CCOCC3)c2)CC1 10.1021/jm049747g
70685471 73488 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 576 8 2 5 5.1 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@H]1CC[C@H](CCC2=NCCN2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018866 73488 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 576 8 2 5 5.1 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@H]1CC[C@H](CCC2=NCCN2)CC1 10.1016/j.bmcl.2012.03.065
44593650 183998 0 None - 1 Human 9.0 pKi = 9 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 498 5 2 7 3.6 CC(NC(=O)C1(O)CCC(F)(F)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL484882 183998 0 None - 1 Human 9.0 pKi = 9 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 498 5 2 7 3.6 CC(NC(=O)C1(O)CCC(F)(F)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
11786597 67121 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 583 8 2 6 4.4 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(-n2ccnc2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL189245 67121 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 583 8 2 6 4.4 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(-n2ccnc2)cc1 10.1016/j.bmcl.2004.09.074
57382750 126650 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cncnc4)COC3)c(F)c2)no1 nan
CHEMBL3657613 126650 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cncnc4)COC3)c(F)c2)no1 nan
57382839 126660 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 585 8 2 10 3.2 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)cn1 nan
CHEMBL3657623 126660 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 585 8 2 10 3.2 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)cn1 nan
57383057 126684 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 599 10 2 8 4.0 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)cn1 nan
CHEMBL3657647 126684 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 599 10 2 8 4.0 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)cn1 nan
57383099 126688 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 584 8 2 10 2.7 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)cn1 nan
CHEMBL3657651 126688 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 584 8 2 10 2.7 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)cn1 nan
44432215 86520 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 528 6 2 6 3.9 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
CHEMBL232354 86520 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 528 6 2 6 3.9 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
11444668 154992 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 586 11 2 7 5.4 CCOc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)on1 10.1016/j.bmcl.2007.11.057
CHEMBL404280 154992 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 586 11 2 7 5.4 CCOc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)on1 10.1016/j.bmcl.2007.11.057
11386138 84006 0 None -1 3 Rabbit 9.0 pKi = 9.0 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL221998 84006 0 None -1 3 Rabbit 9.0 pKi = 9.0 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
44587185 188341 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 630 7 3 6 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL508043 188341 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 630 7 3 6 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
11306090 84709 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 476 6 2 4 6.6 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1 10.1021/jm049394l
CHEMBL225006 84709 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 476 6 2 4 6.6 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1 10.1021/jm049394l
57382924 126668 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 8 4.3 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
CHEMBL3657631 126668 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 8 4.3 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
57383053 126680 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 585 8 2 11 2.0 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)cn1 nan
CHEMBL3657643 126680 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 585 8 2 11 2.0 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)cn1 nan
44432221 86798 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 501 7 2 5 4.1 CCOC(=O)c1c(Cl)cccc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL232945 86798 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 501 7 2 5 4.1 CCOC(=O)c1c(Cl)cccc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
16202227 73493 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 636 8 2 5 6.1 O=C(CC1c2cc(F)ccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018871 73493 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 636 8 2 5 6.1 O=C(CC1c2cc(F)ccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
24895253 186130 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 538 10 3 5 4.7 O=C(NCCCN1CCCC(F)C1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL488662 186130 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 538 10 3 5 4.7 O=C(NCCCN1CCCC(F)C1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
44455364 154491 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 9 2 6 5.0 C[C@@H](NC(=O)C1(NC(=O)c2ccon2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL401619 154491 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 9 2 6 5.0 C[C@@H](NC(=O)C1(NC(=O)c2ccon2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
44587181 188082 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 588 7 3 6 4.3 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL503847 188082 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 588 7 3 6 4.3 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
44421279 84718 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 442 7 2 6 5.2 COC(=O)c1ccc(C)cc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225133 84718 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 442 7 2 6 5.2 COC(=O)c1ccc(C)cc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1021/jm049394l
57398978 69700 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 496 7 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939757 69700 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 496 7 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
57382967 126674 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 554 7 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cccnc4)COC3)c(F)c2)no1 nan
CHEMBL3657637 126674 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 554 7 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cccnc4)COC3)c(F)c2)no1 nan
11281533 64731 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL182378 64731 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
24895550 173343 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL454086 173343 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
44455549 155003 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 506 7 2 3 5.6 CCOc1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL404328 155003 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 506 7 2 3 5.6 CCOc1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
11215913 136003 0 None 26915 2 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
CHEMBL373654 136003 0 None 26915 2 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
11017305 59993 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744084 59993 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
16102920 82783 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 500 7 2 4 4.7 CCOC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL218553 82783 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 500 7 2 4 4.7 CCOC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
11050306 59992 0 None 1 2 Human 8.9 pKi = 8.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744083 59992 0 None 1 2 Human 8.9 pKi = 8.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
10128412 86956 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 5 4.9 Cc1nc(-c2ccc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)no1 10.1016/j.bmcl.2007.04.040
CHEMBL233351 86956 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 5 4.9 Cc1nc(-c2ccc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)no1 10.1016/j.bmcl.2007.04.040
57382838 126659 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 574 8 2 10 3.4 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
CHEMBL3657622 126659 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 574 8 2 10 3.4 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
57382965 126672 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 569 7 3 9 3.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cncc(N)c4)COC3)c(F)c2)no1 nan
CHEMBL3657635 126672 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 569 7 3 9 3.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cncc(N)c4)COC3)c(F)c2)no1 nan
57383098 126687 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 573 8 2 10 2.8 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
CHEMBL3657650 126687 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 573 8 2 10 2.8 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
44411062 76953 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 9 1 6 5.0 CCCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL208320 76953 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 9 1 6 5.0 CCCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
11307467 154672 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 556 9 2 6 5.3 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)no1 10.1016/j.bmcl.2007.11.057
CHEMBL402630 154672 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 556 9 2 6 5.3 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)no1 10.1016/j.bmcl.2007.11.057
16102899 83914 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 480 5 2 2 5.0 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1F 10.1021/jm061094b
CHEMBL221695 83914 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 480 5 2 2 5.0 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1F 10.1021/jm061094b
44432181 87314 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 6 3.7 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)ccc2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
CHEMBL233764 87314 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 6 3.7 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)ccc2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
16102907 161183 0 None 1 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 456 6 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL413775 161183 0 None 1 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 456 6 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
10233880 77086 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 714 17 3 6 4.8 Cc1c(Cl)ccc(S(=O)(=O)N(CCc2ccccc2)CC(=O)NCC(=O)N(CCCCN2CCCC2)Cc2ccc(C(=N)N)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087031 77086 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 714 17 3 6 4.8 Cc1c(Cl)ccc(S(=O)(=O)N(CCc2ccccc2)CC(=O)NCC(=O)N(CCCCN2CCCC2)Cc2ccc(C(=N)N)cc2)c1Cl 10.1021/jm2016057
44411358 75164 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 7 1 6 5.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL204356 75164 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 7 1 6 5.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411364 77369 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 8 1 6 5.0 CCC(C)N1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL208991 77369 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 8 1 6 5.0 CCC(C)N1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
44411101 140333 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 8 1 6 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL381974 140333 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 8 1 6 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
16102907 161183 0 None 1 2 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 456 6 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL413775 161183 0 None 1 2 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 456 6 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.050
44455089 96962 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 507 7 2 4 5.0 CCOc1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL269963 96962 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 507 7 2 4 5.0 CCOc1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
44455366 154786 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 543 8 2 4 5.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL403202 154786 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 543 8 2 4 5.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
44561786 172084 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 580 9 1 4 7.0 O=C(CC(CS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL449789 172084 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 580 9 1 4 7.0 O=C(CC(CS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
44432212 144624 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 6 2 6 4.4 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
CHEMBL391227 144624 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 6 2 6 4.4 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
57382794 126652 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 512 7 2 7 3.1 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)COC2)c(F)c1 nan
CHEMBL3657615 126652 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 512 7 2 7 3.1 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)COC2)c(F)c1 nan
57382877 126661 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 575 7 2 10 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4snnc4C)COC3)c(F)c2)no1 nan
CHEMBL3657624 126661 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 575 7 2 10 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4snnc4C)COC3)c(F)c2)no1 nan
57382881 126665 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 7 2 10 2.5 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
CHEMBL3657628 126665 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 7 2 10 2.5 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
16108960 168682 0 None 30902 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL441188 168682 0 None 30902 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
10196170 136019 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 520 7 2 4 4.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL373803 136019 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 520 7 2 4 4.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
11340940 77157 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087421 77157 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
44580047 191983 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 496 5 2 8 1.9 C[C@@H](NC(=O)C1(O)CC[S+]([O-])C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL521454 191983 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 496 5 2 8 1.9 C[C@@H](NC(=O)C1(O)CC[S+]([O-])C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
57395448 69699 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 468 6 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939756 69699 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 468 6 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
57382922 126666 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 544 6 2 7 3.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F nan
CHEMBL3657629 126666 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 544 6 2 7 3.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F nan
44411054 76707 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 8 1 6 4.6 CCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL207378 76707 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 8 1 6 4.6 CCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
44411093 139788 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 8 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL380679 139788 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 8 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
23627521 73495 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 648 9 2 6 6.0 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018873 73495 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 648 9 2 6 6.0 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
44587182 188095 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 602 7 2 6 4.6 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL504119 188095 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 602 7 2 6 4.6 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
11663809 173019 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL453339 173019 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
44432222 86799 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 535 7 2 5 4.8 CCOC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL232946 86799 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 535 7 2 5 4.8 CCOC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
11620238 72676 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 497 7 2 5 4.1 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)c3cncc(C(F)(F)F)c3)CC2)cc1 10.1021/jm0511280
CHEMBL201041 72676 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 497 7 2 5 4.1 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)c3cncc(C(F)(F)F)c3)CC2)cc1 10.1021/jm0511280
44455853 168139 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 560 7 2 3 6.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL436854 168139 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 560 7 2 3 6.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)(F)F)cc1F 10.1016/j.bmcl.2007.11.057
44587188 192758 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 562 7 3 6 4.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.055
CHEMBL525092 192758 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 562 7 3 6 4.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.055
71454501 78584 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 471 7 2 5 5.9 COC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL2113087 78584 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 471 7 2 5 5.9 COC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
44432198 146764 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 7 2 4 5.4 CCOC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL392903 146764 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 7 2 4 5.4 CCOC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
16726096 154717 7 None 2 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to monkey bradykinin B1 receptor expressed in CHO cellsBinding affinity to monkey bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 154717 7 None 2 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to monkey bradykinin B1 receptor expressed in CHO cellsBinding affinity to monkey bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
11398971 94947 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 570 10 2 6 5.5 CCc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)no1 10.1016/j.bmcl.2007.11.057
CHEMBL256903 94947 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 570 10 2 6 5.5 CCc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)no1 10.1016/j.bmcl.2007.11.057
16102923 84186 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 3 5.1 CCC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL222159 84186 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 3 5.1 CCC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
11050306 59992 0 None -1 2 Rat 8.7 pKi = 8.7 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744083 59992 0 None -1 2 Rat 8.7 pKi = 8.7 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
659 2842 13 None -1 2 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm049747g
9831083 2842 13 None -1 2 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm049747g
CHEMBL273869 2842 13 None -1 2 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm049747g
9961595 64258 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 687 10 1 7 4.4 CC(C)N1CCN(C(=O)C2CCN(S(=O)(=O)c3ccc(NCC(c4ccccc4)c4ccccc4)c(C(=O)N4CCOCC4)c3)CC2)CC1 10.1021/jm049747g
CHEMBL181695 64258 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 687 10 1 7 4.4 CC(C)N1CCN(C(=O)C2CCN(S(=O)(=O)c3ccc(NCC(c4ccccc4)c4ccccc4)c(C(=O)N4CCOCC4)c3)CC2)CC1 10.1021/jm049747g
11377529 66356 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 706 19 2 8 3.8 CN(C)CCCN(CCCN(C)C)C(=O)CCNS(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c(C(=O)N2CCOCC2)c1 10.1021/jm049747g
CHEMBL185551 66356 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 706 19 2 8 3.8 CN(C)CCCN(CCCN(C)C)C(=O)CCNS(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c(C(=O)N2CCOCC2)c1 10.1021/jm049747g
11479448 127011 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 678 17 1 8 5.0 CN(C)CCCN(CCCN(C)C)C(=O)C1CCN(S(=O)(=O)c2ccc(NCC(c3ccccc3)c3ccccc3)c([N+](=O)[O-])c2)CC1 10.1021/jm049747g
CHEMBL366294 127011 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 678 17 1 8 5.0 CN(C)CCCN(CCCN(C)C)C(=O)C1CCN(S(=O)(=O)c2ccc(NCC(c3ccccc3)c3ccccc3)c([N+](=O)[O-])c2)CC1 10.1021/jm049747g
16221229 85128 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 605 10 3 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CNC3CCC3)ccc21 10.1021/jm070055c
CHEMBL227977 85128 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 605 10 3 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CNC3CCC3)ccc21 10.1021/jm070055c
68868975 77162 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 498 13 0 7 1.4 CCN(CC)CCN1CCN(C(=O)COCCN(C)S(=O)(=O)c2c(C)cc(OC)cc2C)CC1 10.1021/jm2016057
CHEMBL2087426 77162 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 498 13 0 7 1.4 CCN(CC)CCN1CCN(C(=O)COCCN(C)S(=O)(=O)c2c(C)cc(OC)cc2C)CC1 10.1021/jm2016057
11214151 77164 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 497 11 0 6 2.8 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C(C)(C)CN(C)C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087428 77164 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 497 11 0 6 2.8 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C(C)(C)CN(C)C)CC2)c(C)c1 10.1021/jm2016057
16102919 82739 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 452 6 2 4 3.7 COC(=O)c1ccccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL218319 82739 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 452 6 2 4 3.7 COC(=O)c1ccccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
10168110 77085 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 625 15 3 6 3.2 Cc1c(Cl)ccc(S(=O)(=O)N(CCc2ccccc2)CC(=O)NCC(=O)N(CCCCN)CC2CCNCC2)c1Cl 10.1021/jm2016057
CHEMBL2087030 77085 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 625 15 3 6 3.2 Cc1c(Cl)ccc(S(=O)(=O)N(CCc2ccccc2)CC(=O)NCC(=O)N(CCCCN)CC2CCNCC2)c1Cl 10.1021/jm2016057
44561641 186132 0 None - 1 Human 7.0 pKi = 7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(C[C@@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL488677 186132 0 None - 1 Human 7.0 pKi = 7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(C[C@@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
44411252 76522 0 None - 1 Human 5.0 pKi = 5 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207011 76522 0 None - 1 Human 5.0 pKi = 5 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
10875606 62729 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1788318 62729 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
44455182 154836 0 None - 1 Human 6.0 pKi = 6.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 349 5 2 4 2.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL403519 154836 0 None - 1 Human 6.0 pKi = 6.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 349 5 2 4 2.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
11476944 77161 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 470 11 0 7 0.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CCN(C)C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087425 77161 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 470 11 0 7 0.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CCN(C)C)CC2)c(C)c1 10.1021/jm2016057
24895114 178392 3 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 428 6 2 4 4.3 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(Cl)c2)cc1 10.1021/jm800199h
CHEMBL470693 178392 3 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 428 6 2 4 4.3 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(Cl)c2)cc1 10.1021/jm800199h
44455150 96957 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 403 5 2 4 3.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL269949 96957 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 403 5 2 4 3.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
44455227 94921 0 None - 1 Human 6.0 pKi = 6.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 7 2 4 3.6 CCC(O)(CC)C(=O)NCc1ccc(-c2cccc(F)c2C(=O)OC)cc1F 10.1016/j.bmcl.2007.11.050
CHEMBL256793 94921 0 None - 1 Human 6.0 pKi = 6.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 7 2 4 3.6 CCC(O)(CC)C(=O)NCc1ccc(-c2cccc(F)c2C(=O)OC)cc1F 10.1016/j.bmcl.2007.11.050
44570026 175734 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 508 11 2 5 3.3 O=C(O)CCNC(=O)CN(CCOc1cccc(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL459532 175734 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 508 11 2 5 3.3 O=C(O)CCNC(=O)CN(CCOc1cccc(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
60142437 125372 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648466 125372 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
44392025 64484 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 414 7 2 6 4.3 COC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL181968 64484 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 414 7 2 6 4.3 COC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
49863235 15046 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 613 10 3 4 6.7 C=C(CNC(C)(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210752 15046 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 613 10 3 4 6.7 C=C(CNC(C)(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
25181410 171638 1 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1021/jm1000776
CHEMBL447392 171638 1 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1021/jm1000776
25181410 171638 1 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL447392 171638 1 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
44402076 71336 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 456 7 3 4 4.9 CNC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL196494 71336 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 456 7 3 4 4.9 CNC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
44401932 71415 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 400 7 2 6 4.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL196698 71415 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 400 7 2 6 4.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.02.077
44402028 69464 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 400 7 3 5 4.2 Cc1ccnc(NCc2ccc(-c3ccccc3C(=O)O)cc2)c1NC(=O)CC#N 10.1016/j.bmcl.2005.02.077
CHEMBL193684 69464 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 400 7 3 5 4.2 Cc1ccnc(NCc2ccc(-c3ccccc3C(=O)O)cc2)c1NC(=O)CC#N 10.1016/j.bmcl.2005.02.077
16102908 141432 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 402 6 2 4 2.7 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(C)=O)CC2)c(F)c1 10.1021/jm061094b
CHEMBL387331 141432 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 402 6 2 4 2.7 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(C)=O)CC2)c(F)c1 10.1021/jm061094b
60141042 125403 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 537 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)COC2)no1 nan
CHEMBL3648497 125403 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 537 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)COC2)no1 nan
10388673 71044 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
CHEMBL195883 71044 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
57382747 126647 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 545 6 2 7 3.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)COC3)c(F)c2)no1 nan
CHEMBL3657610 126647 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 545 6 2 7 3.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)COC3)c(F)c2)no1 nan
44569937 187680 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 612 13 1 6 4.6 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1 10.1016/j.bmcl.2008.11.005
CHEMBL499999 187680 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 612 13 1 6 4.6 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1 10.1016/j.bmcl.2008.11.005
57383097 126686 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 535 10 2 6 3.5 COCC(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(Cl)c3OCC(F)F)cc2F)COC1 nan
CHEMBL3657649 126686 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 535 10 2 6 3.5 COCC(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(Cl)c3OCC(F)F)cc2F)COC1 nan
11719314 139966 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 448 7 2 4 3.7 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCC2)cc1 10.1021/jm0511280
CHEMBL381009 139966 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 448 7 2 4 3.7 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCC2)cc1 10.1021/jm0511280
16102909 82905 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(C)(Cl)Cl)CC2)c(F)c1 10.1021/jm061094b
CHEMBL219164 82905 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(C)(Cl)Cl)CC2)c(F)c1 10.1021/jm061094b
11225601 141483 0 None -239 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
CHEMBL387638 141483 0 None -239 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
44401887 69486 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 389 7 2 5 4.5 CCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL193819 69486 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 389 7 2 5 4.5 CCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
49863229 15040 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210746 15040 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
49863230 15041 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 597 10 2 4 6.0 C=C(CN1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210747 15041 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 597 10 2 4 6.0 C=C(CN1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
12085131 77090 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 8 1 5 3.5 Cc1c(Cl)ccc(S(=O)(=O)N(C)C/C=C/C(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087036 77090 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 8 1 5 3.5 Cc1c(Cl)ccc(S(=O)(=O)N(C)C/C=C/C(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
11466010 83979 0 None -1 3 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
CHEMBL221984 83979 0 None -1 3 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
10388673 71044 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL195883 71044 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
60141327 125413 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 554 6 2 10 3.3 Cc1nnc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)o1 nan
CHEMBL3648507 125413 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 554 6 2 10 3.3 Cc1nnc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)o1 nan
11685446 186112 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
CHEMBL488501 186112 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
16221227 142474 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 614 9 3 6 5.5 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(C#N)cc1 10.1021/jm070055c
CHEMBL389477 142474 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 614 9 3 6 5.5 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(C#N)cc1 10.1021/jm070055c
11224694 92320 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 447 6 3 4 3.4 O=C(Nc1[nH]nc(C(=O)NCCc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL243667 92320 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 447 6 3 4 3.4 O=C(Nc1[nH]nc(C(=O)NCCc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
44570136 183012 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 514 12 1 5 3.7 COCCCNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL480203 183012 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 514 12 1 5 3.7 COCCCNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
60142026 125358 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 480 5 2 4 4.1 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648453 125358 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 480 5 2 4 4.1 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
44455229 166319 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 363 5 2 4 2.8 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C(C)(C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL428601 166319 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 363 5 2 4 2.8 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C(C)(C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
44392138 122082 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 404 7 2 6 4.0 COC(=O)C1=C(c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)CCC1 10.1016/j.bmcl.2005.05.133
CHEMBL360260 122082 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 404 7 2 6 4.0 COC(=O)C1=C(c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)CCC1 10.1016/j.bmcl.2005.05.133
16221225 168791 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1Cl)c1ccccc1 10.1021/jm070055c
CHEMBL442056 168791 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1Cl)c1ccccc1 10.1021/jm070055c
44401768 124988 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 418 8 2 6 3.6 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CN(C)C)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL364670 124988 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 418 8 2 6 3.6 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CN(C)C)cc1 10.1016/j.bmcl.2005.02.077
60142963 125395 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125395 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
11293092 64914 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 421 7 2 7 3.4 COC(=O)c1ccccc1N1CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
CHEMBL182785 64914 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 421 7 2 7 3.4 COC(=O)c1ccccc1N1CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
16726096 154717 7 None -15 4 Rabbit 7.9 pKi = 7.9 Binding
Binding affinity to rabbit bradykinin B1 receptor expressed in CHO cellsBinding affinity to rabbit bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 154717 7 None -15 4 Rabbit 7.9 pKi = 7.9 Binding
Binding affinity to rabbit bradykinin B1 receptor expressed in CHO cellsBinding affinity to rabbit bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
16221162 143779 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 611 9 2 5 6.7 CC1CCCC(C)N1Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL390540 143779 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 611 9 2 5 6.7 CC1CCCC(C)N1Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
11039234 59994 0 None 1 2 Human 7.9 pKi = 7.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744085 59994 0 None 1 2 Human 7.9 pKi = 7.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
16102882 141022 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 438 7 2 4 2.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL384893 141022 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 438 7 2 4 2.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)F)CC2)c(F)c1 10.1021/jm061094b
44392012 64535 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 419 7 2 7 3.3 COC(=O)c1ccccc1N1CC=C(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
CHEMBL182177 64535 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 419 7 2 7 3.3 COC(=O)c1ccccc1N1CC=C(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
44392544 125705 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 635 19 2 7 4.5 CC(=O)c1cc(S(=O)(=O)NCCC(=O)N(CCCN(C)C)CCCN(C)C)ccc1NCC(c1ccccc1)c1ccccc1 10.1021/jm049747g
CHEMBL365009 125705 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 635 19 2 7 4.5 CC(=O)c1cc(S(=O)(=O)NCCC(=O)N(CCCN(C)C)CCCN(C)C)ccc1NCC(c1ccccc1)c1ccccc1 10.1021/jm049747g
44570139 183445 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 474 11 2 5 2.7 O=C(O)CCNC(=O)CN(CCOc1ccccc1)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL482173 183445 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 474 11 2 5 2.7 O=C(O)CCNC(=O)CN(CCOc1ccccc1)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
16108968 165574 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 541 10 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL426165 165574 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 541 10 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
16221163 85131 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL228030 85131 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/jm070055c
44432176 86834 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1cc(Cl)ccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL233150 86834 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1cc(Cl)ccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
70683374 73486 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 640 7 1 5 6.8 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018864 73486 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 640 7 1 5 6.8 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1016/j.bmcl.2012.03.065
16220914 85129 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 529 9 3 5 4.6 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL228014 85129 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 529 9 3 5 4.6 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
11584184 172533 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 500 8 3 6 2.7 Cc1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL452057 172533 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 500 8 3 6 2.7 Cc1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
44430680 141532 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 416 6 2 4 5.0 N#CC1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL388029 141532 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 416 6 2 4 5.0 N#CC1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
16221056 85120 0 None 14 2 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227870 85120 0 None 14 2 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
49863228 15036 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 639 10 2 4 6.8 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1)N[C@@H]1CCCc2cc(C3(CN4CCCCC4)CC3)ccc21 10.1016/j.bmcl.2010.06.010
CHEMBL1210742 15036 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 639 10 2 4 6.8 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1)N[C@@H]1CCCc2cc(C3(CN4CCCCC4)CC3)ccc21 10.1016/j.bmcl.2010.06.010
57382966 126673 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cccnn4)COC3)c(F)c2)no1 nan
CHEMBL3657636 126673 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cccnn4)COC3)c(F)c2)no1 nan
11422305 63413 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 638 19 2 8 4.2 CN(C)CCCN(CCCN(C)C)C(=O)CCNS(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
CHEMBL180143 63413 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 638 19 2 8 4.2 CN(C)CCCN(CCCN(C)C)C(=O)CCNS(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
70691811 73479 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 489 5 2 4 4.5 O=C(CC1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccccc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018857 73479 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 489 5 2 4 4.5 O=C(CC1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccccc1 10.1016/j.bmcl.2012.03.065
10166801 102297 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 569 8 1 5 6.3 O=C(CCCN1C(=O)CN=C(C2CCCCC2)c2ccccc21)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1021/jm034020y
CHEMBL30525 102297 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 569 8 1 5 6.3 O=C(CCCN1C(=O)CN=C(C2CCCCC2)c2ccccc21)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1021/jm034020y
44392040 172301 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 444 7 2 6 4.3 COC(=O)C1C2C=CC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL451549 172301 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 444 7 2 6 4.3 COC(=O)C1C2C=CC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
57343016 77152 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 480 10 1 6 1.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1c(F)cccc1F 10.1021/jm2016057
CHEMBL2087416 77152 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 480 10 1 6 1.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1c(F)cccc1F 10.1021/jm2016057
16108963 161406 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL415849 161406 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
44430679 142009 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 421 7 2 4 5.1 COC1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL389094 142009 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 421 7 2 4 5.1 COC1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
60142025 125357 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 7 2 3 5.6 O=C(NC1(C(=O)NC2CCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
CHEMBL3648452 125357 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 7 2 3 5.6 O=C(NC1(C(=O)NC2CCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
44569938 188302 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 629 14 1 7 4.7 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCOCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL507546 188302 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 629 14 1 7 4.7 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCOCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
57399671 69211 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
CHEMBL1934265 69211 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
24895455 185832 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 479 8 3 5 4.0 O=C(NCC1CCCO1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487621 185832 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 479 8 3 5 4.0 O=C(NCC1CCCO1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
12085130 77088 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 8 1 5 3.3 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087034 77088 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 8 1 5 3.3 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
60142835 125390 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 7 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648484 125390 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 7 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
23627520 73492 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 580 9 2 6 4.7 COc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018870 73492 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 580 9 2 6 4.7 COc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
16108965 160771 0 None 1000 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
CHEMBL412552 160771 0 None 1000 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
44561643 185056 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL486456 185056 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
60143098 125398 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 428 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648492 125398 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 428 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(N)CC2)no1 nan
44570137 190373 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 518 11 2 7 2.4 O=C(O)CCNC(=O)CN(CCOc1ccc2c(c1)OCO2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL518616 190373 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 518 11 2 7 2.4 O=C(O)CCNC(=O)CN(CCOc1ccc2c(c1)OCO2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
11604201 72969 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 422 7 2 4 3.2 COC(=O)c1ccccc1-c1ccc(CNC(=O)[C@@H](C)NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
CHEMBL201310 72969 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 422 7 2 4 3.2 COC(=O)c1ccccc1-c1ccc(CNC(=O)[C@@H](C)NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
49863234 15045 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 12 3 4 6.3 C=C(CNCC1CC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210751 15045 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 12 3 4 6.3 C=C(CNCC1CC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
11526891 188281 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL507168 188281 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
57396212 69207 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccc(Cl)cc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934261 69207 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccc(Cl)cc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
11676747 87449 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 449 7 2 5 4.7 COC(=O)C1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL233873 87449 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 449 7 2 5 4.7 COC(=O)C1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
16102897 86797 13 None -1737 3 Rat 5.8 pKi = 5.8 Binding
Binding affinity to rat bradykinin B1 receptorBinding affinity to rat bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL232943 86797 13 None -1737 3 Rat 5.8 pKi = 5.8 Binding
Binding affinity to rat bradykinin B1 receptorBinding affinity to rat bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
70693872 73484 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 587 8 1 6 4.2 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCN1CCN(c2ccncc2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018862 73484 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 587 8 1 6 4.2 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCN1CCN(c2ccncc2)CC1 10.1016/j.bmcl.2012.03.065
11555599 173018 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 534 9 1 5 5.2 CO[C@H](CCS(=O)(=O)c1ccc2ccccc2c1)C(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL453338 173018 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 534 9 1 5 5.2 CO[C@H](CCS(=O)(=O)c1ccc2ccccc2c1)C(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
56835163 69210 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934264 69210 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
44411355 76436 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 6 1 6 3.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(C)=O)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL206935 76436 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 6 1 6 3.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(C)=O)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11039234 59994 0 None -1 2 Rat 7.8 pKi = 7.8 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744085 59994 0 None -1 2 Rat 7.8 pKi = 7.8 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
16108966 83945 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 555 10 2 4 6.1 C[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)c1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL221925 83945 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 555 10 2 4 6.1 C[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)c1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
16108962 141176 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL385740 141176 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
60142836 125391 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 8 4.7 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)on1 nan
CHEMBL3648485 125391 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 8 4.7 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)on1 nan
11421944 85106 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/jm070055c
CHEMBL227778 85106 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/jm070055c
88925471 125371 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 3.5 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648465 125371 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 3.5 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
44430681 87556 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2ccccc2F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234296 87556 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2ccccc2F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
11071992 59991 0 None -3 2 Rat 7.7 pKi = 7.7 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744082 59991 0 None -3 2 Rat 7.7 pKi = 7.7 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
60142834 125389 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 580 7 2 8 4.5 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)cn1 nan
CHEMBL3648483 125389 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 580 7 2 8 4.5 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)cn1 nan
57401425 69205 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934259 69205 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
44411050 76835 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 453 7 1 6 4.3 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(CN3CCOCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207922 76835 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 453 7 1 6 4.3 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(CN3CCOCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895252 185704 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 452 9 4 5 3.1 CNCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL1203967 185704 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 452 9 4 5 3.1 CNCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487444 185704 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 452 9 4 5 3.1 CNCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
60143099 125399 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 534 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648493 125399 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 534 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
11519239 185168 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL486640 185168 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
57383009 126677 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 8 2 4 5.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
CHEMBL3657640 126677 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 8 2 4 5.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
16108964 141177 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL385741 141177 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
24970503 169199 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation counting
ChEMBL 576 10 2 7 3.4 COc1cc2c(cc1OC)C(CC(=O)NCCc1ccc(C3=NCCN3)cc1)N(S(=O)(=O)c1ccc(C)cc1)CC2 10.1016/j.ejmech.2007.10.030
CHEMBL443900 169199 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation counting
ChEMBL 576 10 2 7 3.4 COc1cc2c(cc1OC)C(CC(=O)NCCc1ccc(C3=NCCN3)cc1)N(S(=O)(=O)c1ccc(C)cc1)CC2 10.1016/j.ejmech.2007.10.030
44392068 64465 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 442 7 2 7 4.8 Cc1noc([C@H]2CC=CC[C@@H]2c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)n1 10.1016/j.bmcl.2005.05.133
CHEMBL181961 64465 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 442 7 2 7 4.8 Cc1noc([C@H]2CC=CC[C@@H]2c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)n1 10.1016/j.bmcl.2005.05.133
44430686 141534 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 452 6 2 4 5.3 N#CC1(c2cccc(F)c2F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL388031 141534 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 452 6 2 4 5.3 N#CC1(c2cccc(F)c2F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
16102897 86797 13 None 7 3 Human 8.7 pKi = 8.7 Binding
Binding affinity to rhesus monkey bradykinin B1 receptorBinding affinity to rhesus monkey bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL232943 86797 13 None 7 3 Human 8.7 pKi = 8.7 Binding
Binding affinity to rhesus monkey bradykinin B1 receptorBinding affinity to rhesus monkey bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
11259064 136589 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 433 6 2 5 5.4 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2C#N)cc1 10.1021/jm049394l
CHEMBL374779 136589 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 433 6 2 5 5.4 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2C#N)cc1 10.1021/jm049394l
10128103 144978 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL391491 144978 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
16041612 172389 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL451761 172389 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
24895454 186006 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 522 10 3 6 3.6 O=C(NCCCN1CCOCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487876 186006 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 522 10 3 6 3.6 O=C(NCCCN1CCOCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
57342336 77089 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 526 10 1 6 2.9 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087035 77089 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 526 10 1 6 2.9 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
16726096 154717 7 None -2 4 Rat 8.7 pKi = 8.7 Binding
Binding affinity to rat bradykinin B1 receptor expressed in CHO cellsBinding affinity to rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 154717 7 None -2 4 Rat 8.7 pKi = 8.7 Binding
Binding affinity to rat bradykinin B1 receptor expressed in CHO cellsBinding affinity to rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
57383010 126678 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 574 8 2 11 2.2 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
CHEMBL3657641 126678 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 574 8 2 11 2.2 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
44392156 64596 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 420 7 2 6 4.3 COC(=O)C1CCCCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL182275 64596 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 420 7 2 6 4.3 COC(=O)C1CCCCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
44411095 168242 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 7 1 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL437704 168242 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 7 1 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
70695989 73483 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.4 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018861 73483 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.4 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
57383008 126676 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 9 2 6 4.8 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)COC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
CHEMBL3657639 126676 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 9 2 6 4.8 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)COC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
44455492 94622 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 520 7 2 3 6.0 CC(C)Oc1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL255325 94622 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 520 7 2 3 6.0 CC(C)Oc1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
57382748 126648 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 544 7 2 9 3.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4ccno4)COC3)c(F)c2)no1 nan
CHEMBL3657611 126648 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 544 7 2 9 3.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4ccno4)COC3)c(F)c2)no1 nan
44432207 86795 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 6 2 5 5.5 Cc1nc(-c2c(Cl)cc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)no1 10.1016/j.bmcl.2007.04.040
CHEMBL232933 86795 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 6 2 5 5.5 Cc1nc(-c2c(Cl)cc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)no1 10.1016/j.bmcl.2007.04.040
57382749 126649 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 7 2 9 3.7 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
CHEMBL3657612 126649 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 7 2 9 3.7 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
16102884 82729 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 472 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)Cl)CC2)c(F)c1 10.1021/jm061094b
CHEMBL218267 82729 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 472 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)Cl)CC2)c(F)c1 10.1021/jm061094b
57523216 125382 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 562 7 2 8 4.4 COc1ncc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
CHEMBL3648476 125382 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 562 7 2 8 4.4 COc1ncc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
57382746 126646 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 639 7 2 7 5.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cc(F)cc(C(F)(F)F)c4)COC3)c(F)c2)no1 nan
CHEMBL3657609 126646 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 639 7 2 7 5.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cc(F)cc(C(F)(F)F)c4)COC3)c(F)c2)no1 nan
57382835 126656 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 569 9 2 7 4.0 C[C@@H](NC(=O)C1(NC(=O)c2cncnc2)COC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
CHEMBL3657619 126656 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 569 9 2 7 4.0 C[C@@H](NC(=O)C1(NC(=O)c2cncnc2)COC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
44432220 86759 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 521 6 2 5 4.4 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL232750 86759 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 521 6 2 5 4.4 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
24895550 173343 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL454086 173343 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
11456015 154826 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 582 10 2 6 5.8 C[C@@H](NC(=O)C1(NC(=O)c2cc(C3CC3)on2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL403434 154826 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 582 10 2 6 5.8 C[C@@H](NC(=O)C1(NC(=O)c2cc(C3CC3)on2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
44587041 187284 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 574 6 3 6 4.0 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL496459 187284 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 574 6 3 6 4.0 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
71454502 78587 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 428 7 2 6 4.9 COC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL2113091 78587 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 428 7 2 6 4.9 COC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.02.077
11363856 84100 0 None -5 3 Rabbit 8.6 pKi = 8.6 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
CHEMBL222038 84100 0 None -5 3 Rabbit 8.6 pKi = 8.6 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
44411442 139893 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 7 1 6 5.5 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL380920 139893 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 7 1 6 5.5 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
16102885 82782 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 454 7 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)Cl)CC2)c(F)c1 10.1021/jm061094b
CHEMBL218552 82782 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 454 7 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)Cl)CC2)c(F)c1 10.1021/jm061094b
57342845 77145 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.4 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccccc1C(F)(F)F 10.1021/jm2016057
CHEMBL2087409 77145 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.4 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccccc1C(F)(F)F 10.1021/jm2016057
44411353 75199 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 7 1 6 4.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL204562 75199 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 7 1 6 4.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
70691814 73490 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 592 8 2 5 5.6 Cc1cc(C)c(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1C 10.1016/j.bmcl.2012.03.065
CHEMBL2018868 73490 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 592 8 2 5 5.6 Cc1cc(C)c(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1C 10.1016/j.bmcl.2012.03.065
16102881 82930 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 7 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL219309 82930 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 7 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
60142027 125359 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648454 125359 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
16221054 141528 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 591 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cc(Cl)c(F)cc1F)c1ccccc1 10.1021/jm070055c
CHEMBL387982 141528 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 591 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cc(Cl)c(F)cc1F)c1ccccc1 10.1021/jm070055c
11452874 151845 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 418 4 3 3 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL397037 151845 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 418 4 3 3 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
44402075 71650 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 9 2 5 5.3 CCCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1021/jm049394l
CHEMBL197462 71650 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 9 2 5 5.3 CCCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1021/jm049394l
44402075 71650 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 417 9 2 5 5.3 CCCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL197462 71650 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 417 9 2 5 5.3 CCCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
24895354 178302 3 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1 10.1021/jm800199h
CHEMBL469875 178302 3 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1 10.1021/jm800199h
16726096 154717 7 None -239 4 Dog 6.7 pKi = 6.7 Binding
Binding affinity to dog bradykinin B1 receptor expressed in CHO cellsBinding affinity to dog bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 154717 7 None -239 4 Dog 6.7 pKi = 6.7 Binding
Binding affinity to dog bradykinin B1 receptor expressed in CHO cellsBinding affinity to dog bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
49863232 15043 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 601 12 4 5 4.9 C=C(CNCCO)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210749 15043 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 601 12 4 5 4.9 C=C(CNCCO)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
44569935 168914 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 646 13 1 6 5.3 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL443207 168914 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 646 13 1 6 5.3 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Cl 10.1016/j.bmcl.2008.11.005
16221160 96808 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 597 10 3 5 6.3 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CNC3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL268911 96808 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 597 10 3 5 6.3 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CNC3CCCCC3)ccc21 10.1021/jm070055c
44569939 178143 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 580 12 1 7 4.2 COc1ccccc1CCNC(=O)CN(CCOc1ccc2c(c1)OCO2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL468492 178143 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 580 12 1 7 4.2 COc1ccccc1CCNC(=O)CN(CCOc1ccc2c(c1)OCO2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
60141184 125407 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 7 2.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)n1 nan
CHEMBL3648501 125407 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 7 2.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)n1 nan
44410972 76910 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 6 1 6 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2cc(C(=O)N3CCOCC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208086 76910 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 6 1 6 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2cc(C(=O)N3CCOCC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
60142305 125370 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648464 125370 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
44411349 139821 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 550 6 1 6 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(=O)C(C)(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL380834 139821 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 550 6 1 6 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(=O)C(C)(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895450 190787 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 423 6 2 4 3.8 CN(C)C(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL519247 190787 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 423 6 2 4 3.8 CN(C)C(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
24895186 185585 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 409 6 3 4 3.5 CNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487263 185585 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 409 6 3 4 3.5 CNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
60142024 125356 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 446 5 2 4 3.5 COC(=O)c1ccccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648451 125356 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 446 5 2 4 3.5 COC(=O)c1ccccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
10311064 77615 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 4.2 COC(=O)c1c(F)cccc1-c1ccc([C@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL2096845 77615 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 4.2 COC(=O)c1c(F)cccc1-c1ccc([C@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
44570138 183013 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 456 8 1 4 3.3 CNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL480204 183013 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 456 8 1 4 3.3 CNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
44411360 76514 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 7 1 7 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(S(C)(=O)=O)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL206982 76514 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 7 1 7 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(S(C)(=O)=O)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895351 189256 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cc2)cc1 10.1021/jm800199h
CHEMBL516783 189256 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cc2)cc1 10.1021/jm800199h
11284458 140045 2 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.055
CHEMBL381366 140045 2 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.055
11670860 185170 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL486641 185170 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
60141039 125401 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 553 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
CHEMBL3648495 125401 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 553 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
11376509 63970 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 567 16 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
CHEMBL181098 63970 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 567 16 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
44401703 132944 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 403 7 2 5 4.7 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)C(C)C)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL370704 132944 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 403 7 2 5 4.7 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)C(C)C)cc1 10.1016/j.bmcl.2005.02.077
70695304 77082 0 None -17 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 556 8 2 6 4.0 Cc1ccc2cccc(OCc3cc(S(=O)(=O)N4CCC[C@H]4C(=O)NCC4CCNCC4)ccc3Cl)c2n1 10.1021/jm2016057
CHEMBL2087027 77082 0 None -17 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 556 8 2 6 4.0 Cc1ccc2cccc(OCc3cc(S(=O)(=O)N4CCC[C@H]4C(=O)NCC4CCNCC4)ccc3Cl)c2n1 10.1021/jm2016057
70688994 77083 0 None 18 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 433 5 2 4 2.6 Cc1c(Cl)ccc(S(=O)(=O)N2CCC[C@H]2C(=O)NCC2CCNCC2)c1Cl 10.1021/jm2016057
CHEMBL2087028 77083 0 None 18 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 433 5 2 4 2.6 Cc1c(Cl)ccc(S(=O)(=O)N2CCC[C@H]2C(=O)NCC2CCNCC2)c1Cl 10.1021/jm2016057
60142168 125364 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 7 2 3 6.0 O=C(NC1(C(=O)NC2CCCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
CHEMBL3648459 125364 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 7 2 3 6.0 O=C(NC1(C(=O)NC2CCCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
CHEMBL2369828 207940 0 None - 1 Human 7.6 pKi = 7.6 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1c2ccccc2C[C@H]1C(=O)O 10.1021/jm990961s
60142439 125376 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648470 125376 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
24895256 185830 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 453 9 3 5 3.5 COCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487620 185830 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 453 9 3 5 3.5 COCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
24895184 192971 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 413 6 2 5 3.2 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1 10.1021/jm800199h
CHEMBL530549 192971 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 413 6 2 5 3.2 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1 10.1021/jm800199h
9919335 106090 1 None 489 2 Human 7.6 pKi = 7.6 Binding
Binding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligandBinding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligand
ChEMBL 922 22 9 13 -2.1 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC2(CC1)C(=O)N(CC(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc3ccccc3N(CC(=O)O)C1=O)CN2CCc1ccccc1 10.1021/jm990962k
CHEMBL3142392 106090 1 None 489 2 Human 7.6 pKi = 7.6 Binding
Binding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligandBinding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligand
ChEMBL 922 22 9 13 -2.1 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC2(CC1)C(=O)N(CC(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc3ccccc3N(CC(=O)O)C1=O)CN2CCc1ccccc1 10.1021/jm990962k
44430684 87602 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.1 N#CC1(c2cccc(C(F)(F)F)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234512 87602 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.1 N#CC1(c2cccc(C(F)(F)F)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
44455108 154593 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL402114 154593 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
16221164 161185 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 577 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(C)(C)C)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL413786 161185 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 577 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(C)(C)C)cc1)c1ccccc1 10.1021/jm070055c
57382878 126662 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 521 8 2 8 2.7 COCC(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)COC1 nan
CHEMBL3657625 126662 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 521 8 2 8 2.7 COCC(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)COC1 nan
44392045 131248 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.3 COC(=O)c1ccccc1C1=CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
CHEMBL369307 131248 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.3 COC(=O)c1ccccc1C1=CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
44411347 76520 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 504 7 1 6 3.8 C#CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL207000 76520 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 504 7 1 6 3.8 C#CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
16221053 141805 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 573 9 3 5 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(F)c(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL388720 141805 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 573 9 3 5 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(F)c(Cl)c1)c1ccccc1 10.1021/jm070055c
11575578 73574 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 430 7 2 6 2.5 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1021/jm0511280
CHEMBL202090 73574 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 430 7 2 6 2.5 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1021/jm0511280
60141181 125404 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 551 6 2 8 4.1 Cc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
CHEMBL3648498 125404 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 551 6 2 8 4.1 Cc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
44391977 122245 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 403 7 2 7 3.4 COC(=O)c1cccn1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL360500 122245 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 403 7 2 7 3.4 COC(=O)c1cccn1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
11180748 167768 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 581 17 1 7 4.8 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(Cc2ccccc2)Cc2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
CHEMBL434341 167768 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 581 17 1 7 4.8 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(Cc2ccccc2)Cc2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
24895111 176136 3 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2F)cc1 10.1021/jm800199h
CHEMBL460045 176136 3 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2F)cc1 10.1021/jm800199h
44411080 165662 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 556 8 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(Cc4ccccc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL426681 165662 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 556 8 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(Cc4ccccc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
60141326 125412 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(N)CC2)n1 nan
CHEMBL3648506 125412 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(N)CC2)n1 nan
16220987 78687 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL2113274 78687 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/jm070055c
44411071 76513 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 530 8 1 6 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(F)F)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL206975 76513 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 530 8 1 6 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(F)F)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895182 178276 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(F)c2F)cc1 10.1021/jm800199h
CHEMBL469675 178276 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(F)c2F)cc1 10.1021/jm800199h
10187347 192747 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 544 7 2 5 5.5 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(N(C)C)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL52498 192747 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 544 7 2 5 5.5 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(N(C)C)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
44411252 76522 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human BK1 receptor E273 mutantBinding affinity to human BK1 receptor E273 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207011 76522 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human BK1 receptor E273 mutantBinding affinity to human BK1 receptor E273 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
57390932 69200 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934254 69200 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
60142962 125394 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)on1 nan
CHEMBL3648488 125394 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)on1 nan
88574592 126663 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 588 10 2 8 4.2 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
CHEMBL3657626 126663 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 588 10 2 8 4.2 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
11225601 141483 0 None -6 3 Rabbit 8.5 pKi = 8.5 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
CHEMBL387638 141483 0 None -6 3 Rabbit 8.5 pKi = 8.5 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
60142570 125381 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)CC2)no1 nan
CHEMBL3648475 125381 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)CC2)no1 nan
23627396 73489 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 618 8 2 5 6.0 O=C(CC1c2ccccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018867 73489 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 618 8 2 5 6.0 O=C(CC1c2ccccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
57342494 77147 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1cccc(Cl)c1Cl 10.1021/jm2016057
CHEMBL2087411 77147 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1cccc(Cl)c1Cl 10.1021/jm2016057
57383011 126679 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 598 10 2 7 4.6 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)cn1 nan
CHEMBL3657642 126679 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 598 10 2 7 4.6 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)cn1 nan
44411368 76784 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 8 1 6 4.8 C/C=C/CN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL207800 76784 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 8 1 6 4.8 C/C=C/CN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
11331054 15037 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 625 10 2 4 6.8 C=C(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210743 15037 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 625 10 2 4 6.8 C=C(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
68869570 77156 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 522 9 0 7 1.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CC4CCC(C3)N4C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087420 77156 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 522 9 0 7 1.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CC4CCC(C3)N4C)CC2)c(C)c1 10.1021/jm2016057
44411457 76344 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 8 1 6 5.0 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL206519 76344 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 8 1 6 5.0 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411051 76706 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 494 7 1 6 4.2 CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL207377 76706 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 494 7 1 6 4.2 CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
49863236 15048 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 11 3 4 6.5 C=C(CNC1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210754 15048 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 11 3 4 6.5 C=C(CNC1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
60141324 125411 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 10 2.8 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
CHEMBL3648505 125411 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 10 2.8 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
57383054 126681 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 587 10 2 7 4.8 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
CHEMBL3657644 126681 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 587 10 2 7 4.8 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
44411138 165269 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4cccnc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL424868 165269 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4cccnc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11433587 15039 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210745 15039 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
68867798 77165 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 469 11 0 6 2.1 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(CCN(C)C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087429 77165 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 469 11 0 6 2.1 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(CCN(C)C)CC2)c(C)c1 10.1021/jm2016057
60142703 125383 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648477 125383 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
60141182 125405 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 567 7 2 9 3.8 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
CHEMBL3648499 125405 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 567 7 2 9 3.8 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
44430694 87479 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 500 7 2 5 5.9 N#CC1(c2ccccc2OC(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL233887 87479 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 500 7 2 5 5.9 N#CC1(c2ccccc2OC(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
44430692 87478 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 450 6 2 4 5.7 N#CC1(c2ccccc2Cl)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL233886 87478 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 450 6 2 4 5.7 N#CC1(c2ccccc2Cl)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
44430682 141533 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2cccc(F)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL388030 141533 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2cccc(F)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
16220918 160911 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 585 9 2 6 4.7 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCOCC3)ccc21 10.1021/jm070055c
CHEMBL412762 160911 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 585 9 2 6 4.7 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCOCC3)ccc21 10.1021/jm070055c
11227059 67011 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 584 8 2 7 3.8 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(-n2cnnc2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL188617 67011 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 584 8 2 7 3.8 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(-n2cnnc2)cc1 10.1016/j.bmcl.2004.09.074
44432223 166585 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 545 6 2 7 3.8 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
CHEMBL429074 166585 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 545 6 2 7 3.8 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
70687620 73487 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 624 7 1 5 5.5 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N1CCC(Cc2ccc(C3=NCCN3)cc2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018865 73487 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 624 7 1 5 5.5 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N1CCC(Cc2ccc(C3=NCCN3)cc2)CC1 10.1016/j.bmcl.2012.03.065
11341448 77168 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 524 10 0 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(N3CCN(C(C)C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087432 77168 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 524 10 0 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(N3CCN(C(C)C)CC3)CC2)c(C)c1 10.1021/jm2016057
60142706 125386 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 551 7 2 8 4.6 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
CHEMBL3648480 125386 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 551 7 2 8 4.6 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
44430687 87604 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.3 N#CC1(c2ccc(Cl)c(Cl)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234514 87604 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.3 N#CC1(c2ccc(Cl)c(Cl)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
49863237 15049 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 625 11 3 4 6.9 C=C(CNC1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210755 15049 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 625 11 3 4 6.9 C=C(CNC1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
11454567 77166 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 485 11 1 7 1.1 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C(O)CN(C)C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087430 77166 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 485 11 1 7 1.1 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C(O)CN(C)C)CC2)c(C)c1 10.1021/jm2016057
60142167 125363 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 2.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)n1 nan
CHEMBL3648458 125363 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 2.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)n1 nan
11284303 65995 0 None -2 2 Human 5.5 pKi = 5.5 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 553 15 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
CHEMBL185068 65995 0 None -2 2 Human 5.5 pKi = 5.5 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 553 15 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
16220913 85112 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 515 8 3 5 4.3 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227828 85112 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 515 8 3 5 4.3 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
11467345 161390 0 None 489 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL415629 161390 0 None 489 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
57403175 69204 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3c(Cl)cccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934258 69204 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3c(Cl)cccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
44401834 123487 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 442 7 3 4 4.6 CNC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL362974 123487 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 442 7 3 4 4.6 CNC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
60142566 125375 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648469 125375 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
24895353 178365 3 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)c(F)c2)cc1 10.1021/jm800199h
CHEMBL470487 178365 3 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)c(F)c2)cc1 10.1021/jm800199h
11757682 121513 0 None -1949 4 Rat 7.5 pKi = 7.5 Binding
Binding affinity of the [35S]- radiolabeled compound to rat Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rat Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 121513 0 None -1949 4 Rat 7.5 pKi = 7.5 Binding
Binding affinity of the [35S]- radiolabeled compound to rat Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rat Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
44411392 140712 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 524 6 1 7 4.0 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(=O)OC)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL383089 140712 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 524 6 1 7 4.0 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(=O)OC)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
49863227 15035 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 2 4 6.9 CC(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210741 15035 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 2 4 6.9 CC(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
68869351 77155 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN([C@H]3CN4CCC3CC4)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087419 77155 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN([C@H]3CN4CCC3CC4)CC2)c(C)c1 10.1021/jm2016057
44569936 172604 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 627 14 1 6 5.9 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCCCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL452238 172604 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 627 14 1 6 5.9 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCCCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
11495796 73173 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 436 7 2 4 3.6 COC(=O)c1ccccc1-c1ccc(CNC(=O)C(C)(C)NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
CHEMBL201717 73173 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 436 7 2 4 3.6 COC(=O)c1ccccc1-c1ccc(CNC(=O)C(C)(C)NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
44391980 64670 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.4 COC(=O)C1=C(c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)CCCC1 10.1016/j.bmcl.2005.05.133
CHEMBL182331 64670 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.4 COC(=O)C1=C(c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)CCCC1 10.1016/j.bmcl.2005.05.133
11442712 84788 0 None -89 3 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225607 84788 0 None -89 3 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
11386138 84006 0 None -50 3 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL221998 84006 0 None -50 3 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
44392010 65513 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 435 7 2 7 3.7 COC(=O)c1ccccc1N1CCC(C)(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
CHEMBL183538 65513 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 435 7 2 7 3.7 COC(=O)c1ccccc1N1CCC(C)(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
60142569 125380 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 426 4 2 5 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648474 125380 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 426 4 2 5 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(N)CC2)no1 nan
60142837 125392 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 7 5.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648486 125392 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 7 5.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
16220988 85096 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1C(F)(F)F)c1ccccc1 10.1021/jm070055c
CHEMBL227697 85096 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1C(F)(F)F)c1ccccc1 10.1021/jm070055c
25181410 171638 1 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1021/jm1000776
CHEMBL447392 171638 1 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1021/jm1000776
60142166 125362 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)no1 nan
CHEMBL3648457 125362 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)no1 nan
44392040 172301 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 444 7 2 6 4.3 COC(=O)C1C2C=CC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL451549 172301 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 444 7 2 6 4.3 COC(=O)C1C2C=CC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
60142165 125361 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 496 5 2 5 3.3 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CC[C@@H]2NC(=O)C1(NC(=O)C(F)(F)F)COC1 nan
CHEMBL3648456 125361 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 496 5 2 5 3.3 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CC[C@@H]2NC(=O)C1(NC(=O)C(F)(F)F)COC1 nan
123884 2264 13 None -87 3 Human 6.4 pKi = 6.4 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
641 2264 13 None -87 3 Human 6.4 pKi = 6.4 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
CHEMBL80472 2264 13 None -87 3 Human 6.4 pKi = 6.4 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
16108967 83912 0 None 147 2 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 541 10 2 4 5.6 O=C(CC(NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL221691 83912 0 None 147 2 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 541 10 2 4 5.6 O=C(CC(NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
44391962 64389 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 420 7 2 6 4.4 COC(=O)c1ccccc1C1CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
CHEMBL181899 64389 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 420 7 2 6 4.4 COC(=O)c1ccccc1C1CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
10001334 69767 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 405 8 2 6 3.7 COCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL194018 69767 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 405 8 2 6 3.7 COCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
16220986 137079 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1Cl)c1ccccc1 10.1021/jm070055c
CHEMBL375709 137079 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1Cl)c1ccccc1 10.1021/jm070055c
57403174 69202 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934256 69202 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
60142963 125395 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125395 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
60143095 125396 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)cn1 nan
CHEMBL3648490 125396 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)cn1 nan
56835162 69206 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934260 69206 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
44411343 76896 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 9 1 6 4.8 C=CCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL208006 76896 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 9 1 6 4.8 C=CCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
60142704 125384 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 521 6 2 7 4.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
CHEMBL3648478 125384 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 521 6 2 7 4.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
11635365 173979 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
CHEMBL455642 173979 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
57342496 77148 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1c(Cl)cccc1Cl 10.1021/jm2016057
CHEMBL2087412 77148 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1c(Cl)cccc1Cl 10.1021/jm2016057
57382921 123887 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 545 6 2 8 2.5 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F nan
CHEMBL3639564 123887 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 545 6 2 8 2.5 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F nan
57383055 126682 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 572 9 2 7 4.5 Cc1nnc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)o1 nan
CHEMBL3657645 126682 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 572 9 2 7 4.5 Cc1nnc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)o1 nan
70693873 73485 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 576 8 2 5 5.4 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@H]1CC[C@H](CCC2=NCCN2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018863 73485 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 576 8 2 5 5.4 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@H]1CC[C@H](CCC2=NCCN2)CC1 10.1016/j.bmcl.2012.03.065
57342849 77149 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 11 1 7 2.0 COc1ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(Cl)c1 10.1021/jm2016057
CHEMBL2087413 77149 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 11 1 7 2.0 COc1ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(Cl)c1 10.1021/jm2016057
60142303 125368 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 6 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648462 125368 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 6 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60141466 125416 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 10 3.6 COc1cc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)on1 nan
CHEMBL3648510 125416 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 10 3.6 COc1cc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)on1 nan
16047262 76840 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 480 6 1 6 3.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207937 76840 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 480 6 1 6 3.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
60141185 125408 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 10 2.6 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)cn1 nan
CHEMBL3648502 125408 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 10 2.6 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)cn1 nan
11260745 77160 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.4 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CC3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087424 77160 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.4 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CC3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
46911684 15047 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 599 11 3 4 6.3 C=C(CNC(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210753 15047 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 599 11 3 4 6.3 C=C(CNC(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
57382797 126655 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 9 2 7 4.2 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)COC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
CHEMBL3657618 126655 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 9 2 7 4.2 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)COC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
23627458 73491 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 564 8 2 5 5.0 Cc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018869 73491 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 564 8 2 5 5.0 Cc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
16221228 165453 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 593 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL425490 165453 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 593 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
68870388 77171 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.4 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(CN3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087435 77171 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.4 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(CN3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
60141041 125402 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 548 6 2 8 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)COC2)no1 nan
CHEMBL3648496 125402 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 548 6 2 8 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)COC2)no1 nan
60141464 125414 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 9 3.4 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3cncnc3)CC2)n1 nan
CHEMBL3648508 125414 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 9 3.4 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3cncnc3)CC2)n1 nan
16221055 142204 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL389249 142204 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
44430688 87717 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.3 N#CC1(c2cccc(Cl)c2Cl)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234720 87717 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.3 N#CC1(c2cccc(Cl)c2Cl)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
10456579 124084 0 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 453 8 2 7 3.1 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CS(C)(=O)=O)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL364073 124084 0 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 453 8 2 7 3.1 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CS(C)(=O)=O)cc1 10.1016/j.bmcl.2005.02.077
16221226 143853 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 569 9 3 5 5.6 Cc1c(Cl)cccc1S(=O)(=O)N[C@H](CC(=O)N[C@@H]1CCOc2cc(CNC(C)(C)C)ccc21)c1ccccc1 10.1021/jm070055c
CHEMBL390603 143853 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 569 9 3 5 5.6 Cc1c(Cl)cccc1S(=O)(=O)N[C@H](CC(=O)N[C@@H]1CCOc2cc(CNC(C)(C)C)ccc21)c1ccccc1 10.1021/jm070055c
11663606 192972 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(C[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL530554 192972 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(C[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
11466010 83979 0 None -6 3 Rabbit 7.4 pKi = 7.4 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
CHEMBL221984 83979 0 None -6 3 Rabbit 7.4 pKi = 7.4 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
60142302 125367 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648461 125367 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
44569940 178144 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 514 11 2 5 3.1 O=C(O)CCNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL468493 178144 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 514 11 2 5 3.1 O=C(O)CCNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
57401426 69208 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cc(Cl)ccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934262 69208 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cc(Cl)ccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
49863233 15044 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 615 13 3 5 5.6 C=C(CNCCOC)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210750 15044 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 615 13 3 5 5.6 C=C(CNCCOC)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
57399670 69199 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
CHEMBL1934253 69199 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
24895449 186125 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 413 6 2 5 3.2 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)nc2)cc1 10.1021/jm800199h
CHEMBL488626 186125 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 413 6 2 5 3.2 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)nc2)cc1 10.1021/jm800199h
11620980 173130 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1C(F)(F)F 10.1016/j.bmcl.2008.07.108
CHEMBL453596 173130 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1C(F)(F)F 10.1016/j.bmcl.2008.07.108
24895355 186107 3 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccncc2)cc1 10.1021/jm800199h
CHEMBL488461 186107 3 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccncc2)cc1 10.1021/jm800199h
4227718 178458 7 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 394 6 2 4 3.7 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL471371 178458 7 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 394 6 2 4 3.7 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
4227718 178458 7 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 394 6 2 4 3.7 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm1000776
CHEMBL471371 178458 7 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 394 6 2 4 3.7 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm1000776
60142833 125388 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648482 125388 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
11641218 72870 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 462 7 2 4 4.1 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCCC2)cc1 10.1021/jm0511280
CHEMBL201210 72870 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 462 7 2 4 4.1 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCCC2)cc1 10.1021/jm0511280
60142707 125387 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 544 5 2 6 5.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648481 125387 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 544 5 2 6 5.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
11596635 86374 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 407 6 3 4 4.5 O=C(CC(F)(F)F)Nc1cccnc1NCC1CCC(O)(c2ccccc2)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL232237 86374 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 407 6 3 4 4.5 O=C(CC(F)(F)F)Nc1cccnc1NCC1CCC(O)(c2ccccc2)CC1 10.1016/j.bmcl.2007.03.059
44455147 97592 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 403 5 2 4 3.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@H](O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL273156 97592 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 403 5 2 4 3.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@H](O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
11635364 173980 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL455643 173980 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
70689675 73480 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 572 8 2 6 4.0 O=C(CC1COc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018858 73480 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 572 8 2 6 4.0 O=C(CC1COc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
57392728 69209 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3c(Cl)cccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934263 69209 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3c(Cl)cccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
70685470 73482 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.2 O=C(CC1Cc2ccccc2CN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018860 73482 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.2 O=C(CC1Cc2ccccc2CN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
44430685 87603 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 474 7 2 6 4.8 COC(=O)c1cccc(C2(C#N)CCC(CNc3ncccc3NC(=O)CC(F)(F)F)CC2)c1 10.1016/j.bmcl.2007.03.059
CHEMBL234513 87603 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 474 7 2 6 4.8 COC(=O)c1cccc(C2(C#N)CCC(CNc3ncccc3NC(=O)CC(F)(F)F)CC2)c1 10.1016/j.bmcl.2007.03.059
16221111 85100 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 571 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227721 85100 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 571 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
16221109 143503 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 9 3 5 6.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL390311 143503 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 9 3 5 6.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
88574478 126654 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 572 9 2 7 4.5 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
CHEMBL3657617 126654 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 572 9 2 7 4.5 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
57382880 126664 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 559 7 2 10 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4nnc(C)o4)COC3)c(F)c2)no1 nan
CHEMBL3657627 126664 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 559 7 2 10 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4nnc(C)o4)COC3)c(F)c2)no1 nan
11620871 165471 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL425588 165471 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411068 140368 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 512 8 1 6 4.2 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CCF)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL382228 140368 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 512 8 1 6 4.2 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CCF)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
57382795 126653 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 516 7 2 5 3.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)COC2)c(F)c1 nan
CHEMBL3657616 126653 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 516 7 2 5 3.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)COC2)c(F)c1 nan
60141038 125400 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 564 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
CHEMBL3648494 125400 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 564 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
16220916 85121 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 571 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227879 85121 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 571 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44411393 76639 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 466 6 2 6 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCNCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207122 76639 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 466 6 2 6 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCNCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
16221108 85092 0 None 27 2 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL227600 85092 0 None 27 2 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
57342847 77146 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 488 11 1 7 1.6 COc1ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm2016057
CHEMBL2087410 77146 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 488 11 1 7 1.6 COc1ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm2016057
44316621 81690 0 None 57 2 Human 8.3 pKi = 8.3 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1091 24 13 15 -4.9 NC(N)=NCCCC(N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)NC(C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990961s
CHEMBL216618 81690 0 None 57 2 Human 8.3 pKi = 8.3 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1091 24 13 15 -4.9 NC(N)=NCCCC(N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)NC(C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990961s
24895255 184784 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 556 10 3 5 5.0 O=C(NCCCN1CCCC(F)(F)C1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL486052 184784 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 556 10 3 5 5.0 O=C(NCCCN1CCCC(F)(F)C1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
9852117 77154 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN([C@@H]3CN4CCC3CC4)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087418 77154 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN([C@@H]3CN4CCC3CC4)CC2)c(C)c1 10.1021/jm2016057
16221161 143777 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 569 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL390539 143777 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 569 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
11071992 59991 0 None 3 2 Human 8.2 pKi = 8.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744082 59991 0 None 3 2 Human 8.2 pKi = 8.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
71229238 125409 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 9 2.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
CHEMBL3648503 125409 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 9 2.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
68868627 77163 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 484 12 0 7 1.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CCCN(C)C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087427 77163 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 484 12 0 7 1.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CCCN(C)C)CC2)c(C)c1 10.1021/jm2016057
60142438 125373 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648467 125373 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
16221057 142476 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL389478 142476 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
3102216 187574 6 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 493 6 2 5 4.2 COc1ccccc1NC(=O)CC1C(=O)Nc2ccccc2N1S(=O)(=O)c1c(C)cc(C)cc1C 10.1016/j.bmcl.2008.07.055
CHEMBL498679 187574 6 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 493 6 2 5 4.2 COc1ccccc1NC(=O)CC1C(=O)Nc2ccccc2N1S(=O)(=O)c1c(C)cc(C)cc1C 10.1016/j.bmcl.2008.07.055
57382963 126670 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4nccn4C)COC3)c(F)c2)no1 nan
CHEMBL3657633 126670 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4nccn4C)COC3)c(F)c2)no1 nan
44455255 94978 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 335 5 2 4 2.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)CO)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL257053 94978 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 335 5 2 4 2.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)CO)c(F)c1 10.1016/j.bmcl.2007.11.050
44411153 140686 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 7 1 6 4.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(F)(F)F)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL382909 140686 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 7 1 6 4.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(F)(F)F)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11553268 74031 0 None - 1 Human 4.3 pKi = 4.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 408 7 2 4 2.8 COC(=O)c1ccccc1-c1ccc(CNC(=O)CNC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
CHEMBL202463 74031 0 None - 1 Human 4.3 pKi = 4.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 408 7 2 4 2.8 COC(=O)c1ccccc1-c1ccc(CNC(=O)CNC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
60142169 125366 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 494 5 2 4 4.5 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648460 125366 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 494 5 2 4 4.5 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
44392133 65749 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 446 7 2 6 4.5 COC(=O)C1C2CCC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL183876 65749 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 446 7 2 6 4.5 COC(=O)C1C2CCC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
11555433 188392 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL508632 188392 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
10282203 187823 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 600 9 2 5 6.8 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL50208 187823 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 600 9 2 5 6.8 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
24895181 178364 3 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cc2F)cc1 10.1021/jm800199h
CHEMBL470486 178364 3 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cc2F)cc1 10.1021/jm800199h
11605512 173021 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 486 8 3 6 2.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.108
CHEMBL453340 173021 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 486 8 3 6 2.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.108
44587207 187555 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 573 6 2 6 4.4 O=Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL498489 187555 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 573 6 2 6 4.4 O=Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
44455074 154980 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL404246 154980 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
70688995 77084 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 611 14 5 6 2.9 Cc1c(Cl)ccc(S(=O)(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](CCCCN)C(=O)NCC2CCNCC2)c1Cl 10.1021/jm2016057
CHEMBL2087029 77084 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 611 14 5 6 2.9 Cc1c(Cl)ccc(S(=O)(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](CCCCN)C(=O)NCC2CCNCC2)c1Cl 10.1021/jm2016057
44455256 166510 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 361 5 2 4 2.6 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(O)CC2)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL428954 166510 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 361 5 2 4 2.6 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(O)CC2)c(F)c1 10.1016/j.bmcl.2007.11.050
11691896 186113 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 504 8 1 4 5.6 O=C(CCCS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL488512 186113 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 504 8 1 4 5.6 O=C(CCCS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
60142961 125393 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648487 125393 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
11466010 83979 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
CHEMBL221984 83979 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
44402298 71277 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 470 7 3 4 5.5 CNC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL196352 71277 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 470 7 3 4 5.5 CNC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
60142028 125360 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648455 125360 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60143096 125397 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 8 4.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
CHEMBL3648491 125397 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 8 4.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
60141323 125410 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
CHEMBL3648504 125410 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
70691812 73481 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.6 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018859 73481 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.6 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
11526655 185975 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 534 9 1 5 5.2 CO[C@@H](CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL487823 185975 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 534 9 1 5 5.2 CO[C@@H](CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
57382793 126651 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 502 6 2 5 3.6 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)COC2)c(F)c1 nan
CHEMBL3657614 126651 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 502 6 2 5 3.6 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)COC2)c(F)c1 nan
11953367 16875 12 None -19 2 Mouse 8.2 pKi = 8.2 Binding
Binding affinity to mouse bradykinin B1 receptorBinding affinity to mouse bradykinin B1 receptor
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm1000776
CHEMBL1254771 16875 12 None -19 2 Mouse 8.2 pKi = 8.2 Binding
Binding affinity to mouse bradykinin B1 receptorBinding affinity to mouse bradykinin B1 receptor
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm1000776
60142567 125378 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 7 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648472 125378 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 7 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142440 125374 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 6 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648468 125374 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 6 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
16221283 85093 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 609 12 3 6 4.9 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227655 85093 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 609 12 3 6 4.9 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
57342852 77151 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 492 10 1 6 2.3 Cc1c(Cl)cccc1S(=O)(=O)N(C)CCOCC(=O)N(C)Cc1ccc(C2=NCCN2)cc1 10.1021/jm2016057
CHEMBL2087415 77151 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 492 10 1 6 2.3 Cc1c(Cl)cccc1S(=O)(=O)N(C)CCOCC(=O)N(C)Cc1ccc(C2=NCCN2)cc1 10.1021/jm2016057
44430683 87557 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2ccc(F)cc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234297 87557 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2ccc(F)cc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
54585539 61856 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1777973 61856 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
44411338 137888 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 7 1 5 5.9 COC(=O)c1c(Cl)cccc1-c1ccc(CNc2cc(CN3CCCCC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL377440 137888 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 7 1 5 5.9 COC(=O)c1c(Cl)cccc1-c1ccc(CNc2cc(CN3CCCCC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411245 76927 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 542 7 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208210 76927 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 542 7 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
16102922 83804 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1F 10.1021/jm061094b
CHEMBL220978 83804 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1F 10.1021/jm061094b
70691813 73058 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 640 7 1 5 7.0 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2016601 73058 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 640 7 1 5 7.0 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1016/j.bmcl.2012.03.065
11546560 73573 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 434 7 2 4 3.4 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)cc1 10.1021/jm0511280
CHEMBL202089 73573 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 434 7 2 4 3.4 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)cc1 10.1021/jm0511280
60141183 125406 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 8 3.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)n1 nan
CHEMBL3648500 125406 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 8 3.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)n1 nan
12085225 77150 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 469 10 1 7 1.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccccc1C#N 10.1021/jm2016057
CHEMBL2087414 77150 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 469 10 1 7 1.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccccc1C#N 10.1021/jm2016057
56594373 65537 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
CHEMBL1835762 65537 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
56594241 65531 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1835756 65531 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
44411252 76522 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207011 76522 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895112 176137 3 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(F)c2)cc1 10.1021/jm800199h
CHEMBL460046 176137 3 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(F)c2)cc1 10.1021/jm800199h
12085129 77087 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 9 1 5 3.7 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087033 77087 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 9 1 5 3.7 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
44455181 96977 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 349 5 2 4 2.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@H](C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL270017 96977 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 349 5 2 4 2.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@H](C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
60142568 125379 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 526 5 2 6 5.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648473 125379 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 526 5 2 6 5.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
24970501 187539 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation counting
ChEMBL 516 8 2 5 3.4 Cc1ccc(S(=O)(=O)N2CCc3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.ejmech.2007.10.030
CHEMBL498394 187539 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation counting
ChEMBL 516 8 2 5 3.4 Cc1ccc(S(=O)(=O)N2CCc3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.ejmech.2007.10.030
11281533 64731 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL182378 64731 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
60141465 125415 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 539 6 2 9 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
CHEMBL3648509 125415 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 539 6 2 9 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
57383096 126685 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 589 9 2 8 4.4 Cc1nnsc1C(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(Cl)c3OCC(F)F)cc2F)COC1 nan
CHEMBL3657648 126685 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 589 9 2 8 4.4 Cc1nnsc1C(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(Cl)c3OCC(F)F)cc2F)COC1 nan
71456247 78582 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 457 7 2 5 5.3 COC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL2113085 78582 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 457 7 2 5 5.3 COC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
16102897 86797 13 None -7 3 Rabbit 8.1 pKi = 8.1 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL232943 86797 13 None -7 3 Rabbit 8.1 pKi = 8.1 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
60142963 125395 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125395 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
44432178 86955 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 5 4.9 Cc1noc(-c2ccc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1016/j.bmcl.2007.04.040
CHEMBL233350 86955 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 5 4.9 Cc1noc(-c2ccc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1016/j.bmcl.2007.04.040
16220990 85107 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL227786 85107 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/jm070055c
659 2842 13 None 1 2 Rhesus macaque 8.1 pKi = 8.1 Binding
Binding affinity to monkey bradykinin B1 receptorBinding affinity to monkey bradykinin B1 receptor
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
9831083 2842 13 None 1 2 Rhesus macaque 8.1 pKi = 8.1 Binding
Binding affinity to monkey bradykinin B1 receptorBinding affinity to monkey bradykinin B1 receptor
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
CHEMBL273869 2842 13 None 1 2 Rhesus macaque 8.1 pKi = 8.1 Binding
Binding affinity to monkey bradykinin B1 receptorBinding affinity to monkey bradykinin B1 receptor
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
44411091 76734 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 465 6 1 5 5.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCCCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207539 76734 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 465 6 1 5 5.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCCCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895352 178595 3 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 428 6 2 4 4.3 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(Cl)cc2)cc1 10.1021/jm800199h
CHEMBL472303 178595 3 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 428 6 2 4 4.3 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(Cl)cc2)cc1 10.1021/jm800199h
44455148 96956 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 377 6 2 4 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL269948 96956 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 377 6 2 4 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
24895183 187701 3 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccnc2)cc1 10.1021/jm800199h
CHEMBL500312 187701 3 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccnc2)cc1 10.1021/jm800199h
44411252 76522 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207011 76522 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11375297 92126 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 490 6 3 5 3.7 COC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
CHEMBL243467 92126 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 490 6 3 5 3.7 COC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
44392113 65520 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 432 7 2 6 4.2 COC(=O)C1C2CCC(C2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL183562 65520 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 432 7 2 6 4.2 COC(=O)C1C2CCC(C2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
11670114 72727 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 476 7 2 4 4.5 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCCCC2)cc1 10.1021/jm0511280
CHEMBL201107 72727 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 476 7 2 4 4.5 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCCCC2)cc1 10.1021/jm0511280
57390933 69201 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(Cl)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934255 69201 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(Cl)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
16220989 141955 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL389054 141955 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1 10.1021/jm070055c
49863231 15042 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 585 10 2 4 5.9 C=C(CN(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210748 15042 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 585 10 2 4 5.9 C=C(CN(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
10187167 77172 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 539 9 2 6 2.0 Cc1c(Cl)ccc(S(=O)(=O)N(C)CC(=O)NCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087436 77172 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 539 9 2 6 2.0 Cc1c(Cl)ccc(S(=O)(=O)N(C)CC(=O)NCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
44411372 76933 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 506 8 1 6 4.4 C=CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL208241 76933 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 506 8 1 6 4.4 C=CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
659 2842 13 None -1 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
9831083 2842 13 None -1 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
CHEMBL273869 2842 13 None -1 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
16220915 85095 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 557 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227690 85095 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 557 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
57383056 126683 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 573 9 2 8 3.9 Cc1nnc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)o1 nan
CHEMBL3657646 126683 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 573 9 2 8 3.9 Cc1nnc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)o1 nan
23627583 73496 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 655 9 1 5 7.5 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)N[C@H]1CC[C@H](CCN2CCCC2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018874 73496 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 655 9 1 5 7.5 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)N[C@H]1CC[C@H](CCN2CCCC2)CC1 10.1016/j.bmcl.2012.03.065
16221110 84597 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 543 10 3 5 5.0 CCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL224071 84597 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 543 10 3 5 5.0 CCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44411092 76668 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 6 1 6 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCOCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207178 76668 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 6 1 6 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCOCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11363856 84100 0 None -162 3 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
CHEMBL222038 84100 0 None -162 3 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
44411297 76993 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 354 5 1 4 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208538 76993 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 354 5 1 4 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
57382964 126671 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cn(C)cn4)COC3)c(F)c2)no1 nan
CHEMBL3657634 126671 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cn(C)cn4)COC3)c(F)c2)no1 nan
44316620 2081 0 None -19 2 Human 7.1 pKi = 7.1 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
656 2081 0 None -19 2 Human 7.1 pKi = 7.1 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
CHEMBL408846 2081 0 None -19 2 Human 7.1 pKi = 7.1 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
44455107 97532 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 6 2 4 3.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL272791 97532 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 6 2 4 3.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
16220917 165771 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 543 9 2 5 5.0 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL427279 165771 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 543 9 2 5 5.0 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44411252 76522 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207011 76522 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
12085227 77153 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 528 11 1 7 2.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccc(OC(F)(F)F)cc1 10.1021/jm2016057
CHEMBL2087417 77153 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 528 11 1 7 2.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccc(OC(F)(F)F)cc1 10.1021/jm2016057
10281725 963 0 None -7 2 Human 7.1 pKi = 7.1 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 10.1021/jm034020y
666 963 0 None -7 2 Human 7.1 pKi = 7.1 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 10.1021/jm034020y
CHEMBL299164 963 0 None -7 2 Human 7.1 pKi = 7.1 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 10.1021/jm034020y
44587206 187554 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 575 6 3 6 4.0 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CO)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL498488 187554 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 575 6 3 6 4.0 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CO)ccc21 10.1016/j.bmcl.2008.07.055
44402279 70819 0 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 403 8 2 5 4.9 CCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL195617 70819 0 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 403 8 2 5 4.9 CCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
44455145 97450 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 5 2 4 3.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(C)(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL272491 97450 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 5 2 4 3.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(C)(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
44411134 76934 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 480 6 1 6 3.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2cc(C(=O)N3CCN(C)CC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208247 76934 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 480 6 1 6 3.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2cc(C(=O)N3CCN(C)CC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411135 76935 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 451 7 1 5 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(CN3CCCCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208248 76935 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 451 7 1 5 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(CN3CCCCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
23627523 73494 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 654 8 2 5 6.3 O=C(CC1c2cc(F)cc(F)c2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018872 73494 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 654 8 2 5 6.3 O=C(CC1c2cc(F)cc(F)c2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
60142304 125369 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 7 3.0 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648463 125369 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 7 3.0 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142441 125377 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 6 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648471 125377 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 6 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60142705 125385 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 8 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3nnc(C)o3)CC2)no1 nan
CHEMBL3648479 125385 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 8 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3nnc(C)o3)CC2)no1 nan
44411058 76829 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 536 9 1 6 5.2 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CCC(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207913 76829 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 536 9 1 6 5.2 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CCC(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11752335 77167 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(N3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087431 77167 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(N3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
25181411 188694 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 587 14 1 6 5.0 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN(C)C)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL512111 188694 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 587 14 1 6 5.0 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN(C)C)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
44455228 94966 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 471 5 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C(O)(C(F)(F)F)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL257016 94966 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 471 5 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C(O)(C(F)(F)F)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
10120979 101130 0 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccccn4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL298860 101130 0 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccccn4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
122227 1346 27 None 6 3 Human 9.4 pKd None 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None None
3825 1346 27 None 6 3 Human 9.4 pKd None 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None None
644 1346 27 None 6 3 Human 9.4 pKd None 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None None
CHEMBL264100 1346 27 None 6 3 Human 9.4 pKd None 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None None
119376 1803 41 3H-BRADYKININ -54954 27 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 393 7 1 6 1.6 O=C(c1cn(c2c1cccc2)C)OCC1CCN(CC1)CCNS(=O)(=O)C None
247 1803 41 3H-BRADYKININ -54954 27 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 393 7 1 6 1.6 O=C(c1cn(c2c1cccc2)C)OCC1CCN(CC1)CCNS(=O)(=O)C None
CHEMBL33884 1803 41 3H-BRADYKININ -54954 27 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 393 7 1 6 1.6 O=C(c1cn(c2c1cccc2)C)OCC1CCN(CC1)CCNS(=O)(=O)C None
44208932 140163 6 UNDEFINED -120226 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 475 5 1 3 6.8 Cc1ccc(Cn2nc(C(=O)NC3C4(C)CCC(C4)C3(C)C)cc2-c2ccc(Cl)c(C)c2)cc1 None
CHEMBL381689 140163 6 UNDEFINED -120226 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 475 5 1 3 6.8 Cc1ccc(Cn2nc(C(=O)NC3C4(C)CCC(C4)C3(C)C)cc2-c2ccc(Cl)c(C)c2)cc1 None
None 214348 0 3H-BRADYKININ -1 13 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 164 3 1 3 0.8 C1CNC1COC2=CN=CC=C2 None
122173054 216002 0 None 1 6 Rat 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 1304 30 18 17 -4.4 N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CC=CS1)C(=O)N[C@@H](CO)C(=O)N1CC2=C(C[C@@H]1C(=O)N1[C@H]3CCCC[C@H]3C[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C=CC=C2 None
122173054 216002 0 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 1304 30 18 17 -4.4 N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CC=CS1)C(=O)N[C@@H](CO)C(=O)N1CC2=C(C[C@@H]1C(=O)N1[C@H]3CCCC[C@H]3C[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C=CC=C2 None
3812 708 37 None -309029 6 Human 4.0 pKi = 4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
439201 708 37 None -309029 6 Human 4.0 pKi = 4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
649 708 37 None -309029 6 Human 4.0 pKi = 4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
CHEMBL406291 708 37 None -309029 6 Human 4.0 pKi = 4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
DB12126 708 37 None -309029 6 Human 4.0 pKi = 4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
123643 3763 0 None -1 2 Rat 5.1 pKi = 5.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
639 3763 0 None -1 2 Rat 5.1 pKi = 5.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
3812 708 37 None -19498 6 Rat 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
439201 708 37 None -19498 6 Rat 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
649 708 37 None -19498 6 Rat 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL406291 708 37 None -19498 6 Rat 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
DB12126 708 37 None -19498 6 Rat 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
123643 3763 0 None 1 2 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
639 3763 0 None 1 2 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
164234 3409 0 None -35 2 Human 5.7 pKi = 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
164234 3409 0 None -35 2 Human 5.7 pKi = 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8996175
643 3409 0 None -35 2 Human 5.7 pKi = 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
643 3409 0 None -35 2 Human 5.7 pKi = 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8996175
5311111 2135 0 None -44 3 Mouse 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8302267
5311111 2135 0 None -44 3 Mouse 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
650 2135 0 None -44 3 Mouse 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8302267
650 2135 0 None -44 3 Mouse 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
5311111 2135 0 None -25 3 Rat 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
650 2135 0 None -25 3 Rat 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
3812 708 37 None -616 6 Mouse 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
439201 708 37 None -616 6 Mouse 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
649 708 37 None -616 6 Mouse 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
CHEMBL406291 708 37 None -616 6 Mouse 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
DB12126 708 37 None -616 6 Mouse 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
662 3611 0 None - 1 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 14747609
9853583 3611 0 None - 1 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 14747609
CHEMBL2021721 3611 0 None - 1 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 14747609
642 2266 17 None 12 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
642 2266 17 None 12 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
CHEMBL384721 2266 17 None 12 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
CHEMBL384721 2266 17 None 12 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
661 3215 0 None 63 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
654 560 0 None 10 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
654 560 0 None 10 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8995263
654 560 0 None 10 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
655 561 0 None - 1 Human 9.7 pKi = 9.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16368899
655 561 0 None - 1 Human 9.7 pKi = 9.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9650825
122227 1346 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
122227 1346 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8735629
122227 1346 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
122227 1346 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
3825 1346 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
3825 1346 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8735629
3825 1346 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
3825 1346 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
644 1346 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
644 1346 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8735629
644 1346 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
644 1346 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
CHEMBL264100 1346 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL264100 1346 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8735629
CHEMBL264100 1346 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
CHEMBL264100 1346 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
658 2816 0 None 3981 2 Human 10.2 pKi None 10.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8995263
665 957 2 None 1023 2 Human 10.5 pKi None 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
9916412 957 2 None 1023 2 Human 10.5 pKi None 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
CHEMBL189123 957 2 None 1023 2 Human 10.5 pKi None 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
5128451 1348 0 None -2818 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
5128451 1348 0 None -2818 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
646 1348 0 None -2818 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
646 1348 0 None -2818 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
100978427 1347 0 None -35 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
645 1347 0 None -35 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
155817380 1361 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
648 1361 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
102061602 1360 0 None - 1 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
647 1360 0 None - 1 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
651 260 0 None - 1 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
667 1934 32 None -5128 6 Rat 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
71364 1934 32 None -5128 6 Rat 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL2028850 1934 32 None -5128 6 Rat 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
DB06196 1934 32 None -5128 6 Rat 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
123884 2264 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
123884 2264 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
123884 2264 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
123884 2264 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9203620
123884 2264 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
641 2264 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
641 2264 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
641 2264 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
641 2264 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9203620
641 2264 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
CHEMBL80472 2264 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL80472 2264 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
CHEMBL80472 2264 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
CHEMBL80472 2264 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9203620
CHEMBL80472 2264 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
653 559 0 None -316 4 Mouse 6.6 pKi None 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
667 1934 32 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
667 1934 32 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
71364 1934 32 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
71364 1934 32 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
CHEMBL2028850 1934 32 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL2028850 1934 32 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
DB06196 1934 32 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
DB06196 1934 32 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
101607591 2389 0 None - 1 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
637 2389 0 None - 1 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
3081308 2815 0 None -15 2 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8995263
657 2815 0 None -15 2 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8995263
44316620 2081 0 None -19 2 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10882364
656 2081 0 None -19 2 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10882364
CHEMBL408846 2081 0 None -19 2 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10882364
665 957 2 None -1023 2 Rat 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
9916412 957 2 None -1023 2 Rat 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
CHEMBL189123 957 2 None -1023 2 Rat 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
164234 3409 0 None 35 2 Rat 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
643 3409 0 None 35 2 Rat 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
100978427 1347 0 None 35 2 Rat 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
645 1347 0 None 35 2 Rat 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
661 3215 0 None -63 2 Mouse 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
663 1345 0 None -1 3 Human 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
663 1345 0 None -1 3 Human 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
663 1345 0 None -1 3 Rat 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
640 3557 0 None - 1 Human 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
123884 2264 13 None -7 3 Rat 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
641 2264 13 None -7 3 Rat 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL80472 2264 13 None -7 3 Rat 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
663 1345 0 None 1 3 Mouse 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
653 559 0 None -15 4 Human 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856115
653 559 0 None -15 4 Human 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
5311111 2135 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
5311111 2135 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
5311111 2135 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
650 2135 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
650 2135 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
650 2135 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
659 2842 13 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15341478
659 2842 13 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15685199
9831083 2842 13 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15341478
9831083 2842 13 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15685199
CHEMBL273869 2842 13 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15341478
CHEMBL273869 2842 13 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15685199
642 2266 17 None -12 2 Mouse 8.1 pKi None 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
CHEMBL384721 2266 17 None -12 2 Mouse 8.1 pKi None 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
20814785 3142 0 None - 1 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 577 11 3 7 6.6 Clc1ccc(cc1)CNC(=O)C(Nc1nc(NCc2cccc(c2)Cl)nc(c1)n1ccnc1)CC1CCCCC1 10596850
660 3142 0 None - 1 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 577 11 3 7 6.6 Clc1ccc(cc1)CNC(=O)C(Nc1nc(NCc2cccc(c2)Cl)nc(c1)n1ccnc1)CC1CCCCC1 10596850
654 560 0 None -17 3 Mouse 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
123884 2264 13 None 7 3 Mouse 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
641 2264 13 None 7 3 Mouse 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
CHEMBL80472 2264 13 None 7 3 Mouse 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
654 560 0 None -10 3 Rat 8.6 pKi None 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
122227 1346 27 None -6 3 Rat 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
3825 1346 27 None -6 3 Rat 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
644 1346 27 None -6 3 Rat 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL264100 1346 27 None -6 3 Rat 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
122227 1346 27 None -6 3 Mouse 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
3825 1346 27 None -6 3 Mouse 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
644 1346 27 None -6 3 Mouse 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
CHEMBL264100 1346 27 None -6 3 Mouse 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
10281725 963 0 None 7 2 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
666 963 0 None 7 2 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
CHEMBL299164 963 0 None 7 2 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
10281725 963 0 None -7 2 Human 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
666 963 0 None -7 2 Human 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
CHEMBL299164 963 0 None -7 2 Human 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
5128451 1348 0 None 2818 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
646 1348 0 None 2818 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
652 556 0 None - 1 Human 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16368899
636 3556 0 None - 1 Human 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052